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RÉSUMÉ 
Un grand nombre de médicaments, de produits naturels et de substances 
endogènes subissent les transformations métaboliques en formant des « métabolites 
réactifs » qui peuvent réagir avec des biomolécules, altérer leurs fonctions 
moléculaires et affecter des processus biologiques. Le foie joue un rôle prédominant 
dans le métabolisme, et les protéines hépatiques sont souvent ciblées par les 
métabolites réactifs causant potentiellement l'hépatotoxicité. L'identification de ces 
protéines est donc essentielle pour mieux comprendre les mécanismes reliés à cette 
toxicité. Plusieurs essais ont été effectués afin d'étudier les liaisons covalentes sur les 
protéines et identifier leurs cibles potentielles. Toutefois, la faible abondance des 
protéines modifiées, les problèmes techniques, et l'absence de méthodes appropriées 
pour analyser des échantillons biologiques ont été les défis limitant le progrès de cette 
recherche. Parmi les techniques analytiques employées en bioanalyse, la 
spectrométrie de masse (MS) est devenue la méthode de choix en raison de sa 
capacité exceptionnelle d'acquérir des grandes quantités de données qualitatives et 
quantitatives à partir de mélanges complexes. La spectrométrie de masse en tandem 
(MS/MS) couplée à la chromatographie liquide (LC) a permis 1 'analyse efficace des 
échantillons protéiques avec une grande sensibilité dans la recherche protéomique. 
La thématique principale de cette thèse a été le développement d 'une 
approche analytique pour identifier les protéines cibles des métabolites réactifs et 
leurs sites de modifications par LC-MS/MS. Cette recherche a été organisée en trois 
phases, selon un des principaux défis posés dans ce type d ' analyse : (1) préparation 
d'échantillon, (2) détection par LC-MS/MS, et (3) traitement des données. 
Premièrement, la méthode analytique a été optimisée pour l' analyse protéomique 
dans les fractions S9 et microsomales de foie de rat, souris, et humain. Puis, des 
microsomes de rat ont été incubés avec l' acétaminophène, formant un métabolite 
réactif, afin de générer des adduits protéiques, puis analysés par la méthode 
développée en utilisant une stratégie de traitement de données multi-étage. Une 
approche plus ciblée a été également établie afin d 'étudier la modification covalente 
de métalloprotéase matricielle 13 par le produit de peroxydation lipidique, 
4-hydroxynonénal. 
Mots-clés : liaison covalente, métabolites réactifs, LC-MS/MS, microsomes de foie 
de rat, acétaminophène, métalloprotéase matricielle 13, 4-hydroxynonénal 
ABSTRACT 
Numerous drugs, naturally-occurring products and endogenous compounds 
undergo metabolic transformations to form "reactive metabolites". These species can 
covalently bind to biomolecules, including proteins, altering their molecular functions 
affecting biological processes. The liver plays a predominant role in metabolic 
transformations and hepatic proteins are often targeted by reactive metabolites 
potentially leading to hepatotoxicity. Identification of these proteins is therefore 
important to understand the mechanisms involved in this type of toxicity. 
Several previous attempts have been made to study protein covalent binding 
reactions and identify their potential targets. However, low abundance of the 
modified proteins, technological issues, and lack of appropriate methods for efficient 
analysis of complex biological samples are challenges that have limited the progress 
of this research. Amongst the analytical techniques employed in bioanalysis, mass 
spectrometry (MS) has become the method of choice due to its incredible capacity to 
acquire large amount of qualitative and quantitative information from complex 
mixtures. Tandem mass spectrometry (MS/MS) in combination with liquid 
chromatography (LC) has enabled efficient analysis of protein samples with high 
sensitivity fostering new possibilities in proteomics research. 
The main theme of this dissertation was to systematically develop an 
analytical approach to identify reactive metabolite protein targets and their sites of 
modification using LC-MS/MS. This research was designed in three phases to 
address the main challenges posed in this type of analysis: (1) sample preparation, (2) 
LC-MS/MS detection, and (3) data analysis strategies. The analytical method was 
first optimized for proteomics analysis of rat, mouse and human liver S9 and 
rnicrosomal fractions. Next, rat liver microsomes were incubated with 
acetaminophen, known to form a reactive metabolite, to produce protein adducts, 
which were then subjected to the developed method and identified using a multi-stage 
data processing work:flow. A more targeted approach was also established to study 
covalent binding of matrix metalloproteinase 13 by the lipid peroxidation product, 
4-hydroxynonenal . 
Keywords: covalent binding, reactive metabolites, LC-MS/MS, rat liver microsomes, 
acetaminophen, matrix metalloproteinase 13, 4-hydroxynonenal 
CHAPTER ONE 
INTRODUCTION 
Most compounds which a living organism is exposed to are changed upon 
excre6on. The sophisticated molecular machinery of the cell encompasses a myriad 
of highly specialized mechanisms to cope with different groups of chemicals that 
bind to or cross its plasma membrane. These biotransformations however, are not 
necessarily flawless , and under certain conditions, can jeopardize cell homeostasis 
and survival. 
Scientific and technological breakthroughs in the last decades gave rise to 
novel areas of research that enabled a clearer understanding of biological 
mechanisms. Bioanalytical chemistry, or bioanalysis, is a sub-discipline of analytical 
chemistry that concentrates on qualitative and quantitative analysis of small and large 
molecules in biological systems using efficient instrumental techniques such as 
chromatographie and electrophoretic separation, ligand binding assays, mass 
spectrometry (MS), and nuclear magnetic resonance (NMR). The expanding role of 
bioanalytical chemistry in academie and industrial environrnents has made it an 
important area of research for scientists in chemistry and biochemistry. The 
exceptional capacity of bioanalytical techniques in providing high-quality data on the 
chemical composition of complex matrices have, in recent years, facilitated numerous 
scientific endeavors that depend on accurate measurements in biological samples, 
such as pharmacological, molecular toxicology, forensic, and environmental research. 
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This introductory chapter will briefly discuss the chemistry of intrinsically 
reactive products of biotransforrnation, known as the "reactive metabolites", which 
are the major focus of this dissertation, followed by a short overview on bioanalytical 
techniques used in this work. The chapter will be concluded by discussing current 
challenges in this area and how they are addressed in this thesis. 
1.1 Molecular Toxicology of Reactive Metabolites 
Metabolism usually produces "non-toxic" metabolites, which are relatively 
polar and can readily be excreted from the living organism and thus detoxified. 
However, certain xenobiotics and endogenous compounds form highly reactive 
metabolites, wbich can interact with vital intracellular macromolecules, and result in 
toxicity. In the 1940s and 1950s, James and Elizabeth Miller demonstrated for the 
first time that N,N-dimetbyl-4-aminoazobenzene (DAB), a hepatocarcinogen in rats, 
would covalently bind to proteins and nucleic acids through a process they called 
"metabolic activation". They also demonstrated tbat covalent binding of these species 
was an essential part of the carcinogenic process (Conney, 200 1). 
Norrnally, reactive metabolites can be detoxified via a series of enzymatically-
assisted covalent reactions to endogenous scavenger molecules known as the 
"conjugation reactions". However, overabundance or excessive reactivity may help 
these chemicals skip or saturate designated conjugation mechanisms to trigger 
undesired reactions within the tissue depending on the nature of the reactive species 
and the physiology of the organism (Attia, 201 0) . 
The following section briefly discusses major intracellular sources of the 
reactive metabolites, their formation and fate within the organism, the chemistry of 
the covalent binding reaction, and its preferred molecular targets. 
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1.1.1 Biologie Oxidation and Oxidative Stress 
Oxygen is the vital element of aerobic life in which oxidation of organic 
compounds is exploited for the release of free energy. However, not only is 0 2 fatal 
to anaerobie bacteria, due to its high chemical reactivity, excess oxygen is also toxic 
to aerobic organisms. Even at non-toxic concentrations, aerobic organisms must deal 
with the toxic consequences of partial oxidation-reduction reactions, that is the 
formation of reactive oxygen-derived compounds (Joseph y, 1997). 
An oxidation-reduction, or redox, reaction is of the general form 
which can be written as two separate yet dependent and complementary half-reactions 
involving an electron-donor (reductant) and electron-acceptor ( oxidant) species : 
The direction of a redox reaction depends on which spec1es bas a greater 
tendency (or potential, E0) to accept the available electrons. The potential difference 
(Mo) of a redox system is an important thermodynamic factor, and determines if a 
redox reaction can proceed spontaneously. 
In living organisms, redox reactions are catalyzed by "oxidoreductases", a 
large class of enzymes th at utilize pyridine- or flavin-cofactors (Figure 1.1) to trans fer 
electrons from one molecule to another. Oxidoreductases are generally classified into 
four groups (oxidases, dehydrogenases, hydroperoxidases, and oxygenases) and 
reduce or oxidize a wide range of organic functional groups and inorganic elements 
(Murray et al. , 2009). 
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Redox reactions are also the core of the electron transport chain (ETC), the 
essential component of photosynthesis and cellular respiration in prokaryotic and 
eukaryotic cells. In eukaryotes, the ETC transfers electrons from NADH to Oz 
(Mo = 1.1 V) through three large protein complexes: NADH-ubiquinone 
oxidoreductase (Complex I), ubiquinone-cytochrome c oxidoreductase (Complex III), 
and cytochrome c oxidase (Complex IV). This electron transfer creates an 
electrochemical proton gradient across the inner mitochondrial membrane that drives 
adenosine triphosphate (A TP) synthesis (Murray et al. , 2009). 
e X:NH2 0 
1 N ""<:::, O=r-O~<N 1 N) 
1 H H o=P-o6 1 H H 
~ HO OH 
H2c 
1 
H-C-OH 
1 
H-C-OH 
1 
H- C - OH 
1 
H2C 
1 
1 # .<9 NH 
H,cxxNx;Nyo 
H3C N 
0 
Figure 1.1 Chemical structure of flavin adenine dinucleotide (F AD) (left) and 
nicotinamide adenine dinucleotide (NAD) (right) cofactors involved in biologie redox 
reactions 
The final stage of the ETC involves a four-step reduction of molecular oxygen 
(O z) to water: 
OH 
-0.33 v 0.89V 0.38 v 2.32 v 
5 
The above reduction reaction bas a very large positive ~Eo value and is 
therefore thermodynamically favorable in the presence of almost any biochemical 
reductant. In the cell, the transfer of four electrons to 0 2 involves iron and copper 
ions, and is accomplished in a controlled and concerted manner; however, the release 
of intermediary products (superoxide, peroxide, hydroxyl radical) cannot be fully 
avoided (Josephy, 1997). Oxygen reduction intermediates are extremely reactive and 
immediately react with other species to give rise to radical and non-radical 
metabolites, including "reactive oxygen species (ROS)" and "reactive nitrogen 
species (RNS)", representing the major sources of oxidative and nitroxidative stress. 
A list of the most important reactive oxygen metabolites is given in Table 1.1 (Kohen 
and Nyska, 2002). 
Table 1.1 Radical and non-radical oxygen metabolites 
Radical Non-radical 
Oxygen bi-radical (02••) 
Superoxide ion (02·-) 
Hydroxyl (HO•) 
Peroxyl (ROO•) 
Alkoxyl (RO•) 
Nitric oxide (NO•) 
Hydrogen peroxide (H20 2) 
Organic peroxide (ROOH) 
Hypochlorous acid (HOC!) 
Ozone (03) 
Aldehydes (RCOH) 
Singlet oxygen (10 2) 
Peroxynitrite (ONOOH) 
Oxidative stress can be induced either directly by "primary ROS" or indirectly 
via partial oxidation of biomolecules, such as lipids and carbohydrates. The products 
of these reactions, which are usually classified under "secondary ROS", are also 
highly reactive towards biomolecules such as proteins and nucleic acids. Secondary 
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ROS include malondialdehyde (MDA), 4-hydroxy-2-(E)-nonenal (HNE), 4-oxo-2-
(E)-nonenal (ONE), and 2-oxoaldehydes such as glyoxal (GO) and methylglyoxal 
(MGO). The chemistry of these reactions will be discussed in more details in Chapter 
6. Free radical chain reactions, such as autoxidation reactions, metal ions ( especially 
iron, copper, and cobalt), and certain oxidoreductases, including NADPH oxidase, 
xanthine oxidase, superoxide dismutase, and myeloperoxidase are other key players 
of ROS formation and oxidative stress. Figure 1.2 summarizes chemical species, 
enzymes and the mechanisms involved in these processes (Chondrogianni et al. , 
2014). 
H10 + 0 2 
ETC 
1 
Caralase 
:.\IPO SOD 
\'OX and X.AO wT --c-r--+ ci~ ..................... J ..................... . 
Autoxidation 
·oH + -oH -------..:. Proreins, R'IA, D\'A 
u,;,, c.,,~~~ 1 ___________ ~r~~-~~r·~~~~·r -, 
1 i 00 00 1 
: Ro· 1 Roo· --+--+--+ H Jl A H oH o / : 
1 :\IDA K\t: GO and :\!GO 1 
1 1 
1 Secouda1TROS 1 1----~-----------------------------J 
Figure 1.2 Key players of oxidative stress and potential molecular targets. 
ETC: electron transfer chain; GO: glyoxal; HNE: 4-hydroxy-2-(E)-nonenal; MDA: 
malondialdehyde; MGO: methylglyoxal; MPO: myeloperoxidase; NOX: NADPH 
oxidase; ROS : reactive oxygen species; SOD : Superoxidase dismutase; XAO: 
xanthine oxidase. M2+ is a bivalent metal ion. 
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Living organisms have adapted to continuously control and tightly regulate 
the presence of oxygen metabolites. This is extremely important for maintaining vital 
cellular and biochemical functions and any interference or imbalance leading to an 
uncontrolled state can cause excessive oxidative stress and cellular damage. 
1.1.2 Xenobiotic Metabolism 
The Unified Medical Language System classifies any chemical substance that 
is foreign to the biological system including natural products, drugs, environmental 
agents, etc. as a "xenobiotic".1 
In animais, xenobiotics enter the body through digestion, inhalation, or 
intracutaneously, and exit via urine, faeces, sweat or breath. Most environmentally 
persistent xenobiotics are hydrophobie, thus can easily cross biological membranes. 
For the same reason, these compounds cannot be removed by ultrafiltration of the 
blood in the kidneys . Hydrophobie xenobiotics can sometimes be extracted by the 
li ver and excreted into faeces through bile; yet the majority of these species tend to be 
passively readsorbed and thus cannot be effectively eliminated. This problem is 
solved by metabolic transformation of lipophilic xenobiotics into more water-soluble 
conjugates (Josephy, 1997). 
One of the liver ' s mam physiological functions is the metabolism of 
xenobiotics into hydrophilic metabolites through a series of oxidation, reduction, or 
bydrolysis (phase I) followed by conjugation reactions (phase II) . Cytochrome P450 
(CYP) enzymes play a predominant role in the phase I metabolism of a large variety 
of chemical compounds (Williams, 2006). CYPs represent a group of heme-
containing proteins that bind two atoms of oxygen, to form a molecule of water 
1 The word "xenos" is the Greek equivalent for "stranger". 
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together with the production of a metabolite, which is generally more polar than the 
original substrate, through the following reaction: 
CYP 
RH + 0 2 + NADPH + W 
CYPs often catalyze hydroxylation, dealkylation, oxidation, ring-opening, and 
reduction reactions and, based on the nature of the electron transfer proteins, are 
usually classified into mitochondrial, microsomal, and bacterial P450 systems 
(Hanukoglu, 1996). ln human, more than 50 CYP isoforrns have been isolated among 
which the CYPl , CYP2 and CYP3 families are known to be more involved in 
xenobiotic metabolism, althougb most CYPs also cata lyze metabolic conversion of a 
variety of endogenous compounds such as fatty acids, steroids, vitamins, bile acids 
and hormones. In higber animais, CYPs are localized in nearly all organs, especially 
the liver, small intestine, skin, nasal epitheli a, lung and kidney. However, the highest 
concentration bas been found in the liver (300 pmol/mg microsomal protein) and the 
intestinal epithelia (20 pmollmg microsomal protein) (Martignoni et al. , 2006). 
Table 1.2 and Table 1.3 summarize human CYPs based on their substrates 
(Ioannides, 2008). 
Table 1.2 Human cytochrome P450 enzymes and their substrates 
Substrates CYP involved 
Fatty Acids 4All , 4B1 , 4F12, 212 
Eicosanoids 4F2, 4F3, 4F8, 5A1 , 8Al 
Vi ta mins 24Al , 26A1 , 26B1 , 27B1 
Steroids 7Al , 7B1 , 8Bl , 11Al , llBl , 11B2, 17Al , 19A1 , 21A2, 27Al , 
39Al , 46Al , 51Al 
Xenobiotics 1Al , 1A2, lBl , 2A6, 2Al3, 2B6, 2C8, 2C9, 2C18, 2C19, 2D6, 2El , 
2Fl , 3A4, 3A5, 3A7 
9 
Table 103 Selected human cytochrome P450 xenobiotic substrates 
CYP Substrates 
CYP1A2 
CYP2A6 
CYP2B6 
CYP2C9 
CYP2C19 
CYP2D6 
CYP2El 
acetaminophen, antipyrine, caffeine, clozapine, clomipramine, 
imipramine, phenacetin, propranolol, tacrine, theophylline 
cotinine, coumann, 2,6-dichlorobenzonitrile, fadrozole, indole, 
losigamone, nicotine, 4-nitroanisole, quinolone 
arteether, 7 -benzyloxyresorufin, benzphetamine, bupropion, 
cinnarizine, deprenyl, 7 -ethoxycoumarin, testosterone 
antipyrine, diclofenac, flurbiprofen, ibuprofen, mefenamic acid, 
R-naproxen, phenytoin, tienilic acid, tolbutamide, S-warfarin 
amitriptyline, citalopram, clomipramine, diazepam, 0 0 0 Imipramme, 
S-mephenytoin, mephobarbital, omeprazole, proguanil, propranolol 
amitriptyline, aprindine, clomipramine, codeine, debrisoquine, 
desipramine, N-desmethylclomipramine, dextromethorphan, dihydro-
codeine, ethyl-morphine, encainide, fluoxetine, haloperidol, hydro-
codone, imipramine, maprotiline, MDMA, metoprolol, mexiletine, 
nortriptyline, paroxetine, perphenazine, propafenone, propranolol, 
sparteine, thioridazine, tramadol, trimipramine, zuclopenthixol 
acetaminophen, benzene, chlorzoxazone, dapsone, dimethyl-
nitrosamine, enflurane, ethanol, halothane, 4-nitrophenol, salicylic acid 
alprazolam, amiodarone, carbamazepine, clomipramine, cortisol, 
cyclosporin A, diazepam, diltiazem, ethynyloestradiol, erythromycin, 
CYP3A4 felopidine, ifosfamide, imipramine, lidocaine, midazolam, nifedipine, 
omeprazole, proguanil, propafenone, quinidine, tamoxifen, terfenadine, 
testosterone, toremifene, triazolam, verapamil, vinblastine 
Phase II biotransformations modify the structure of xenobiotics by conjugating 
endogenous metabolites, often to increase their water-solubilityo Moreover, sorne of 
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the functional groups used in these reactions, such as the carboxylate terminal 
glucuronate conjugates, are recognized by specifie organic anion active transporters 
in the liver and kidney, facilitating excretion into the bile and urine, respectively. The 
majority of Phase Il conjugations occur via electrophilic addition of an "activated 
donor" to nucleophilic centers in xenobiotic substrates, including oxygen in hydroxyl 
and nitrogen in amine groups. Glutathione (GSH), on the contrary, reacts with 
electrophilic centers of the xenobiotic or its reactive metabolite. Table 1.4 lists the 
most common xenobiotic conjugation reactions, their associated enzymes and 
subcellular localizations (Joseph y, 1997; Badenhorst et al. , 20 13). 
Table 1.4 Selected xenobiotic conjugation reactions 
Reaction Enzyme Cellular Component 
Glucuronidation UDP-glucuronyltransferase Micros omal 
Sulfation Sulfotransferase Cytosolic, Microsomal 
Methylation Methyltransferase Cytosolic, Microsomal 
Acetylation Acety 1 transferase Cytosolic 
Glycine conjugation Glycine N-acyltransferase Cytosolic, Microsomal 
Glutathione conjugation Glutathione S-transferase Cytosolic, Microsomal 
Depending on the organ involved, xenobiotic metabolism can sometimes 
involve multiple biotransformation routes. Figure 1.3 shows the metabolic pathway 
for N-acetyl-p-aminophenol (AP AP), also known as paracetamol or acetaminophen. 
As illustrated, a therapeutic dose of APAP is primarily metabolized in the liver via 
glucuronylation and sulfation and then excreted into bile or blood by ATP-binding 
cassette (ABC) transporters. However, a small portion of the drug undergoes a 
phase I transformation to N-acetyl-p-benzoquinone imine (NAPQI), a reactive 
metabolite, which can subsequently be conjugated with GSH, enzymatically 
degraded, and excreted via urine (Mazaleuskaya et al. , 20 15). 
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Phase l and II biotransformations often serve as an efficient detoxification 
pathway; bowever, sorne CYP-catalyzed reactions may generate metabolites that are 
more reactive than the original xenobiotic ("bioactivation") and can covalently bind 
to endogenous compounds other than GSH or phase Il activated donors . These 
reactions can particularly occur on the reactive centers of biological macromolecules, 
such as proteins and nucleic acids, affecting cellular processes, and potentially 
causing organ toxicity. The severity of the resulting insult largely depends on the 
extent of binding and the biochemical function of the target molecule(s). The 
subsequent pathological consequences will be a balance between the rate of tissue 
damage and the rate of cellular repair (Williams, 2006). The CYP-induced formation 
of NAPQI (Figure 1.3) is a well-studied example of reactive metabolite-associated 
toxicity since being first reported in 1973 by Jollow et al. APAP toxicity will be 
discussed in further detail in Chapter 5. Figure 1.4 illustrates the steps involved in the 
metabolism of xenobiotics and the relationship between reactive metabolites, 
covalent binding and toxicity. 
Cellular Accumulation ----7 Toxicity 
Phase 1/11 Bioactivation (i.e. CYPs} 
Covalent Binding 
-------------~ Toxicity 
Phase Il (proteins, nudeic acids, etc.) 
Excretion 
Figure 1.4 Relationship between xenobiotic metabolism and reactive metabolite-
induced toxicity 
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Theoretically, both the nucleophilic and electrophilic reactive metabolites can 
undergo covalent binding reactions and induce toxicity; however, in nature, the 
reactions involving reactive electrophiles occur more frequently due to the lack of 
intrinsic highly electrophilic groups in biomolecules. Instead, nucleophilic centers are 
significantly present in pro teins ( cysteine, lysine, histidine, arginine, serine, 
threonine, selenocysteine, asparagine, aspartate and glutamate residues), nucleic acids 
(nitrogenous bases) and other compounds such as GSH. Therefore the study of 
reactive metabolites often involves the chemistry of biologically-occurring 
electrophiles (Gersch et al. , 20 12). 
Based on the mechanism of their reaction with nucleophiles, electrophilic 
metabolites can be classified into three major groups: (1) Michael acceptor systems, 
(2) ring-strained scaffolds, and (3) other electron-deficient systems. Table 1.5 lists the 
most common classes of reactive electrophiles under each category with selected 
xenobiotics known to form examp1es of each class (Zhou et al. , 2005 ; Kalgutkar, 
2011). 
According to the "electronic theory of acids and bases", electrophiles 
spontaneously react with nucleophiles, if energetic parameters are met. However, the 
selectivity of such a reaction mainly depends on the size and electron density of the 
species involved. From this perspective, an electrophile-nucleophile reaction is a 
Lewis acid-base reaction and its product results from the addition of two complete 
chemical entities, therefore often referred to as an "acid-base complex" or "adduct" 
(House, 2008). The selectivity of electrophilic (reactive) metabolites, the mechanisms 
of their reactions, and the types of adducts formed lie within an interesting research 
area and will be further discussed in the next section. 
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Table 1.5 Most conunon classes of electrophi lic reactive metabolites 
Reactive Electrophile Structure Example(s) 
Michael Acceptor Systems 
a,p-Unsaturated carbonyl ~0 carbamazepine, L-dopa, tolcapone 
a,p-Unsaturated imine ~NH acetaminophen, lidocaine 
a,p-Unsaturated diimine =N trimethoprim 
"=NH 
Ring-Strained Scaffolds 
Epoxide ) o bergamottin, diallyl sulfone, 
Arene oxide (>o capsaicin, imipramine, raloxifene 
Otber Electron-Deficient Systems 
Nitroso N=O erythromycin, pbenacetin, 1 sulfarnetboxazole 
1 
Diazene N=N isoniazid 
1 
\Œ=< Iminium ion N- aminopyrine, haloperidol , mirtazapine 
1 
(±) 
Diazonium ion N::N hydralazine 
1 
Nitrenium ion 
(±) 
aristolochic acids, clozapine 
,....-- N, 
Isocyanate -N=C=O sulofenur, tolbutamid, troglitazone 
e 
S-oxide 0 tienilic acid 1 ~s<±l 
Aldehyde/ketone )=o diclofenac, indomethacin 
Acyl halictes )=o chloramphenicol, halothane 
x 
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1.1.3 Adduct Formation and Protein Targets 
A covalent binding reaction on a protein does not automatically lead to 
toxicity. On the contrary, the efficacy of sorne drugs, such as penicillin, aspirin and 
omeprazole, relies on their ability to covalently bind to their protein targets 
(Williams, 2006). Nonetheless, irreversible chemical modification of a biomolecule 
by a reactive metabolite can affect its biological function and the cellular processes 
involving this molecule. It is therefore important to identify potential targets of a 
reactive metabolite to assess the extent and direction of such potential biological 
consequences. 
Hard and soft acids and bases (HSAB) theory explains that hard electrophiles 
generally react with hard nucleophiles and soft species prefer the soft counterparts. 
In 1983, Parr and Pearson explained the concept of "chemical hardness" ('1) as the 
second derivative of the total energy of a chemical system (E) with respect to changes 
in the number of electrons (N) at a fixed nuclear environment (z). 
By this definition, "hard" species are small, have a high electron density, and are 
weakly polarizable, whereas "soft" species are large, have a low electron density, and 
can be readily polarized. 
Applying HSAB theory to reactive metabolites, hard electrophiles, including 
cations, epoxides, and aldehydes, should react with hard nucleophilic centers such as 
the amine functional groups in DNA/RNA nucleobases and lysine residues in 
proteins. Soft electrophiles, such as Michael acceptor systems, would prefer soft 
nucleophiles, which include cysteine residues in proteins and glutathione. Free 
radicals can also react with lipids to initiate lipid peroxidation chain reactions . It is 
------------------
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however important to consider that, in addition to the chemical hardness, the 
microenvironment (pKa, hydrophobicity, etc.) of a nucleophilic center in the tertiary 
structure of the target molecule can also affect an adduction reaction (Park et al. , 
2005). 
As discussed earlier, toxicological response of a covalent binding reaction 
largely depends on the biological role of the target molecule and the cellular 
processes affected by the target' s structural alteration. These responses usually 
include (1) mutagenicity, teratogenicity or carcinogenicity, (2) necrotic or apoptotic 
cell death, and (3) hypersensitivity reactions (Williams, 2006). For example, the 
endogenous lipid peroxidation product, malondialdehyde (MDA), is known to 
covalently bind to guanine, adenine, and cytosine residues in DNA structure 
demonstrating mutagenic properties in bacterial and mammalian cells and 
carcinogenicity in rats (Figure 1.5) (Mamett, 2000). Phase l transformation of 
5-aminosalicylic acid (also known as mesalazine), a non-steroidal anti-inflammatory 
drug (NSAID), by myeloperoxidase generates a quinone intermediate, which then 
binds to hemoglobin Jeading to hypersensitivity (Liu et al., 1995). Similarly, the 
metabolism of severa! other drugs such as dapsone, carbamazepine, trimethoprim, 
and olanzapine results in covalent modification of neutrophil proteins leading to 
agranulocytosis (Zhou et al. , 2005). 
)lH 
HO)LH DNA 
0 0 
1 1 0 HN HN 
eN :SN> ~N N:) A N t ) OAN N N l N N 1 1 
dR dR dR 
MDA M1G M1A M 1C 
Figure 1.5 Covalent binding of malondialdehyde (MDA) with DNA leading to the 
formation of potentially mutagenic (modified) guanine (M 1G), adenine (M 1A), and 
cytosine (M 1C). dR: deoxyribose. 
_1 
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A comprehensive list of reactive metabolite in vivo target 
proteins can be found on Target Protein Database (TPDB) VIa 
http ://tpdb.medchem.ku.edu:8080/protein database (Hanzlik et al. , 2007). Figure 1.6 
illustrates liver metabolism of trimethoprim, a bacteriostatic antibiotic, and the 
resulting covalent binding reaction of hepatic pro teins (Lai et al. , 1999). 
OCH3 H3CO~NVNH2 
1 1 ~~ MPO 
HJCO # .6 N H202, Cl· 
NH2 
trimethoprim 
CYP IA2, 3A4 t 
OCH3 H3CO~""" 7 NfNH __ _____ 
H CO # # .6 N 
3 HS 
NH2 
Figure 1.6 Liver metabolism of trimethoprim, formation of a reactive iminoquinone 
methide (an a,~-unsaturated diimine) metabolite, and its subsequent covalent binding 
to hepatic proteins. CYP: cytochrome P450; MPO: myeloperoxidase. 
Approximately 1000 xenobiotics are known to induce hepatotoxicity (Chen et 
al. , 2014). More than half of the TPDB entries are liver protein targets. The liver 
plays a key role in the metabolism of xenobiotics and thus is exposed to high 
concentrations of reactive metabolites, making it an important target for covalent 
binding reactions. Although these reactions do not always lead to hepatotoxicity, 
drug-induced liver injury (DILI) is a serious challenge in drug development and often 
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results in regulatory actions including denied approval, use restrictions, or post-
market withdrawal. lt is also believed that severa! adverse drug reactions (ADRs) are 
also related to drug-induced organ toxicity (Williams, 2006). ldentifying potential 
covalent target proteins can shed light on the biological mechanisms involved in a 
drug ' s ADRs and thus has become an important area of research in pharmacology and 
molecular toxicology. The following section will briefly discuss the methods 
developed in recent decades for systematic study of proteins in biological samples 
including techniques particularly adapted for covalent binding investigations. 
1.2 Experimental Techniques: MS-Based Proteomics 
The word "protein" was coined by Swedish chemist Jons Jacob Berzelius, and 
introduced as a new class of organic substances by Dutch chemist Gerardus Johannes 
Mulder, who carried out the first elemental analysis of proteins in 1838 (Hartley, 
1951). ln 1845, Justus von Liebig, the German organic chemist, found that proteins, 
regardless of their slight difference in solubility under different conditions, are largely 
similar in their chemistry, and play an important role in biological processes in the 
body (Carpenter, 1986). 
Analysis of proteins in biological systems has al ways been a challenge. Heat 
and pH sensitivity, extremely large molecular weights, and relatively high water-
solubility make them difficult targets for traditional analytical techniques. Pioneering 
work on separation methods by Frederick Sanger paved the road for the development 
of protein and DNA/RNA sequencing, eventually bringing him two Nobel prizes. 
Tedious and time-consuming protein sequencing was later greatly improved by the 
development of phenylisothiocyanate sequencing chemistry by Edman in 1949, and 
its automation in 1967 (James, 1997). 
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The proteomics era began with the invention of sodium dodecyl sulphate 
polyacrylamide gel-electrophoresis (SDS-PAGE) (Kenrick and Margolis, 1970), and 
two-dimensional gel-electrophoresis (2D-GE) (O'Farrell, 1975; Klose, 1975) in the 
1970s. 2D techniques significantly enhanced protein analysis resolving power and 
sensitivity, and enabled electro-blotting for protein identification with antibodies or 
Edman sequencing. However, low rate of detection of membrane pro teins due to their 
poor water-solubility, limited reproducibility, and problems with spot identification in 
complex mixtures were major drawbacks of initial gel-based methods (James, 1997). 
The development of bio-analytical mass spectrometry and the parallel growth 
of protein databases, in late 1990s and early 2000s (Aebersold and Mann, 2003 ; 
Washbum et al. , 2001), greatly enhanced the performance and throughput of 
traditional proteomics methods. The following section will briefly describe the state-
of-the-art proteomics technology and use of mass spectrometry to address numerous 
challenges in protein analysis in biological samples. 
1.2.1 Proteomics Technology 
Proteomics is the large-scale study of proteins to obtain a global, integrated 
view of cellular processes at the protein leve! (Blackstock and Weir, 1999). The term 
"proteomics" was first introduced by Peter James (1997) from the Swiss Federal 
Institute of Technology to make an analogy with "genomics", the large-scale study of 
genes. The aim of a proteomics study was, at first, limited to describing protein 
expression changes under biological perturbations such as a specifie disease state or 
drug treatment (Anderson and Anderson, 1998). Today, boundaries of proteomics 
have largely expanded to include qualitative and quantitative analysis of proteins, 
their functions , structure, and interactions with other molecules in a cell, within a 
tissue or a whole organism, or even across different species. 
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From a "systems biology" perspective, while genomics deals with the analysis 
of the complete set of DNA within an organism, and transcriptomics can be defined 
as the study of all RNA molecules and their relationships with protein biosynthesis, 
proteomics is the intermediary that links these areas to metabolomics, being the study 
of cellular processes involving small molecules known as metabolites (Mann et al. , 
2013). The relationship between different levels of "omics" research and the type of 
molecules normally involved in each area of study are depicted in Figure 1. 7. 
L_ ___ G __ en_o~In_j_cs_· __ ~~ .. ~~L~ ______ D_N~A------~ 
~_T_r_a_ns_c_0~p_to_rru_._cs __ ~ .... ~~L~ ______ RN_~A------~ 
L_ ___ P_ro_t_e;~n_,_ic_s __ ~--.. ·~~L~ _____ P_ro_;~ei_n_s ____ ~ 
' 
' ' 
'Il 'V 
L_ __ M_e_t_ab_o_lo_m __ ic_s __ ~ .... ~~L~ ____ M_e_ta_b_o_li_te_s __ ~ 
Figure 1.7 Simplified depiction of the four major domains of "omics" research and 
their primary molecular classes of interest 
Initial proteomics analyses utilized gel-electrophoresis for separation and 
identification of proteins using manual (Sanger) sequencing. Modem methods 
however are usually based on automated gel-free approaches. Gel-based analysis 
includes protein separation followed by an in-gel protein digestion and subsequent 
peptide analysis using cbemical sequencing techniques, such as Edman degradation 
(Edman et al., 1950), or peptide mass fmgerprinting (PMF) using matrix-assisted 
laser desorption ionization (MALDI) mass spectrometry. The latter is sometimes 
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referred to as gel-electrophoresis-mass spectrometry or GE-MS (Michaud and 
Snyder, 2002). Gel-based techniques are known for their accuracy and simplicity 
however, gel manipulation steps are time-consuming, and the method is not 
applicable to all proteins (Van Summeren et al. , 2012). 
Gel-free proteomics usually involves in-solution digestion of the proteins 
prior to peptide fractionation or separation using one or multi-dimensional liquid 
chromatography (LC) coupled with atmospheric-pressure ionization (API) tandem 
mass spectrometry (MS/MS). Unlike gel-based techniques, gel-free proteomics could 
be readily used for high-throughput analysis and is applicable to most proteins; 
however, LC-MSIMS instruments are costly and require extensive method 
development (Van Summeren et al. , 2012). Figure 1.8 exhibits major steps involved 
in gel-based and gel-free proteomics analytical workflows. 
(a) 
Gel electrophoresis In-gel digestion MALDI-MS Data Mining 
(b) 
In-solution digestion LC ( ID or 2D) MS l (API) Data Mining 
Figure 1.8 Different steps involved in a typical experimental workflow in a ge1-based 
(a) or gel-free (b) proteomics approach. API: atmospheric-pressure ionization; LC: 
liquid chromatography; MALDI: matrix-assisted laser desorption ionization; MS: 
mass spectrometry; PMF: peptide mass fingerprinting. 
A proteomics experiment can be "top-down" or "bottom-up" (Walther and 
Mann, 201 0) . Characterization of proteins by their molecular weight is known as 
" top-down" proteomics (McLafferty et al. , 2007). However, since the mass difference 
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between proteins with similar compositions is small, this method is not weil suited for 
the analysis of protein mixtures, and thus "top-down" experiments are often limited 
to single protein analysis in relatively pure samples. For most experiments, proteins 
are first digested with resulting peptides separated and analyzed using tandem mass 
spectrometry. Computerized peptide sequencing algorithrns then determine "peptide 
spectral matches" based on mass-to-charge (m/z) ratios and MS/MS fragmentation 
patterns. The software then compares putative peptide sequences to a protein database 
for identification. Since, in this approach, the analyte is qualitatively characterized 
based on the data obtained from its building blocks, this approach is often referred to 
as "bottom-up" or "shotgun" proteomics. 
The bottom-up approach is known for its high compatibility with complex 
samples and is often used for quantitative and high-throughput studies. However, 
since proteins need to be denatured and digested prior to analysis, a portion of the 
structural information may be !ost using this method (Van Summeren et al., 2012). 
Typical bottom-up and top-down proteomics analysis workflows are demonstrated in 
Figure 1.9. 
(a) 
t: digestion fragmentat ion 
(b) j - ____. l :+ ''"'~'''" ~
m,; 
Figure 1.9 Steps involved in bottom-up (a) and top-down (b) proteomics analysis 
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In bottom-up proteomics, a peptide is usually fragmented at its amide 
(peptide) bonds, by collision with an inert gas such as He or N 2 at low pressure. This 
method of fragmentation is called collision-induced dissociation (CID) . The resulting 
MS/MS spectrum is basically a list of m/z values of different fragments with sorne of 
the differences corresponding to the exact mass of an amino acid residue. Connecting 
the fragments with increasing size from the N-terminus (b-ion series) or C-terminus 
(y-ion series), in addition to the exact mass of the precursor ion, allows for the 
deduction of the peptide sequence from the series of residue-specific mass 
differences. This technique is known as de novo peptide sequencing. A CID-
fragmented peptide (in positive ionization mode) and the structure of the N-terminal 
a, b, c and the C-terminal x, y, z fragment ions are depicted in Figure 1.1 O. 
H 0 H 0 
1 Il H 1 Il 
11,:--1 - C - C- N - C- C E> 
- 1 1 
RI R2 
H 0 H 0 
' ' ''~y, e 1 Il 11 1 Il H3;-.l -l - C- N - T-C-OH 
R2 R3 
Figure 1.10 Peptide fragmentation via CID and structure of b- and y-type product ions 
often used for de novo peptide sequencing or peptide spectral matching 
Proteomics analysis can be used for qualitative or quantitative purposes. 
Qualitative proteomics concentrates on protein identification and structural analysis 
including morphology, post-translational modification (PTM), and protein-protein 
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interaction (PPI) analyses. The state-of-the-art protein identification primarily relies 
on de nova peptide sequencing. Severa! probability-based searching sequence 
databases are developed for protein identification using mass spectrometry data 
including MASCOT (Perkins et al. , 1999), SEQUEST (Eng et al. , 1994), X!Tandem 
(Craig and Beavis, 2004) and Paragon (Shilov et al. , 2007). Qualitative proteomics 
information are routine! y collected, reviewed and catalogued by user-based or curated 
proteomics knowledgebases such as the UniProt consortium (http: //www.uniprot.org) 
and NCBI 2 (http://www.ncbi.nlm.nih.gov). Other web-based tools such as 
PANTHER 3 (http: //www.pantherdb.org) (Thomas et al., 2003), InnateDB 
(http ://www.innatedb .ca) (Lynn et al. , 2008), and ExPASl (http ://www.expasy.org) 
(Artimo et al., 2012) also provide possibilities for gene ontology (GO) classification, 
PPI analysis, and bioinformatics calculations, respectively. 
The goal of quantitative proteomics is to determine the relative abundance of 
proteins between two experimental conditions or cellular states. Most quantitative 
proteomics approaches that are frequently used fall under one of the following two 
categories: (1) isotopie labeling and (2) label-free quantitation (Walther and Mann, 
201 0). In isotopie labeling, stable isotope-containing tags or ami no ac ids are 
incorporated into the protein (or peptide). The sample containing the labeled protein 
("heavy") will then be mixed with the non-treated (" light") sample. The MS signal 
ratio between the heavy and light samples enables relative quantitation at both protein 
and peptide levels. The most common techniques in use for stable isotope-labeling 
are SILAC5 (Ong et al., 2002), ICAT6 (Gygi et al. , 1999) and iTRAQ7 (Ross et al. , 
2004). Figure 1.11 demonstrates a typical SILAC quantitation workflow where one 
cell population (light) is cultured in a growth medium containing regular amino acids 
2 National Center for Biotechnology Information 
3 Protein Analysis through Evolutionary Relationships 
4 Expert Protein Analysis System 
5 Stable Isotope-Labeling with Ami no Acids in Cel! Culture 
6 Isotope-Coded Affini ty Tag 
7 Isobari c Tags for Relati ve and Absolute Quantitation 
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while the other (heavy) grows in a medium that only contains 15N- or 13C-labeled 
arginine or lysine. Label-free quantitation works by aligning separate LC-MS/MS 
runs of peptide mixtures to calculate differences in peak intensities of the same 
peptides detected in each run (Old et al. , 2005). In general, isotope-labeling 
techniques are time-consuming and costly and are not applicable to all proteins but 
are also more accurate than label-free methods which are, in turn, faster, cheaper and 
simpler (Walther and Mann, 2010) . 
Control 
(Light) 
ml::. 
* 
Treated * 
(He avy) 
2 
r/l 
c 
.3 
c 
b 
RT (min) 
Figure 1.11 A typical SILAC quantitation workflow. The heavy-to-light LC-MS peak 
area ratio (b/a) in the [treated + control] mixture determines the relative abundance of 
labeled protein(s) in the treated sample. 
MS is currently the method of choice in proteomics analysis (Altelaar and 
Heck, 2012). Advances in MS have been crucial for the development of proteomics 
and significantly contributed to the ability to identify and quantify low abundant 
proteins in complex mixtures. Severa! MS technologies have been developed, or 
combined with other analytical techniques, in recent years, to improve the resolving 
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power, sensitivity, and selectivity of proteomics analysis. High-resolution (Makarov, 
2000), data-dependent (Mann et al., 2001) and data-independent (Bem et al. , 2010; 
Gillet et al. , 2012) MS, in parallel with multidimensional (Washbum et al. , 2001), 
nano-scale (Tao et al. , 2011 ), and ultra-high-pressure liquid chromatography 
(UHPLC) (De Vos et al. , 2012) made drastic changes to the analytical capacity of 
modem proteomics. These techniques will be described later in this chapter. 
1.2.2 LC-MS/MS 
Mass spectrometry was first introduced by British physicist Joseph John 
Thomson, in 1897, with a series of experiments designed to study the nature of 
electric discharge in a high-vacuum cathode-ray tube coupled to a fluorescent screen 
(a "mass spectrograph"), leading to his Nobel Prize-winning discovery of the 
"electron". Early MS was often used to measure the atomic mass of elements and 
study their natural isotopes. Magnetic sector mass spectrometers, initially known as 
"calutrons", were devised by Canadian physicist Arthur Jeffrey Dempster, and used 
in the Manhattan Project for uranium enrichment during the Second World War. 
From the 1950s to the present, MS has changed dramatically, and numerous 
technological enhancements have tumed it into one of the most powerful analytical 
tools available in chemistry, biochemistry, pharmacy, and medicine (Gross, 2004). 
The basic principle of MS is to generate ions from organic or inorganic 
compounds using an " ionization" method, and then separate them by their mass-to-
charge (m/z) ratio directly (quadrupole, ion trap) or indirectly based on a measurable 
physical property such as momentum (magnetic sector), kinetic energy (time-of-
flight) , or resonance frequency (orbital ion trap, ion cyclotron resonance). The 
compound may be ionized them1ally or by electric fields , impacting energetic 
electrons, ions, or photons (Gross, 2004). 
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A mass spectrometer is comprised of three mam components: (1) an ion 
source, (2) a mass filter or analyzer, and (3) a detector. A sample introduction system, 
such as a GC (gas chromatograph) or HPLC (high-pressure liquid chromatograph), 
vacuum supply, and data system are other parts of the MS system. The general 
scheme of a typical mass spectrometer is shown in Figure 1.12. 
1 
1 
1 ,_ 
--------------------------------
-
1--'-
sample inlet ion source 
- ~-
-----------
- -- --------------
atmosphere/vacuum 
-mass 
analyzer detector data system 
-
vacuum 
supply 
Figure 1.12 Major components of a typical mass spectrometer. Depending on system 
configuration, the sample inlet and ion source may or may not be under vacuum. 
An ion source applies energy to the analyte (and matrix/medium) molecules to 
transform them into gas phase ions. This can occur under vacuum or at atmospheric 
pressure. Depending on the ionization process, an ion source can function in positive 
or negative ionization mode. Currently, the most frequently employed ion sources 
include electron ionization (El), chemical ionization (CI), matrix-assisted laser 
desorption ionization (MALDI), and electrospray ionization (ESI) . The energy 
applied to the sample to generate ions can transfer "excess energy" that 
thermodynamically destabilizes covalent bonds and breaks the molecule into 
"fragment" ions ("hard" ionization). El is a "hard" ion source and is often coupled 
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with GC for analysis of volatile compounds and has a wide range of applications in 
environmental, forensic, and pharmaceutical analysis. MALDI and ESI are "soft" ion 
sources and thus are preferred for the analysis of biomolecules, which are fragile 
under harsher conditions, and thus are the ionization methods of choice in bio-
analytical MS. 
ESI, APCI (atmospheric-pressure chemical ionization) and APPI 
(atmospheric-pressure photoionization) do not require vacuum to help ionize the 
sample, and are known as API (atmospheric-pressure ionization) methods. API was 
the first technique to allow direct introduction of a solution phase enabling a more 
efficient LC-MS coupling compared to the previous less feasible counterparts, 
including the "moving belt" and PBI (particle bearn interface) (Gross, 2004). ESI, the 
most common API method, was developed by American chemist John Bennett Feno, 
laureate of the Nobel Prize of Chemistry in 2002. 
There exists a great variety of mass analyzers as well. The separation of ions 
based on their m/z ratios occurs as a result of static or dynamic electric and magnetic 
fields (alone or combined). Most mass analyzers differ in the manner in which such 
fields are used to achieve separation. Analyzers can generally be divided into two 
major classes on the basis of their separation properties. Scanning analyzers, such as 
magnetic sector (B) and quadrupole (Q), transmit the ions with different m/z ratios 
successively along a time scale. Other analyzers allow the simultaneous transmission 
of all ions. Time-of-flight (TOF), Fourier-transfom1 ion cyclotron resonance (FT-
ICR) or orbital ion traps belong to this class. Mass analyzers cao be coupled m 
tandem to ena ble fragmentation of precursor ions into fragment (product) ions. 
Tandem MS (MS/MS) is an incredibly powerful technique for molecular 
structure detem1ination and, as discussed earlier, the basis of MS-assisted peptide 
sequencing. Depending on the nature of the analyzer, precursor ions can be 
"activated" (ob tain ex cess energy) through different methods to undergo selected 
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types of fragmentation. Ion activation can occur as a result of collision (collision-
induced dissociation, CID), electron capture (electron-capture dissociation, ECD), 
electron transfer ( electron-transfer dissociation, ETD), and infrared irradiation 
(infrared multi-photon dissociation, IRMPD), to name a few. Table 1.6 lists the most 
cornmonly used mass analyzers and their performance characteristics (Gross, 2004; 
de Hoffmann and Stroobant, 2007). 
Tandem MS can be accomplished m a spatial or temporal domain. The 
physical coup ling of mass analyzers constitutes the spatial domain and is often called 
"tandem-in-space" mass spectrometry. However, ion trapping mass analyzers 
including quadrupole ion trap, FT-ICR, and Orbitrap can isolate a precursor ion of a 
specifie m/z value during one time interval, activate the ion, and collect (or store) 
product ions during a second time interval to obtain a product-ion mass spectrum by 
scanning the product ions out of the trap during a third time interval. This is an 
example of MS/MS in a temporal domain, and often referred to as " tandem-in-time" 
mass spectrometry. Tandem-in-time MS can be repeated multiple times and MS 11 
product ions can be scanned for as long as the signal-to-noise (SIN) ratio permits 
(Watson and Sparkman, 2007). 
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In a product-ion scan, productions produced by the decomposition of a given 
precursor are recorded by setting the first mass analyzer to a fixed value while a 
second mass analyzer acquires ion current over a range of m/z values. Product-ion 
spectra are rich sources of structural information as they include m/z values of the 
ions formed from the fragmentation of an activated precursor ion, usually as a result 
of collision with atoms or molecules of a neutra! gas , such as He and N2. The 
precursor ion is selected and directed into a "collision cell", where it collides with the 
collision gas converting sorne of its translation energy into "internai energy" (Ein1). 
The difference between Eint and the amount of energy required to initiate 
decomposition (activation energy), known as the "excess energy" (Eex), determines 
the type of fragmentation induced. According to "quasi-equilibrium theory (QET)", 
the rate constant of a gas-phase unimolecular reaction (kE) can be defined as 
where v and s represent the number of vibrational states available to the 
activated molecule (the frequency factor) and its total degree of freedom, 
respectively. Generally, activated ions decomposing at rates below 105 s-1 will reach 
the detector without fragmentation ("stable ions"), whereas ions dissociating at above 
106 s-1 fragment into product ions before reaching the detector ("unstable ions") 
(Gross, 2004). 
Decomposition of an unstable ion can lead to the formation of ions, radicals 
and molecules (or "neutrals"). A "neutra! loss" can pro vide useful structural 
information, particularly for peptide characterization. For example, Joss of a molecule 
of water can usually be linked to the presence of Ser, Thr, and Glu residues, while 
Arg, Lys, Gln and Asn-containing peptides may !ose molecules of ammonia. Loss of 
a • NO radical can be an indication of post-trans1ational nitrosylation. In Chapter 6, 
neutralloss of 156.1150 Da was related to the modification by 4-hydroxynonenal. 
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Another useful MS/MS experiment, selected-reaction monitoring (SRM), or 
multiple-reaction monitoring (MRM), monitors the dissociation of one or a set of 
specifie precursor ions (mlz 1) to one or a set of given product ions (m/z 2). Each 
[ m/z 1, m/z 2] pair is called a " transition" or "reaction". MRM pro vides a better 
selectivity compared to "selected-ion monitoring" (SIM), in which only the m/z of the 
precursor is selected, and thus the former usually bas better SIN making MRM an 
ideal technique for quantitative analysis in complex samples (Watson and Sparkman, 
2007) . 
Product-ion scan and MRM are most widely used in MS-based proteomics for 
structure elucidation and selective detection of target peptides, respectively. A 
peptide ' s product-ion spectrum comprises C-terminal (x, y, z) and N-terminal (a , b, c) 
fragment ions allowing for de nova peptide sequencing. Other "diagnostic" fragment 
ions can provide useful information on PTMs and metabolically-occurring covalent 
modifications. MRM however is often employed for quantitative analysis where 
selectivity and sensitivity are crucial. MRM is utilized in combination with online 
chromatographie separation to quantify a specifie compound in a complex (often 
biological) rnat:rix. The three degrees of separation (retention tirne, precursor mlz, and 
fragment m/z) in LC-MRM greatly enhance the SIN enabling targeted quantitation of 
low-abundance peptides otherwise not detectable in an ambiguous product-ion 
spectrurn (Ekman et al., 2009). 
Mass analyzers can also be combined into "hybrid" instruments that unite the 
advantageous properties of each analyzer they are composed of. For example, a 
hybrid quadrupole-time-of-flight (QqTOF) instrument combines the scanning speed 
of a quadrupole with the resolving power of a TOF analyzer to enab le high-speed 
acquisition of spectra at higher resolution. An LTQ-Orbitrap is a hybrid mass 
spectrometer comprising linear ion trap and Orbitrap analyzers for enhanced 
resolution and more flexibility. QqTOF and LTQ-Orbitrap instruments have become 
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the two most prominent high-resolution technologies for proteomics applications for 
their high resolving power, mass accuracy (stability), linearity, sensitivity, and 
isotopie fidelity (Eichhom et al., 2012). Figure 1.13 shows the schematic of 
TripleTOF™ 5600 (AB Sciex), the hybrid QqTOF used to accomplish the research 
described in most of this dissertation. Other hybrid MS instruments include 
quadrupole-ion trap, ion trap-TOF, TOF-TOF, and LTQ-FT-ICR. The latter provides 
very high resolving power and is especially desired for in-depth structural analysis of 
intact proteins in top-down proteomics. For example, Laurette et al. (2010) used a 
LC-Q-FT-ICR mass spectrometer to study nitration and oxidation of intact 
calmodulin as resulted by endogenous oxidative stress. 
from LC 
y ct quadrupole 
(collision cell) 
2"d quadrupole 
(1 sr mass analyzer) \ 
1 sr quadrupole 
(ion guide) ~ 
~ 
orifice 
~ 
ReTOF __ 
(2"d mass analyzer) 
Figure 1.13 General scheme of AB Sciex TripleTOF™ 5600 mass spectrometer, the 
hybrid QqTOF instrument used in this dissertation. LC: liquid chromatography; 
ReTOF: reflectron time-of-flight; TDC: time-to-digital converter. 
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The analysis of complex mixtures reqmres powerful separation techniques 
coupled to MS. GC was the first to be coupled with MS and soon became a routine 
technique for the analysis of mixtures . As discussed in Section 1.2.1 , it also became 
possible in the early 2000s to excise SDS-PAGE or 2D-GE gel spots and subject 
them to MALDI-MS. However, the application of GC-MS is limited to volatile 
compounds, and GE-MS was not always feasible. The development of API methods 
eventually gave rise to more flexible "hyphenated" techniques such as LC-MS, CE-
MS8 and SFC-MS9 (Gross, 2004). Since most proteins, peptides and metabolites are 
relatively polar and water-soluble; LC-MS quickly became one of the most efficient 
and routinely used approaches in proteomics analyses . However, despite the rapid and 
massive advances in LC technology, current analytical workflows are still not 
sufficient to fully resolve complex biological samples. 
The LC approaches employed in proteomics often aim at separating peptides, 
for MS-based sequencing, via reversed-phase (RP) chromatography. RP-LC is a 
relatively fast, effective and reproducible technique; however, most proteomics 
samples, such as celllysate digests, are far too complex to be efficiently resolved in a 
single analytical dimension. The search for a solution to this problem eventually 
fostered the development of orthogonal multidimensional separation procedures (Di 
Palma et al. , 2012). 
1.2.3 Multidimensional Separation in MS-based Proteomics 
One of the most powerful two-dimensional (2D) separation techniques was 
invented in 1975 by O'Farrell and Klose with excellent resolving power for intact 
proteins, consisting of 2D-GE, and dominated the protein separation field for a long 
8 CE = Capillary Electrophoresis 
9 SFC = Supercritical Fluid Chromatography 
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time. Another widely used technique, LC, soon gained popularity as it overcame 
numerous issues associated with GE, including difficulty of automation, lack of 
reliable quantitation and reproducibility, and especially problematic detection of 
proteins with large molecular weight, high pl, strong hydrophobicity, or Jow 
abundance, such as membrane proteins (Donato et al., 2011). 
In 2001, Washburn et al. introduced an efficient method for large-scaJe 
anaJysis of yeast proteome using Multidimensional Protein Identification TechnoJogy 
(MudPIT), a 2D-LC-MS/MS approacb combining strong cation exchange (SCX) with 
RP-LC. The goal in multidimensional LC (MD-LC) is to increase peak capacity and 
thus resolving power to decrease peptide mixture complexity prior to MS/MS 
analysis. This greatJy minimizes " ion suppression" effects, as it dramatically reduces 
the number of ions entering the mass analyzer at a given time. Ion suppression occurs 
where highly abundant peptides obscure the detection of other lower-abundance 
peptides present in the mixture resulting in the loss of information particuJarly related 
to Jess-abundant or Jess-soluble pro teins (Donato et al., 2011 ). This is likeJy to be a 
major challenge in membrane proteomics, where hydrophobie proteins tightly bound 
within or associated to cell plasma, or organellar, membranes are Jess amenabJe to 
digestion and LC-MS/MS analysis. 
Each separation method works based on one or more physicochemical 
properties. Amino acids have differences in their side chains and thus differ in size, 
poJarity and electrostatic charge. These features can be used as the basis for 
separation. Peptide separation can therefore take advantage of differences in size 
(size-exclusion chromatography), polarity (RP and HILIC 10 ) or net electrostatic 
charge (ion exchange and IEF 11 ). Sorne separation techniques combine more than one 
property to increase seJectivity, as "mixed-mode" separations employ different 
10 Hydrophilic Interaction Liquid Chromatography 
11 Isoelectric Focusing 
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analyte-sorbent interaction mechanisms. Electrostatic repulsion-hydrophilic 
interaction chromatography (ERLIC) (Alpert, 2008), zwitterionic HILIC (Di Palma et 
al. , 2011), and mixed-mode ion-exchange solid-phase extraction (SPE) (Lavén et al., 
2009) are examples where peptides are separated based on a combination of more 
than one physicochemical property. The selectivity of sorne common techniques that 
separate peptides based on polarity and charge is demonstrated in Figure 1.14 (Di 
Palma et al. , 2012). 
The efficiency of a LC separation is best described by its "peak capacity" (P) , 
theoretically defined as the maximum number of components that could be separated 
on a LC column within a given rime. Peak capacity of a gradient LC separation can 
be improved by (1) decreasing the gradient slope, (2) increasing the column length 
with proportional increase in gradient time, and (3) decreasing sorbent particle size 
(Gilar et al. , 2005). Proper use of these strategies has been shown to increase the peak 
capacity of a single-dimensional (1D) RP-LC from several hundred to a maximum of 
1400-1600 (Gilar et al. , 2004). Adding another LC dimension to RP-LC can improve 
the separation power of chromatography tremendously, as the peak capacity of a 2D 
approach is the linear combination of peak capacities in both separation dimensions : 
However, to achieve the maximum peak capacity, the selectivity of the two 
LC modes must be completely "orthogonal" (complementary). As shown in Figure 
1.14, anion/cation exchange chromatography is highly orthogonal with RP-LC and 
HILIC, and bence often form ideal 2D combinations (Di Palma et al. , 2012). SCX-
RP-LC is currently the most prevalent MD-LC technique for separating peptides in 
bottom-up proteomics. 
MD-LC can be conducted in "online" or "offline" modes. Online MD-LC, 
such as MudPIT, involves sophisticated instrumentation and suffers from limited 
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robustness and flexibility; however, it allows automation, minimal sample loss and 
contamination, and high-throughput operation. Offline MD-LC is more flexible as it 
permits the use of incompatible mobile phases in the various LC dimensions. 
Moreover, offline MD-LC can be performed with larger amounts of sample, and thus 
is more efficient for the identification of low-abundant proteins, such as membrane 
proteins (Kong et al. , 2011). The SCX-RP-LC approach is compatible with both 
offline and online configurations. Other separation techniques such as GE, SPE, and 
affinity-based methods have also been incorporated into MD-LC (Nice et al. , 2007). 
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Figure 1.14 Selectivity of HILIC, cation exchange (CX), anion exchange (AX) and 
RP chromatography for peptides as a function of their charge and polarity indicated 
as low, medium, high (image adapted from Di Palma et al. , 2012) 
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SPE is one of the most popular sample preparation and enrichment methods, 
where sample constituents are dissolved in a liquid (mobile phase) and pass through a 
solid sorbent (stationary phase) followed by elution in a suitable solvent. Similar to 
chromatography, separation occurs based on the affinity of solutes for the sorbent. 
SPE disposable cartridges were first introduced in 1978, and have been widely used 
in various applications ever since. SPE cao be performed offline, separated from the 
subsequent chromatography, or online by direct connection to the GC or LC system 
(Henni on, 1999). SPE sorbents cao be divided in three main groups: (1) inorganic 
oxides, (2) non-specifie sorbents, and (3) compound-specifie and class-specific 
sorbents (Poole, 2003). 
lnorganic oxide sorbents mostly include silica, alumina and Florisil 
(magnesium silicate) and have a high affinity towards water and very polar 
substances. Non-specifie sorbents have a broader range of applications and include 
surface-modified silica and porous polymers, such as polystyrene-divinylbenzene 
(PS-DVB) resins and carbon-based materials. Surface-modified silica is the most 
widely used class of SPE sorbents, although it suffers from severa! drawbacks 
including limited stability when subjected to low- or high-pH samples. Nevertheless, 
these materials are currently the sorbents of choice for extracting analytes with low or 
moderate polarity from food, environmental and industrial aqueous samples. For 
more complex matrices, such as biological samples that contain highly polar species 
or macromolecules, most conventional non-selective sorbents are not appropriate and 
the use of compound-specifie and class-specific sorbents is preferred (Augusto et al. , 
2013). Compound-specifie and class-specific SPE sorbents generally include: 
(1) surfactant-modified sorbents, (2) mixed-mode polymerie sorbents, (3) molecular 
recognition sorbents, and (4) nanostructured materials (Augusto et al. , 2013). In this 
dissertation, different mixed-mode polymerie compound-specific/class-specific solid 
phases were employed using Oasis® (Waters) disposable cartridges. The chemical 
structure of hydrophilic-lipophilic balanced (HLB), mixed-mode anion exchange 
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(MAX), and mixed-mode cation exchange (MCX) SPE sorbents and their active sites 
are depicted in Figure 1.15. As shown, simultaneous presence of aryl and pyrrolidone 
ring systems in the structure of these sorbents facilitates the retention of amphiphilic 
compounds such as peptides. However, incorporation of quatemary amine and 
sulfonic acid active sites in MAX and MCX materials particularly allows for selective 
retention of peptides with more acidic (rich in Asp and Glu) or basic (rich in Lys, His 
and Arg) properties, respectively. 
(a) 
~p--, 
1 : 
' " 'P_,' 
HLB 
.... -----
. ' 1 N _.. 1 
1/~1 , __ r _  J 
(c) 
MAX MCX 
Figure 1.15 Chemical structure of mixed-mode compound-specific/class-specific 
sorbents used in Oasis HLB, MAX, MCX SPE cartridges showing their hydrophilic 
interaction (a), hydrophobie interaction (b ), anion ex change ( c ), and cation 
exchange (d) sites (image adapted from www.waters.com). Polymerie core structure 
has not been disclosed. 
Multidimensional techniques have provided higher peptide separation 
efficiency and deeper proteome coverage drawing substantial attention during recent 
years. However, increased time and cost of analysis, lack of complete orthogonality 
between consecutive dimensions, and more importantly, loss of less-abundant 
peptides throughout multiple separation steps remain major drawbacks of these 
methods. These issues and limitations will be discussed in more details in Chapters 2 
and 3. 
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1.3 Challenges and Research Design 
The role of reactive metabolite formation and binding to the proteins, and the 
importance of identifying these adduction targets have been discussed. A brief 
overview was then given on the experimental techniques often employed for the 
analysis of proteins and their post-translational modifications in complex mixtures . 
Several attempts have been made in the past to identify proteins targeted by reactive 
metabolites (see reviews by Cohen et al. , 1997; Zhou, 2003; Zhou et al., 2005; 
Hanzlik et al., 2009). However, these studies have largely failed to address major 
challenges in detection of adducted proteins and/or their sites of modification. The 
difficulties to overcome in these types of studies generally arise from (1) low 
abundance of modified proteins compared to the large excess of unmodified 
counterparts, (2) loss of the attached metabolite through hydrolysis or other chemical 
cleavages caused by the resulting oxidative stress, and (3) low concentration of target 
proteins in the analyzed sample due to solubility issues, especially in the case of 
membrane protein targets (Shin et al. , 2007; Tzouros and Pàbler, 2009). 
1.3 .1 Preparation of Li ver Microsomal Samples 
Sample preparation is a key step in proteomics analysis. Denaturing and 
separating proteins from interfering entities, such as lipids and nucleic acids, their 
solubilization and efficient digestion, and reducing sample complexity prior to LC-
MS/MS analysis significantly enhances data quality. One of the most important 
groups of proteins that pose technical difficulties at almost each step of the sample 
preparation procedure is "membrane proteins". These proteins are either physically 
integrated in a membrane (integral membrane proteins, IMPs) or are chemically 
linked to the phospholipid structure of the membrane (peripheral membrane proteins, 
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PMPs). Most proteins need to be active m the cytosol or secreted into the 
extracellular matrix, and bence are hydrophilic. However, in order to remain stable 
inside the membrane, IMPs and membrane-associated domains of PMPs are 
relatively hydrophobie, and have strong intramolecular interactions with membrane 
lipids through electrostatic forces between the lipid backbone and side chains of 
hydrophobie amino acid residues within the protein 's "transmembrane domains" 
(TMDs) (Lee, 2003). 
The presence of lipophilic residues in TMDs not only greatly reduces 
membrane protein solubility in aqueous buffers used during sarnple preparation, but 
also rnakes these parts of the protein less accessible to certain proteolytic digestions 
including widely used trypsin, and endoproteinases Glu-C, Arg-C and Lys-C, which 
cleave polypeptide chains at hydrophilic residues. Table 1.7 lists the site-specificity 
ofproteases most commonly used in bottom-up proteomics (Westermeier and Naven, 
2002). 
Table 1.7 Proteases commonly used in bottom-up proteomics 
Protease Cleavage Site 1 
Trypsin Arg, Lys 
Endoproteinase Glu-C Asp, Glu 
E ndoproteinase Arg-C Arg 
Endoproteinase Lys-C Lys 
Chymotrypsin2 Ile, Leu, Met, Phe, Trp, Tyr, Val 
Elastase2 Ala, Gly, Ile, Leu, Ser, Val 
p . 2 epsm Glu, Leu, Phe 
1 Cleavage occurs at the C-terminal si de of the given residues 
2 Enzymes with low cleavage site-specificity 
Exception 
Adjacent to Pro 
Adjacent to Pro 
Adjacent to Pro 
Adjacent to Pro 
Adjacent to Pro 
42 
Trypsin is a selective endopeptidase that cleaves at the C-terminal side of Arg 
and Lys residues . However, Burkhart et al. (2012) demonstrated that trypsin's 
specificity, efficiency, reproducibility and its potential impact on quantitation and 
proteome coverage can considerably vary depending on the source and grade of the 
enzyme. For large-scale studies, it is often preferable to use a less expensive 
commercial version of trypsin, even with the caveat of less specificity, since 
otherwise the cost of the study would not be feasible for most research groups. 
Figure 1.16 illustra tes the amino a cid sequence of a typical IMP (Scheuring et al. , 
1999). 
Extracellular side 
Cytoplasmic side 
Figure 1.16 Amino acid sequence and approximate topology of Escherichia coli 
water channel aquaporin Z and its transmembrane regions. Trypsin enzymatic 
cleavage sites are coloured in blue. The residues in red mark potential pepsin 
cleavage sites which targets more hydrophobie residues (image adapted from 
Scheuring et al., 1999). 
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As depicted in Figure 1.16, trypsin cleavage sites are usually located on the 
cytosolic and extracellular regions of an IMP. Tberefore, even if protein-lipid 
interactions are broken and TMDs are fully solubilized, a generic trypsin digestion 
procedure would likely not provide enough sequence coverage from the 
transmembrane regions . However, if a protease with more specificity towards 
hydrophobie residues is employed in conjunction; better sequence coverage could be 
obtained for sucb a protein. This idea led to the development of a dual-enzyme 
digestion approach for more efficient analysis of liver microsomes, which are rich in 
membrane pro teins, in the first part (Chapter 2) of this dissertation. 
For protein solubilization, two types of intramolecular interactions must be 
overcome: (1) protein-protein interactions, and (2) protein-lipid interactions. Ionie 
detergents such as alkyl sulfates, alkyl phosphocholines, and bile acid salts can 
efficiently disrupt protein-protein interactions and are commonly used in most 
proteomics applications. Non-ionie detergents, on the contrary, readily interfere with 
protein-lipid and lipid-lipid interactions and are more preferred for samples enriched 
in membrane proteins, such as the microsomal fractions . Chaotropes, such as urea, 
thiourea and guanidinium chloride, are strong denaturing agents that stabilize 
unfolded protein states via hydrogen bonds and electrostatic interactions and are 
effective against ali above-mentioned interactions. Sorne organic solvents and 
carboxylic acids have intrinsic protein denaturing properties and disruptive effect on 
membrane bilayers thus enhancing IMP solubilization (Speers and Wu, 2007). In this 
thesis, memb~rs from each group of solubilizing agents were tested for the analysis of 
liver microsomal proteins, and the method with the highest performance was selected 
(Figure 1.17). Optimization of the solubilization and digestion steps for the analysis 
of rat liver microsomes is discussed in more detail in Chapter 2. 
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Figure 1.17 Solubilizing agents tested for the analysis of liver microsomal proteins 
were selected from different classes: (1) sodium n-dodecyl sulfate (SDS); (2) n-
tetradecyl phosphocholine (FC-14); (3) n-dodecyl maltoside (DDM); ( 4) sodium 
deoxycholate (SDC); (5) guanidinium hydrochloride; (6) methanol; (7) formic acid; 
(8) trifluoroacetic acid. 
Liver microsomes are often used to study xenobiotic metabolism in vitro, and 
covalent binding to microsomal proteins serves as a surrogate marker for toxicity 
mediated by reactive metabolites (Shin et al., 2007). Microsomes are membrane 
vesicles formed in subcellular fractionation, after separation of S9 and cytosolic 
fractions, consisting largely of the endoplasmic reticulum (ER), plasma membranes, 
lysosomes, peroxisomes, nuclear membranes, and cytoplasm, and are rich in CYP, 
UGT, GST, FMO, 12 and other xenobiotic-metabolizing enzymes. In vitro microsomal 
metabolism studies provide useful information on oxidative pathways involved in 
reactive metabolite formation and covalent binding to proteins, which are, to sorne 
extent, comparable to the tendency for covalent binding and toxicity in vivo (Shin et 
12 Flavin-Containing Monooxygenase 
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al., 2007). The workflow used to identify potential target pro teins of reactive 
metabolites from liver microsomal incubations is demonstrated in Figure 1.18. 
liver rnicrosomes - ~ dm~ co-fac tor (NADPH) 
------------------: peptide fractionation 1 
•-------- --------~ 
metabolism r 
solubilization 1 (incubation) l 
------------------digestion l+---t1 protein fi:actionation : 
L-------------------~ l-----------------1 
proteomics data 
analysis target proteins 
Figure 1.18 Workflow of an in vitro experiment using liver microsomes to study 
protein covalent binding 
Microsomal samples contain large quantities of impurities and compounds 
that can hinder protein digestion and/or downstream LC-MS/MS analysis, and hence 
require post-incubation clean-up procedures. Interfering compounds can decrease the 
efficiency of RP-LC separation via selectively binding to the active sites of the 
stationary phase ("column saturation") and also cause ion suppression, affecting the 
MS performance (Polettini, 2006). The main cause of ion suppression in ESI-MS of 
the biological samples is a change in the spray droplet solution properties caused by 
the presence of non-volatile or less volatile solutes including salts, ion-pairing agents, 
endogenous compounds, drugs and metabolites. These compounds change the 
efficiency of droplet formation or droplet evaporation affecting the amount of ions 
that eventually reach the detector. lt has also been shawn that: (1) analytes with 
similar or close m/z values can suppress each other; (2) molecules with higher mass 
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can suppress the signal of smaller molecules; and (3) more polar analytes are more 
susceptible to ion suppression (Annesley, 2003). To minimize potential LC-MS 
interferences from microsomal samples, several clean-up methods were tested in this 
work including protein precipitation, molecular weight eut-off filtration and mixed-
mode SPE. These efforts will be described in details in Chapters 2, 3 and 5. 
1.3 .2 Data Processing Workflow 
Another challenge in modern MS-based protein identification is effectively 
using database search software to figure out the correct peptide spectral match while 
maintaining control over false identifications (" false positives") . Most protein search 
engines provide an estimated probability of correctness of putative identifications 
through "false discovery rate (FDR)" analysis . These analyses usually employ a 
technique known as "target-decoy database searching", in which the database search 
engine is provided with potential incorrect answers (decoys) generated by 
randomizing or reversing true sequences (targets). The rate of occurrence of these 
known-incorrect answers in the search output is then used to estimate the FDR (Tang 
et al. , 2008). False protein IDs usually originate from law-confidence peptide spectral 
matches (inaccurate precursor mass or low-quality MS/MS spectra), or wrong 
modification identification (Shin et al. , 2007). 
Although state-of-the-art software produce lists of identified proteins at as low 
as 1% FDR, false positives can never be fully eliminated and often require manual 
verification of the corresponding LC-MS/MS data. Other efficient strategies to 
efficiently reduce FDR are (1) increasing the number of analytical replicates (n) , and 
(2) the use of control samples (Veenstra and Smith, 2003). ln this thesis, LC-MS/MS 
data from acetaminophen-treated rat liver microsomes were compared to control (no 
drug) samples using multiple complementary data analysis approaches . The final list 
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of putative bits was then manually inspected in terms of accurate mass, charge state, 
and MS/MS spectra to exclude remaining potential false positives. The developed 
data processing workflow will be widely discussed in Chapter 5. 
1.3.3 Research Outline 
This research was originally designed in three phases attempting to address 
important challenges in the proteomic workflow for identifying reactive metabolite 
protein targets. The main focus of Phase 1 was on protein solubilization and digestion. 
ln this phase, several solubilizing agents including detergents, chaotropes, methanol 
and acids were tested for their capability to extract proteins from liver microsornal 
samples. In addition, different proteases were examined separately, and in 
combination, under basic and acidic conditions. The optimal solubilization-digestion 
scenario was selected based on performance characteristics, that is, the number of 
identified peptides and proteins, and average protein sequence coverage. An initial 
offline 2D-LC-MS/MS approach was also developed coupling SCX peptide 
fractionation to ultra-high-pressure RP-LC prior to the MS/MS analysis . The outcorne 
of this part of the study was published as a research article and is presented in 
Chapter 2. 
ln phase II, the objective was to maximize the separation power of the initial 
LC-MS/MS method for the efficient analysis of protein-enriched liver samples. 
Protein- and peptide-leve! ion-exchange fractionation methods were compared, 
separately and combined, to regular (no fractionation) LC-MS/MS and the method 
with the best performance was selected and tested for liver S9 and microsomal 
fractions from rat, mouse, and human. The method development and cross-species 
analysis results were published in two articles and will be discussed in Chapters 3 
and4. 
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Finally, !essons leamed from Phases I and II were applied to real biological 
samples in attempt to identify protein targets of acetaminophen 's reactive metabolite 
following in vitro microsomal incubations. For an in-depth data processing of the 
results, a four-stage data analysis workflow was established for the identification of 
target proteins while focusing on removing false positives (Chapter 5). In the last 
chapter, a semi-targeted approach is presented for detecting covalent binding of a 
specifie protein (MMP-13) in vitro and validated using patient chondrocyte cell 
cultures. Figure 1.19 demonstrates the general layout of this dissertation and 
challenges addressed in each phase. 
Phase 1: 
Sample 
Preparation 
Protein solubilizatlon 
Digestion 
Initial LC-:\15"1 metbod 
" 
Phase li: 
MDLC-MS/MS 
Analysis 
Sample ty pe 
Pre-fractiona lion 
:\IS" IS para met ers 
" 
Phase ill: 
Data Processing 
Final optimlzatlons 
Data analysis workflow 
• Blo loglcal slgnlllcance 
Figure 1.19 Research design in the development of analytical methods for the 
identification of reactive metabolites target proteins 
CHAPTER TWO 
OPTIMIZED PROTEOMIC AN AL YSIS OF RAT LIVER MICROSOMES USING 
DUAL ENZYME DIGESTION WITH 2D-LC-MS/MS 
Makan Golizeh and Lekha Sleno 
Published in Journal of Proteomics 2013, 82, 166-178. Supplementary data available online at 
doi: 10. 10 16/ j. jprot. 201 3.02.00 1. 
The first step towards the identification of reactive metabolite protein targets 
was to develop an analytical method to maximize the number and sequence coverage 
of the proteins identified in liver microsomes. In this chapter, an optimized sample 
preparation workflow was established with a focus on solubilization and digestion of 
rat liver microsomal proteins using 2D-LC-MS/MS. SDS-assisted solubilization with 
parallel trypsin/pepsin dual-digestion combined with SPE clean-up, SCX 
chromatography and RP-UHPLC-HR-MS/MS provided an efficient approach for the 
analysis of rat liver microsomes. The sample preparation method developed in this 
chapter was improved and used to analyze liver proteins in rat, mouse and human in 
Chapters 3 and 4, as well as the acetaminophen-treated samples in Chapter 5. 
Makan Golizeh and Lekha Sleno are co-authors of this article. Makan Golizeh 
conducted the literature survey, prepared experimental protocols, conducted the 
experiments, processed the data, and prepared the original manuscript. Professor 
Lekha Sleno supported and supervised the project, verified data analysis and 
interpretation of the results, revised and finalized the manuscript. 
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2.1 Abstract 
A systematic approach was developed to optimize the analysis of rat liver 
mtcrosomes combining ton exchange fractionation with reversed-phase 
chromatography coupled to high resolution quadrupole-time-of-flight mass 
spectrometry. A comparison was performed with severa! conditions to select the most 
efficient solubilization and proteolysis protocol to achieve highest proteome 
coverage. Optimal trypsin digestion conditions were achieved with SDS and beat to 
increase solubilization of microsomal samples, with an increase from 621 to 686 
identified proteins when SDS and beat were applied. Pepsin digestion yielded 
complementary results, especially in terms of hydrophobie environments, thus 
allowing sequence coverage to be increased substantially. Severa! dual digestion 
strategies were tested, with trypsin and pepsin combined in series or in parallel. 
A parallel tryptic-peptic dual digestion, combining mass spectral data of single 
enzyme digestions, yielded the best results in terms of number of identified proteins, 
increasing by 29% from the best single enzyme procedure, and sequence coverage 
improved by 5% on average for all proteins identified. Using our complete set of 
data, a total of 1095 proteins were identified with less than 1% FDR, out of which 
213 proteins (19.5%) were integral membrane proteins. Proteomics data have been 
deposited to the ProteomeXchange Consortium with dataset identifier PXD000128. 
2.2 Introduction 
Approximately 25% of all translated genes code for membrane proteins, 
possessing two or more transmembrane domains, and this value increases to 40%, if 
lipid-anchored or membrane-associated proteins and those having a single 
transmembrane helix are taken into account (Bendz et al. , 2009). Membrane proteins 
have strong implications in cell survival, with significant roles in cellular events such 
--------------
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as molecule transport, signal transduction, cell- cell interactions, and response to 
changes in environmental conditions (Rietschel, Bornemann, et al. , 2009; 
Vertornmen et al. , 2011 ). They are an extremely valuable class of pro teins sin ce they 
represent the targets of 70-80% of ali drugs (Mathias et al., 2011), among which G-
protein coupled receptors (GPCRs), protein kinase, cytochrome P450, syntaxin, 
prostaglandin G/H synthase 1 (PTGS) or cyclooxygenase (COX) families are sorne 
remarkable examples (Imming et al. , 2006). Two main categories of membrane 
proteins exist; those which are physically integrated into the membrane, tightly bound 
and only released using strong solubilizing agents (integral membrane proteins, IMP) 
and those that are associated with the membrane and more easily released from the 
membrane using gentle extraction procedures (peripheral membrane proteins, PMP) 
(Vertommen et al. , 2011). Integral membrane proteins (IMPs) can be either ~-barrels 
or a-helices. a-Helix bundle proteins are the most abundant membrane proteins, 
having one or more a-helical transmembrane domains (TMDs), and pose technical 
difficulties for proteomic characterization due to their hydrophobie nature. These 
proteins can be either monotopic (membrane-anchored), bitopic (single-pass integral), 
or polytopic (multiple-pass integral) (Gilmore and Washburn, 2010; Speers and Wu, 
2007). 
Because of their solubility issues, membrane proteins can be absent from a 
simple celllysate and thus protein enrichment is essential for their analysis. Cornmon 
strategies include: subcellular fractionation , delipidation and affinity purification 
(Gilmore and Washbum, 2010). ln subcellular fractionation, which is most often 
employed, low abundant hydrophobie proteins can be enriched into a microsomal 
fraction (Van Summeren et al., 2012). Microsomes are small lipid vesicles which 
form spontaneously when cells are mechanically dismpted, and are a rich source of 
IMPs from endoplasmic reticulum (ER), plasma membrane, mitochondria, and Golgi 
apparatus (Mathias et al., 2011). Liver microsomes are of particular interest, since 
they contain many metabolic enzymes for dmgs and endogenous compounds and are 
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extensively used in pharmacokinetic and drug metabolism studies (Huang et al., 
2011). Numerous studies have been performed on rat (Huang et al. , 2011; Galeva and 
Altermann, 2002; Galeva et al. , 2003 ; Arnold et al., 2004; Nisar et al., 2004), mouse 
(Mathias et al. , 2011; Kanaeva et al. , 2005 ; Zgoda et al. , 2009; Peng et al. , 2012) and 
human (Seibert et al. , 2009; Petushkova et al. , 2006; Yukinaga et al. , 2012) liver 
microsomes to study proteins involved in xenobiotic metabolism and drug-induced 
hepatotoxicity. 
In addition to subcellular fractionation, recent improvements in hybrid 
separation techniques have led to the expansion of shotgun proteomics and helped 
overcome sorne of the challenges in studying membrane proteins. Two-dimensional 
techniques using complementary separations can be employed to increase the 
coverage of the proteome (Gilmore and Washburn, 2010). The most common strategy 
remains the combination of strong cation exchange (SCX) ( on-line or off-line) with 
reversed-phase (RP) separation. An automated online SCX-RP-based methodology, 
known as Multidimensional Protein Identification Technology (MudPIT), bas been 
well established for the analysis of comprehensive protein expression profiles 
(Washbum et al. , 2001). However, in comparison with online 2D-LC-MS, which is 
faster and less laborious for high-throughput proteomic studies, an offline approach 
provides increased flexibility and higher resolution due to the continuous linear 
gradient of SCX-chromatography in the first dimension without intermittent RP-
chromatography separations (Nagele et al. , 2004). The primary role of any pre-
fractionation is to reduce the complexity of the peptide mixture, so that the mass 
spectrometer bas sufficient time to fully interrogate the sample, with the added 
benefit ofdecreasing ion suppression (Khan et al. , 2011). 
Mass spectrometry-based proteomics platforms include quadrupole-time of 
flight (QqTOF), linear ion trap, Orbitrap, and Fourier transform ion cyclotron 
resonance (FT-ICR) instruments (Walther and Mann, 2010). Orbitraps and QqTOF 
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instruments in combination with liquid chromatography have become the two most 
prominent systems used in proteomics, with high resolution capabilities for accurate 
mass measurements as well as high sensitivity and isotopie fidelity (Eichhorn et al., 
2012). The most recently introduced platforms have also increased their sequencing 
speeds so many more eluting peaks can be targeted for MS/MS in a data-dependent 
fashion, thus increasing the potential for higher proteome coverage. 
To achieve good sequence coverage, proteins must be fully accessible for 
digestion, which remains a significant challenge for the analysis of membrane 
proteins (Griffin and Schnitzer, 2011). Solubilizing agents thus facilitate sample 
preparation in membrane proteomics, and can be divided into several categories 
(Speers and Wu, 2007; Berridge et al. , 2011; Chen et al., 2007; Le Maire et al. , 
2000). Chaotropes are strong denaturing agents that stabilize unfolded proteins via 
hydrogen bonds and electrostatic interactions. Linear-chain ionie detergents (e.g. 
SDS) are extremely efficient at solubilizing proteins. Bile acid salts are steroidal ionie 
detergents and are significantly milder solubilizing agents . Non-ionie detergents have 
polyoxyethylene (POE) or glycosidic polar groups combined with a hydrophobie 
chain and are also considered to be mild detergents. Zwitterionic detergents also 
exist, including sulfobetaine and phosphocholine derivatives. MS-compatible 
detergents have been developed to solve the interference issue of many detergents 
with mass spectrometry. These detergents either easily break down into non-
surfactant by-products or do not interfere with proteomic analysis due to their 
orthogonal LC elution (high organic %) to most peptides. Aqueous-organic solvent 
systems are another alternative for facilitating protein digestion and are directly 
compatible with LC-MS. Finally, organic acids can also be useful for membrane 
disruption and integral membrane protein solubilization. SDS has been the most 
commonly used detergent for the analysis of li ver micros ornes (Huang et al. , 2011 ; 
Galeva and Altermann, 2002; Galeva et al. , 2003; Nisar et al., 2004; Zgoda et al. , 
2009; Peng et al. , 2012; Seibert et al. , 2009; Petushkova et al. , 2006). However, 
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Triton X-114 (Mathias et al. , 2011), sodium cholate (Kanaeva et al. , 2005) and the 
MS-compatible RapiGest (Arnold et al. , 2004) have also been employed. 
Even though solubilized membrane proteins provide better access to trypsin, 
TMDs often Jack tryptic cleavage sites; therefore the use of this enzyme bas been 
challenged for membrane proteins. Consequently, Jess specifie proteases like 
chymotrypsin (Speers and Wu, 2007; Yu et al., 2003), elastase (Rietschel, Arrey, et 
al. , 2009) and proteinase K (Bendz et al. , 2009; Speers and Wu, 2007) have been 
considered as alternatives. Aside from these, pepsin bas also been suggested as a 
valuable tool in membrane proteomics. It is presumed that, due to its more 
hydrophobie cleavage sites, it can better cleave membrane-embedded lipophilic 
portions of IMPs leading to a better sequence coverage for the analysis of these 
proteins (Rietschel, Bomemann, et al. , 2009; Han and Schey, 2004). However, 
trypsin offers some major advantages for LC-MS/MS analysis, not easily ignored 
even in the case of membrane proteins, such as an optimal average peptide length of 
~ 14 amino acids and the presence of at !east two positive charges, at the N-terminus 
and C-terminal Arg or Lys (Burkhart et al. , 2012). Dual enzyme digestion procedures 
have been employed to combine the benefits of complementary cleavage behaviors, 
increasing protein sequence coverage by generating more analyzable peptides per 
protein. Trypsin-chymotrypsin (Fischer and Poetsch, 2006), trypsin-endoproteinase 
Glu-C (Prabakaran et al. , 2001), trypsin-proteinase K (Distler et al., 2006; Han et al. , 
2002), trypsin-cyanogen bromide (Washbum et al. , 2001 ; Fischer and Poetsch, 2006; 
Van Montfort et al., 2002), proteinase K-cyanogen bromide (Speers et al. , 2007), and 
pepsin-pancreatin (Reyes et al. , 2006) are sorne examples of sequential dual enzyme 
digestions. It is also been suggested in a previous article (Mbeunkui and Goshe, 
2011), where they tested four different and complementary solubilization teclmiques 
for microsome analysis, that applying two different solubilization methods would 
provide a more effective coverage of membrane proteins. Therefore, if using a dual 
enzyme system for increasing coverage of the rat microsome proteome, different 
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solubilizing agents added at each digestion step could potentially ameliorate the 
results even further. 
ln this study, offline 2D-LC was coupled to a high-resolution QqTOF mass 
spectrometer for the analysis of rat liver microsomes with combined tryptic and 
peptic digestions, using SDS and MeOH/TF A as complementary solubilizing 
methods. Results were compared to those using solubilizing agents from different 
classes with single enzymes, as well as sequential and parallel dual digestions in 
terms of number of peptides and proteins, integral membrane proteins, and overall 
sequence coverage. 
2.3 Experimental 
2.3 .1 Materials 
Male Sprague-Dawley rat liver mtcrosomes (20 mg/ml of protein) were 
purchased from Celsis (Baltimore, MD). Sequencing-grade modified trypsin was 
obtained from Promega (Madison, WI). Iodoacetamide and trifluoroacetic acid were 
from Alfa Aesar (Ward Hill, MA), trichloroacetic acid from VWR International 
(West Chester, PA), and n-tetradecyl phosphocholine (FC-14) from Affymetrix 
(Maumee, OH). Porcine gastric mocusa pepsin and type XVII-B endoproteinase 
Glu-C from Staphy lococcus aureus strain V8, as well as ail other chemical reagents 
(analytical grade) were purchased from Sigma-Aldrich (St. Louis, MO). HPLC-grade 
methanol and acetonitrile were acquired from EMD Chemicals (Gibbstown, NJ) . Ail 
solutions were prepared using nanopure water purified by a Millipore Synergy UV 
system (Molsheim, France). 
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2.3.2 Sample Preparation 
Rat liver microsomes (500 J..lg, 25 J..ll) were added to a solubilizing solution 
( 40 J..ll) and sonicated for 10 minutes (Branson 2510 ultra-sonic bath, Dan bury, CT). 
Samples labeled asTO (trypsin only), GC (Glu-C) and P (pepsin) were suspended in 
100 mM ammonium bicarbonate pH 8.5 For other samples, the following solutions 
were used for solubilization: 4% sodium n-dodecyl sulfate (SDS) forTS (trypsin with 
SDS), TSH (trypsin with SDS and beat) and PSH (pepsin with SDS and beat), 1% 
sodium deoxycholate (SDC) for TB (trypsin with bile acid), 2% n-dodecyl maltoside 
(DDM) for TD, 1% n-tetradecyl phospbocholine (FC-14) for TF, 6 M guanidinium 
chloride for TG and 60% methanol in 20 mM Tris-HCl for TM. TSH and PSH were 
incubated for 3 minutes at 95°C. Ail conditions were performed in duplicate. Samples 
were subsequently incubated with ditbiothreitol (DTT) at a final concentration of 
25 mM to reduce disulfide bonds (10 min, RT). Reduced samples were then alkylated 
with iodoacetamide (lAM) at a final concentration of 50 mM for 30 minutes at 37°C 
in the dark. Protein precipitation was performed with 20% trichloroacetic acid (TCA) 
and leaving on ice for 15 minutes. After centrifugation (13 ,000 rpm, 10 min at 4°C), 
the supernatant was discarded and pellets were wasbed with 10 % TCA (150 J..ll) , 
centrifuged (13 ,000 rpm, 5 min), then washed with nanopure water (100 J..ll) three 
times to remove residual acid. 
2.3.3 Digestion Conditions 
Protein pellets were resuspended in 100 mM ammonium bicarbonate, pH 8.5 
(250 J..ll) for trypsin and Glu-C digestions, or in 0.11 % trifluoroacetic acid in 10% 
methanol, pH 2.0 (500 J..ll) for pepsin digestions, and incubated at a 1 :50 (w/w) 
enzyme to protein ratio for 18 h, at 37°C for trypsin and Glu-C and at 25°C for 
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pepsin. Digestion was quenched by adding 1% formic acid (50 J...l.l) (for trypsin and 
Glu-C) or 1% ammonium hydroxide (50 J...1.1) (for pepsin) and protein digests were 
evaporated to dryness under vacuum (ThermoFisher Scientific Universal Vacuum 
System, Asheville, NC). For sequential digestions (T-P, P-T, T-C, TSH-P and 
PSH-T), the resolubilized sample was subjected to a second treatment with either 
pepsin for 4 h, trypsin for 18 h, or cyanogen bromide for 15 h. ln the case of T-C, the 
tryptic digest was incubated first with 90% formic acid (100 J...l.l) at room temperature 
for 5 minutes, followed by the addition of 100 mg cyanogen bromide and the reaction 
stopped by adding methanol (250 J...l.l) . Resulting samples were also evaporated to 
dryness. All samples were kept at -30°C prior to SCX fractionation. 
2.3.4 Strong Cation Exchange Fractionation 
Protein digests were reconstituted in buffer A (100 J...l.l) , sonicated for 10 
minutes, and centrifuged (13 ,000 rpm, 5 min) prior to injection ( 40 J...l.l) onto a Zorbax 
300-SCX 2.1 x 150 mm column with 5 J...l. particles (Agilent Technologies, Palo Alto, 
CA) using an Agilent 1200 series HPLC equipped with a binary pump, degasser, 
diode array detector and fraction collector. Strong cation exchange (SCX) 
fractionation was performed at a flow rate of 300 J...l.llmin using a gradient of 0-50% B 
in 15 min, up to 100% B at 25 min, then held for an additional 7 min at 100% B, 
where buffers A and B were 10 mM potassium dihydrogen phosphate in 25% 
acetonitrile (pH 2.75), and 1 M potassium chloride in buffer A (pH 2.75), 
respectively. Absorbance was monitored at 220 and 280 nrn . One minute fractions 
(300 !J.l) were aliquoted into a 96-well plate. For tryptic digestions, fractions eluting 
from 5-21 min were subsequently evaporated, whereas for peptic digestions, fractions 
eluting from 4-23 min were used (Figure 2.1). ln the case of parallel dual digestions, 
tryptic and peptic digests were mixed and then fractionated (TP-mf); with fraction 
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collection performed as for samples from trypsin-only digests. For TP-fm samples, 
SCX fractions were combined from 16 tryptic fractions and 19 peptic fractions, by 
merging three pairs of peptic fractions with the lowest UV signais, in order to have a 
total of 16 samples for LC-MS/MS analysis . 
2.3.5 Reversed-Phase UHPLC-MS/MS 
Dried fractions were reconstituted in 10% acetonitrile (100 J.ll) and injected 
(20 f.ll) onto a Kinetex XB-C 18 2.1 x 100 mm column, with solid core 1.7 J.lm particles 
(100 Â) (Phenomenex, Torrance, CA) using a Nexera UHPLC (Shimadzu, Columbia, 
MD). Reversed-phase liquid chromatography was performed using 0.1 % formic acid 
in water (A) and 0.1% formic acid in acetonitrile (B), with a gradient of 5-30% B in 
15 min, to 40% B at 24 min, followed by a sharp increase to 80% B at 25 min and 
held for an additional 3 min prior to re-equilibration of the column, and a flow rate of 
300 f.ll/min at 40°C. To protect the ion source against high salt concentrations from 
SCX elution, a Rheodyne switch valve (IDEX Health and Science, Oak Harbor, W A) 
was used to send eluent to waste during the first two minutes of the run. Ail MS and 
MS/MS spectra were collected on a high-resolution hybrid quadrupole-time-of-fligbt 
(QqTOF) TripleTOF 5600 mass spectrometer (AB Sciex, Concord, ON, Canada) 
equipped with a DuoSpray ion source in positive ion mode. The instrument 
performed a survey TOF-MS acquisition from m/z 140-1250 with an accumulation 
ti me of 250 ms, followed by MS/MS on the ten most intense ions with + 1 to +4 
charge states from m/z 250-1250 using information-dependent acquisition (IDA) with 
dynamic background subtraction (DBS). Each MS/MS had an accumulation time of 
100 ms and collision energy ranging from 20 to 40 V, depending on the charge state 
and mass of the product ion. The total cycle time was 1.3 seconds. Figure 2.1 depicts 
representative LC-MS/MS data from tryptic (TSH) and peptic (P) digestions . 
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2.3.6 Data Processing 
MS/MS files from each set of fractions were concatenated and searched 
against the UniProt protein database (release date 12-07-2011 , 241 MB) by 
ProteinPilot software (version 4.1) using Paragon algorithrn (Shilov et al. , 2007) with 
the following parameters: protein identification with thorough ID search effort, 
iodoacetamide for cysteine alkylation and no specified proteolytic enzyme for rattus 
norvegicus with ID focus on biological modifications, detection protein threshold of 
unused ProtScore > 0.05 (confidence > 10.0%) and including false discovery rate 
(FDR) analysis. MS tolerance was 0.05 Da on precursor ions and 0.1 Da on 
fragments and the search was performed for +2 to +4 charge states. For TP-co, 
MS/MS files from TSH and P were co-processed representing a sample in which 
SCX fractionation and RP-LC steps have been performed separately and data then 
combined for searching purposes for two parallel tryptic and peptic digestions. Using 
ProteinPilot Descriptive Statistics Template (version 3.001p) 
(http ://www.absciex.com/PDST), proteins were identified based on 1% global false 
discovery rate criteria using a target-decoy data base search algorithm (Tang et al. , 
2008). ProteinPilot Protein Alignment Template (version 2.000p) was also used for 
rep licate analysis . MS spectra for TSH, P, TP-co data sets have been deposited to the 
ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the 
PRIDE partner repository (Vizcaino et al. , 2010) with the dataset identifier 
PXD000128 . 
The list of UniProt accession numbers was uploaded to NCBI Batch Entrez 
(http://www. ncbi .nlm.nih .gov/sites/batchentrez) to obtain the batch FASTA file , 
which was subsequently submitted to ExPASy (http://www.expasy.org) for 
determination of isoelectric point and monoisotopic molecular weight and to Phobius 
(http ://phobius.sbc.su.se) for the prediction of integral membrane proteins, and 
compared to predictions done by other traditional transmembrane predictive 
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algorithms such as TMHMM (http: //www.cbs.dtu.dk/services/tmhmm), SCAMPI 
(http: //scampi .cbr.su.se), and SOSUI (http ://bp.nuap.nagoya-u.ac.jp/sosui). GRA VY 
Calculator (http://www.gravy-calcu lator.de) was used to calculate grand average of 
hydropathy (GRA VY) scores. The list of accession numbers was also uploaded to 
PANTHER (Thomas et al. , 2003) (http ://www.pantherdb.org) for gene ontology 
classification and to InnateDB (Lynn et al. , 2008) (http ://www.innatedb.ca) in order 
to perform the protein-protein interaction analysis with orthologous UniProt 
identifiers as the cross-reference database and filtered to show only interactions 
between uploaded proteins. The results were subsequently visualized with the 
Cerebral plu gin (Barsky et al. , 2007) of Cytoscape software 
(http ://www.cytoscape.org) version 2.8 .2 to organize the interaction network in the 
context of subcellular localization for all of the proteins displayed and visualized by 
Cerebral. A Venn diagram was created by BiolnfoRx area-proportional Venn diagram 
piotter (http ://apps .bioinforx.com) and other data were processed and visualized by 
Microsoft Excel 2010. 
2.4 Results and Discussion 
In this comparative study, eighteen different treatment conditions, including 
three different enzymes and seven solubilizing agents, were tested in order to select 
the enzyme-detergent combination with the highest proteome coverage, using single 
enzyme, sequential dual enzyme, and parallel dual enzyme digestion procedures. A 
thorough analysis of all proteins identified was then performed to describe the rat 
liver microsomal proteome based on severa! physicochemical characteristics, 
including isoelectric point, molecular weight and hydropathy distributions, as weil as 
the extent of sequence coverage of these pro teins and their functional roi es . 
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2.4.1 Single-Enzyme Digestion 
Trypsin, being the most commonly used protease for shotgun proteomics 
application, but with certain limitations for membrane proteins, was tested in the 
presence of multiple solubilizing agents to increase proteome. coverage. Seven 
different categories of solubilizing agents were used, in order to assess all available 
classes of molecules. Also, in terms of enzymatic proteolysis , since microsomal 
fractions are rich in membrane proteins, it was anticipated that a Jess-specifie 
enzyme, such as pepsin, would help identify more IMPs by cleaving membrane-
embedded portions normally inaccessible to trypsin. As expected, under detergent-
free conditions (TO vs. P), pepsin digestion identified a higher proportion of IMPs 
while trypsin led to a higher number of proteins and a better sequence coverage 
overall. Table 2.1 gives the compiled results of all tested conditions from this study in 
terms of number of pro teins and peptide identified, sequence coverage and proportion 
of IMPs. Glu-C did not provide satisfactory results under the conditions tested in 
comparison to the other two enzymes. Figure 2.2 compares the percentage of 
identified proteins for trypsin, pepsin and endoproteinase Glu-C digestions of the 
total number of proteins covered by these three enzymes without added solubilizing 
agent (786 proteins in total). The Venn diagram clearly demonstrates that Glu-C adds 
the least amount of complementary data, and shows that the combination of pepsin 
and trypsin covers the vast majority of proteins (95%). Glu-C digestion also yielded a 
drastically lower number of peptides than the other two enzymes tested, and thus was 
not chosen for further evaluation. 
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TO (87.8 %) 
p (50.8 %) 
Figure 2.2 V eon diagram representing the proportion of identified proteins for single 
enzyme digestions as a function of the total number of proteins from trypsin (TO), 
pepsin (P) and Glu-C (GC) data sets combined 
In order to examine the solubilizing power of different classes of detergents 
and denaturants, one reagent from each functional category was selected, while 
considering the conditions required for enzyme activity such as pH, temperature and 
critical micelle concentration (CMC). SDS represented linear-chain ionie detergents, 
while SDC, DDM, and FC-14 were used as steroidal ionie, non-ionie and zwitterionic 
detergents, respectively. Guanidinium chloride represents the chaotropic group. 
Methanol was used in an aqueous-organic solvent system, and trifluoroacetic acid 
was employed as an organic acid. Adding solubilizing agents to trypsin sometimes, 
but not always, improved the overall performance of proteomic analysis on rat liver 
microsomes. As illustrated in Table 2.1, all solubilizing agents tested enhanced the 
average protein sequence coverage except guanidinium chloride (TG) which gave a 
slightly higher proportion of identified lMPs, probably due to its membrane-
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disruptive nature as a chaotropic agent. Guanidinium chloride is known to be a strong 
protein denaturant due to efficient charge-charge interactions on the protein surface 
(Vecchio et al., 2002) and has previously been employed in the analysis of liver 
microsomes (Zgoda et al. , 2009). The best overall sequence coverage was obtained 
by the methanol-water solution (TM) and the glycosidic non-ionie detergent DDM 
(TD). However, only heated SDS (TSH) demonstrated a higher number of peptides 
and proteins comparing to trypsin alone. Methanol aqueous solution was also 
previously reported (Blonder et al. , 2004; Y e et al. , 2009) as an effective solubilizing 
agent for the analysis of microsomal membrane proteome providing a better detection 
of hydrophobie proteins despite decreasing trypsin activity (Mbeunkui and Goshe, 
2011 ). The total number of identified pro teins portrays the overall proteome co vera ge 
and, in this set of experiments, was best achieved with the TSH treatrnent, also 
yielding very good results in terrns of characterization of llv1Ps and overall protein 
sequence. Therefore, heated SDS solubilization combined with trypsin digestion was 
found to be the best single enzyme treatment condition for proteomic analysis of rat 
liver microsomes. Concerning compatibility issues with MS detection, because of 
TCA purification and SCX fractionation steps, excess detergent is removed prior to 
applying samples to reversed-phase chromatography. Also, the use of an automated 
switch valve during the LC-MS/MS analysis ensured that residual non-volatile salts 
from SCX fractions did not interfere with downstream electrospray ionization. 
2.4.2 Sequential Dual-Enzyme Digestion 
In a second set of experiments, the idea of usmg two complementary 
digestions was tested using trypsin in combination with either pepsin or cyanogen 
bromide ( chemical digestion). Although it was assumed that a dual digestion of rat 
liver microsomes with trypsin followed by a complementary enzyme (pepsin) would 
exhibit better overall performance, none of the combinations tested represented any 
66 
superiority over trypsin alone. It was interesting though that: (1) performing pepsin 
digestion before trypsin (P-T) digestion led to better results than the reverse order 
(T -P), especially in terms of enhanced protein sequence coverage, and (2) 
solubilizing the microsomes in SDS when two digestions were performed in series 
actually decreased the overall performance (Table 2.1 ). This unanticipated result 
could potentially be explained by interference between SDS and the acidic 
environment needed during pepsin digestion, or the decreased activity ofpepsin in the 
presence of residual SDS during digestion. There is also the notion that using two 
enzymes in series adds complexity to the peptide mixture that is to be fractionated, 
and thus each fraction analyzed by LC-MS/MS is, as a result, much more complex. 
This can lead to increased ion suppression if too many peptides are eluting from the 
column at the same time, as well as a decreased ability to sequence each peptide 
eluting based on data-dependent triggering for MS/MS acquisition. There is most 
likely room for improvement in terms of results from sequential digestion samples if 
the resolution of the pre-fractionation or reversed-phase separation was increased to 
deal with the higher complexity of the sample. For this study, however, it was 
deemed more appropriate to keep ail chromatographie steps identical between 
comparative treatment conditions as well as not to have extremely long LC-MS/MS 
run times. 
2.4.3 Parallel Dual-Enzyme Digestion 
Parallel dual enzyme digestions were can·ied out in three different 
configurations. In the first treatment, tryptic (TSH) and peptic (P) digestions were 
performed separately, and then resulting digests were mixed and fractionated together 
(TP-mf). In the second treatment, digests were fractionated separately, and then 
combined prior to LC-MS/MS (TP-fm). In the third parallel digestion strategy, 
trypsin and pepsin digests were fractionated and analyzed separately by LC-MS/MS, 
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followed by compiling mass spectrometry data from both digests and processing the 
data together in ProteinPilot (TP-co ). As illustrated in Table 2.1 , mixing digests after 
fractionation led to better results than when they were combined prior to SCX 
purification. This shows that the resolution of the ion-exchange separation decreases 
with increased complexity of the peptide digest. This step could potentially be 
optimized for increased resolution by either using a higher capacity chromatographie 
column or a longer gradient elution profile. Less proteins were identified in parallel 
dual enzyme digestion comparing to trypsin digestion alone, except for the condition 
when separate mass spectral data were co-processed from individual tryptic and 
peptic SCX fractions (TP-co), which yielded ideal results both in terms of quantity 
(number of proteins and peptides) and quality (sequence coverage) of data. This 
treatment condition is a good example of a dual enzyme digestion procedure in which 
two proteases act to compensate the practical limitations of each other, and thus 
increase the overall protein sequence coverage by generating more cleavage peptides 
per protein. As the results demonstrate, this treatment yielded more identified 
peptides by MS/MS, translating into a higher number of proteins and better overall 
sequence coverage. Furthermore, for the 34 7 pro teins shared between TSH, P and 
TP-co, a significant increase in average protein sequence coverage was observed for 
the tryptic-peptic dual digestion (TP-co, 38.7%) comparing to tryptic (TSH, 30.7%) 
or peptic (P, 16.5%) digestions alone (see Supplemental Information S1c). In 
addition, 12 proteins were found to be unique to the TP-co condition representing the 
increased statistical value of combining data sets before processing with ProteinPilot 
versus simply combining separate TSH and P searches. 
The difference in sequence coverage between trypsin and pepsm, used 
separately and in parallel is interesting to illustrate for protein of different 
hydrophobicities . Table 2.2 presents a comparison for a globular (soluble) protein, a 
peripheral membrane protein and an integral membrane protein in terms of % 
sequence coverage and number of confident peptides. Glutathione S-transferase Mu 2 
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[P08010], a globular protein, demonstrated much better results for trypsin (TSH) 
than pepsin (P) and since the protein is relatively hydrophilic (GRA VY < 0) and rich 
in tryptic cleavage sites, trypsin-pepsin parallel dual digestion (TP-co) did not yield 
better results than trypsin alone. Cytochrome P450 2D26 [P10634], which is a 
peripheral membrane protein (PMP) and is amphiphilic (GRA VY :::::: 0), represented a 
less significant increase in performance with trypsin compared to pepsin, and the 
parallel dual digestion procedure was more advantageous in this case. In contrast, 
pepsin digestion provided better results than trypsin for microsomal glutathione S-
transferase 1 [P080Il ], an integral membrane protein (IMP). For this relatively 
hydrophobie (GRA VY > 0) membrane protein, parallel dual digestion further 
increased the overall digestion performance and represented a more significant 
complementary behavior for the two enzymes since cleaving at both tryptic and 
peptic sites led to higher protein sequence coverage. This comparison illustrates the 
intrinsic ability of the parallel dual-solubilization/digestion procedure for higher 
sequence coverage over the traditional single digestion, and its increased applicability 
for the analysis of samples enriched in membrane proteins. 
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2.4.4 Analysis of Identified Proteins 
In this study, a total of 1095 proteins were identified in rat liver microsomes 
with a 1% global false discovery rate (FDR) out ofwhich 213 proteins (19.5%) have 
been predicted to be IMPs by Phobius, a combined trans-membrane topology and 
signal peptide predictor. The rest are presumed to be either PMPs, other globular 
proteins from ER, Golgi apparatus and mitochondria matrix, or simply, vesicle-
trapped cytoplasmic proteins co-purified during microsomal preparation. Phobius has 
been reported as the best method to distinguish membrane from non-membrane 
proteins in large-scale proteomics studies compared to traditional transmembrane 
domain (TMD) predictors (such as TMHMM, SCAMPI and SOSUI) (Krogh et al. , 
2007; Tsirigos et al. , 2012). It has also been shown (Xiong, 2006) that the prediction 
accuracy is 94% for Phobius compared to 70% for TMHMM. Prediction results 
obtained from our data set were verified using corresponding UniProt annotations of 
identified proteins. This comparison yielded 31%, 40% and 43 % false positives for 
TMHMM, SCAMPI and SOSUI algorithms, respectively, and only 8% for Phobius, 
further proving the superiority of Phobius when it cornes to predicting membrane 
pro teins. 
This large data set gives a very comprehensive view of the proteome in rat 
liver microsomes, especially considering the restriction of 1% FDR for defining an 
identified protein. This analysis represents a massive increase in the overall proteome 
coverage compared to previous proteomic studies of rat liver microsomes (Huang et 
al., 2011 ; Galeva and Altermann, 2002; Arnold et al. , 2004; Nisar et al. , 2004), where 
different strategies have been employed. In one study, 88 proteins were identified 
using a 2D-GE separation coupled to peptide mass fingerprinting (PMF) by MALDI-
TOF-MS (Galeva and Altermann, 2002). Amold et al. (2004) tested the use of urea 
(chaotrope) and ALS (RapiGest mass-compatible detergent) for identifying proteins 
by nanoLC-MS/MS in different samples from rat liver, including microsomal 
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fractions with a total of 143 microsomal proteins being identified. Also, a more 
targeted analysis for cytochrome P450 isoforms (CYPs) in rat liver microsomes was 
performed by SDS-PAGE-LC-MS/MS identifying a total of 24 CYPs (Nisar et al. , 
2004). In a more recent publication, 391 proteins were identified (at 95% confidence) 
by 2D(RP-RP)-nanoLC-MS/MS (Huang et al., 2011). The proteins identified in the 
present study were compared to a compiled list of 232 proteins from these 
aforementioned studies (Huang et al. , 2011 ; Galeva and Altermann, 2002; Nisar et 
al., 2004) with a resulting overlap of 90.5%. Moreover, the 2D-LC-MS/MS method 
used here represented a relatively high reproducibility (71-84%) in terms ofproteins 
identified in duplicate samples (Table 2.1). This reproducibility is mainly a 
consequence of the ability of the mass spectrometer to acquired MS/MS at very high 
speeds as weil as the dynamic background subtraction IDA criteria which alleviates 
the problem of triggering MS/MS acquisition on background ions. Therefore, most of 
the proteome is reproducibly detected, even when we take into account separate 
digestions and SCX fractionations. 
Of note, the current study utilized mu ch higher flow rates coup led to the mass 
spectrometer than traditional proteomics workflows using nanoLC-MS/MS. This 
increased flow rate affords improved robustness and reproducibility, as well as a 
higher throughput. Nanoscale chromatography is considered the most sensitive 
approach, however, when we take into account the increased loading capacities of 
micro-colurnns as well as the improvements in ionization efficiencies at high flow 
rates in most modem mass spectrometers, this effect becomes less apparent. 
Furthermore, the ultra-high pressure system and sub-2 Jlm core-shell column used 
yielded very high chromatographie resolution, especially considering the reasonably 
fast gradient used for peptide elution, in comparison to severa] hours used in sorne 
nanoscale applications for increasing proteome coverage. This fact also contributed to 
increased sensi tivity since peak widths (on average 8-10 seconds at half height) were 
decreased in comparison to longer gradients coupled to nanoscale systems. 
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From this compiled data set, the rat liver microsomal proteome was analyzed 
rn terms of severa! physicochemical properties. First, a comparison of isoelectric 
point and mol ecu! ar weight distribution for the 1095 identified pro teins was 
performed (Figure 2.3 ). Considering the molecular mass distribution of the proteome, 
63% ofproteins were below 50 kDa, 29% in the range from 50 to 100 kDa, and 8% 
above 100 kDa. Also, a reasonably wide range of theoretical isoelectric points, from 
pH 4-12, was found. This offers the potential for protein-level pre-fractionation based 
on isoelectric focusing as a complementary fractionation step (Michel et al. , 2003), 
which could in tum further increase the resolution of the proteomic analysis . ln terms 
of molecular weight, there is a less dramatic distribution, however, an initial protein 
separation could also be envisioned using size-exclusion chromatography, gel 
electrophoresis or, the more recently described and promising technique of Gel-
Eluted Liquid Fraction Entrapment Electrophoresis (GELFrEE) (Tran and Doucette, 
2008). 
14 
12 , 
10 • • ... 
:., ... 
- 8 .:- . • ••• 
c.. ',: • 
6 i .. If. • 
...... 
4 : • • ". • • 
0 
0 100 200 300 400 500 ~0 
MW (kDa) 
1.5 
1.0 
QI 0.5 
0 
.., 0.0 
"' >- ·0.5 
> 
<t ·1.0 
0:: 
l!) ·1.5 
·2.0 
·2.5 
.. 
:~ ...... 
. .. 
. ' 
v 
0 100 200 300 400 500 600 
MW (kDa) 
Figure 2.3 2D map of isoelectric point (left) and GRA VY scores (right) for the 
pro teins identified in this study as a function of molecular weight 
The list of identified proteins was also analyzed in terms of hyclropathy (as 
measured by GRAVY scores). Here, the mean GRAVY score ofthe RLM was -0.27, 
with 17% of identified proteins being characterized as hydrophobie, thus supporting 
the predicted percentage of integral membrane proteins from Phobius (Figure 2.3). 
73 
Overall, an increase in hydrophobicity is seen for smaller proteins, a fact which has 
also been noted in a previous proteomic study on membrane proteins (Fischer and 
Poetsch, 2006). It was also observed that peptic digestion yielded IMPs with more 
sequence coverage of TMDs compared to trypsin, even though the latter led to a 
higher number of IMPs being identified. Figure 2.4 illustrates that not only were 
more IMPs identified by tryptic-peptic parallel dual digestion than either enzyme 
alone, but more TMDs were also obtained with dual digestion. It was also found that 
other parallel dual digestion strategies are not as efficient as the separately treated 
TP-co method regarding the identification of TMD-rich membrane proteins 
(Figure 2.4). 
70 • TSH • P • TP-co 70 • TP-mf • TP-fm • TP-co 
60 60 
50 50 
40 40 
30 30 
20 20 
10 10 
Figure 2.4 Number of transmembrane domains (TMD) of identified integral 
membrane proteins (IMP) under tryptic, peptic and parallel separately h·eated tryptic-
peptic digestions (left) and under three different strategies of tryptic-peptic parallel 
dual digestion (right) 
Other than simply stating the average sequence coverage as in Table 2.1, we 
have refined results of the complete data set to look at the distribution of sequence 
coverage throughout the proteome. This demonstrated that 36% of the proteins were 
identified using one peptide, 21% by 2-3 peptides, 25% by 4-10 peptides, and 18% 
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with over 10 peptides. lt also revealed that 10% of the identified pro teins had over 
50% sequence coverage, 33% over 25% and 57% over 10% (Figure 2.5). Since liver 
microsomal fractions are often used in molecular toxicology studies, it would be ideal 
to have the highest possible sequence coverage if the regulation of post-translational 
modifications is involved in a pathway of interest. 
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Figure 2.5 Number of confident peptides per protein (A) and overall protein sequence 
coverage (B) from en tire data set (1 095 pro teins in total) 
Detailed analysis was also performed usmg PANTHER (Protein Analysis 
through Evolutionary Relationships) in order to classify the identified proteins by 
gene ontology (GO). As shown in Figure 2.6, GO analysis classified the identified rat 
liver microsomal proteins into 11 groups based on their molecular functions with a 
major contribution representing catalytic functions ( 45%), followed by binding and 
structural functions. When classified by biological processes, 17 groups were 
identified with the highest proportion being involved in metabolic processes (35.2%), 
wbich makes perfect sense when we consider that liver microsomes are highly 
enriched in metabolic enzymes. 
GO Molecular Function 
23.1% 
1.2% 
GO Biological Process r 1.7% 
2.2% 
6.4% 
35.2% 
• ion channel (1 .8 %) 
• t ra nsporter (6.9 %) 
• translat ion regulator (0.8 %) 
• transcri ption regulator (1.1 %) 
• enzyme regulator (2.5 %) 
• cata lytic (45 %) 
• motor (1.1 %) 
• receptor (3.3 %) 
ant ioxidant (1 .2 %) 
• st ructural molecule (13 .2 %) 
binding (23.1 %) 
• cell commun ication (6 .1 %) 
• ce llular process (10.8 %) 
• local ization (0.2 %) 
• tra nsport (11.4 %) 
• ce llular compone nt organi zation (4.1 %) 
• apoptosis (1.2 %) 
• system process (3. 7 %) 
• reproduct ion (0.2 %) 
• res pen se to st imulus (4.5 %) 
• regulation of biologica l process (0.3 %) 
• homeost at ic process (0.4 %) 
• developmenta l pro cess (5.4 %) 
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generation of precursor metabolites and energy (6.2 %) 
metabolic process (35.2 %) 
.2% ce ll cycle (2 .2 %) 
immune system pro ce ss (6.4 %) 
ce li adhesion (1 . 7 %) 
Figure 2.6 GO annotations for identified rat liver microsomal proteins based on their 
molecular funct ion (above) and biological processes (below) 
The subset of proteins involved in metabolic processes was analyzed for the 
presence of known protein-protein interactions using InnateDB. The network shown 
in Figure 2.7 (visualized with the Cerebral plugin of Cytoscape software) is a 
representation of all the known interactions that were found. These interactions are 
displayed within the context of subcellular localization. Since InnateDB does not 
incorporate information of rat interactome, human orthologs were used in this 
analysis. The bulk of the interactions between metabolic proteins visualized in this 
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figure are located within the nucleus and the cytoplasm, which includes aU organellar 
membranes, most of which are presumed to be ER -associated. Protein interaction 
networks will help subsequent studies planned in our group aimed at understanding 
the mechanism of xenobiotic-driven toxicity due to irreversible modification of 
proteins. Modification of a key protein may affect many other proteins via interaction 
networks and in tum affect the overall response to covalent binding. A similar 
analysis as was performed in Figure 2.7 could be carried out with other protein 
subsets or across the whole proteome by submitting accession numbers of interest to 
InnateDB in order to have a closer look on liver microsomes from other perspectives 
as well. 
In fulfilling such a comprehensive proteome analysis of rat li ver microsomes, 
the information contained in this data set could support further studies of biological 
processes applied to drug discovery and toxicological research. A list of identified 
proteins found in each of the tested treatment conditions, as well as a compiled 
comprehensive list of all identified proteins, is provided as supporting information 
S 1. Supplemental information is also provided for individual peptides which 
contributed to the identification of each protein (S2) . This list of peptides could be 
especially useful for developing targeted quantitative assays, based on multiple-
reaction monitoring (MRM) detection. 
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2.5 Conclusions 
The comparative analysis carried out in this study characterized an efficient 
strategy for bottom-up proteomic analysis of rat liver microsomes. Examining 
eighteen different digestion conditions allowed severa! conclusions to be made. For 
single enzyme digestions, trypsin gave better results than pepsin or Glu-C. Among 
the seven tested solubilizing agents, SDS at elevated temperature represented the best 
overall performance and was easily removed by SCX fractionation prior to LC-
MS/MS analysis. Tryptic-peptic sequential dual enzyme digestions did not increase 
the quality of results compared to using trypsin alone, however in terms of digestion 
sequence, using pepsin prior to trypsin was the better choice. Co-processing LC-
MS/MS data of separately analysed tryptic and peptic digests yielded the best results 
with the highest number of peptides and identified proteins. Therefore, co-processed 
parallel enzyme digestions using trypsin, using SDS and heat to aid solubilization, in 
combination with pepsin led to an optimized strategy for comprehensive proteomic 
analysis of rat liver microsomes. This method provided the highest number of 
proteins with the best protein sequence coverage compared to all other treatments 
assessed in this work. Higher sequence coverage allows more in-depth analysis of the 
proteome, especially for characterizing protein modifications which are of great 
interest in drug discovery and toxicology applications. Also, a good characterization 
of integral membrane proteins was observed using this optimized procedure. This 
comprehensive study of the RLM proteome will be useful in various future 
applications, including drug discovery and toxicological studies. 
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2.6 Supporting Information 
(Sl) Protein database: (a) list of proteins identified for each treatrnent 
condition (b) false discovery rate reports for each condition (c) detailed analysis of 
overlap in proteins identified in TSH, P and TP-co conditions (d) Integrated list for 
ali 1095 identified proteins. (S2) Peptide database: compiled list of peptides identified 
for each protein under each treatment condition. 
CHAPTER THREE 
MULTIDIMENSIONAL LC-MS/MS ANAL YSIS OF LIVER PROTEINS IN RAT, 
MOUSE AND HUMAN MICROSOMAL AND S9 FRACTIONS 
Makan Golizeh, Christina Schneider, Leanne B. Ohlund and Lekha Sleno 
Published in EuP A Open Proteomics 2015, 6, 16-27. Supplementary data available online 
doi : 10.10 16/ j.cuprot.20 15.01.003 . 
In this chapter, different combinations of orthogonal LC techniques were 
tested to enhance the nu rn ber and sequence coverage of identified pro teins in rat liver 
microsomal samples . To this end, protein- and peptide-leve! ion exchange 
fractionation was coupled to RP-LC-MS/MS and compared. A peptide-leve] 
fractionation was then employed for the analysis of rat, mouse and human liver S9 
and microsomal fractions. The results of this analysis provided information for cross-
species studies. The improved workflow developed here was also employed m 
Chapter 5 for the identification of adducted rat liver microsomal proteins. 
Makan Golizeh, Christina Schneider, Leanne Ohlund and Lekha Sleno are co-
authors of this article. Makan Golizeh conducted the literature survey, prepared 
experimental protocols, conducted the experiments, processed the data, and prepared 
the original manuscript. Christina Schneider, a summer intem, actively participated in 
the experimental part, data processing, and preparation of the results. Leanne Ohlund 
provided assistance with the literature survey and development of the CATW AX-LC 
method. Professor Lekha Sleno supported and supervised the project, verified data 
analysis and interpretation of the results, revised and finalized the manuscript. 
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3.1 Abstract 
Liver plays a key role in metabolism and detoxification, therefore analysis of 
its proteome is relevant for toxicology and drug discovery studies. To optimize for 
high proteome coverage, protein and peptide-leve! ion exchange fractionation were 
assessed using rat liver microsomes and S9 fractions. 2D-(SCX-RP)LC-MS/MS 
analysis with peptide fractionation was subsequently employed for rat, mouse and 
human samples, yielding between 1400 and 1939 identified proteins, 58% of which 
were shared between species, and with relatively high sequence coverage. This rich 
dataset is specifically interesting for the toxicology community, and could serve as an 
excellent source for targeted assay development. 
3.2 Introduction 
Multidimensional liquid chromatography (MDLC) improves the separation of 
highly complex mixtures, and has been applied to proteomics, lipidomics and the 
analysis of natural compounds (Holcapek et al. , 2012). In both qualitative and 
quantitative proteomics, MDLC has proven to be a powerful tool to increase the 
coverage and sensitivity of protein profiling, as weil as improving the accuracy and 
reproducibility of quantitative analysis (Wu et al. , 2012; Xie et al. , 2012). Generally, 
compared to a single LC, combining multiple chromatographie separations will 
enhance resolving power, limit of detection and dynamic range by significantly 
increasing peak capacity (Di Palma et al. , 2012). Common LC techniques used in 
MDLC often include high-pH and low-pH RP, anion or cation exchange, size-
exclusion chromatography as weil as hydrophilic interaction chromatography 
(HILIC) and affinity chromatography (Nice et al. , 2007). Orthogonality of separation 
is an important parameter for achieving a high peak capacity, thus most common 
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examples include bigh-low pH RP-RP, strong cation exchange (SCX)-RP and HILIC-
RP for expanding proteome coverage (Gilar et al. , 2005). 
Ion-exchange chromatography is often used as a first dimension of separation. 
In principle, there are two modes of ion exchange separation: cation and anion 
exchange. Combining SCX with RP chromatography offers high orthogonality, as 
SCX bas a high loading capacity while RP can achieve high resolution separations 
amenable to LC-MS analysis and both involve different mechanisms (Peng et al., 
2003). It is also possible to combine two complementary ion (cation and anion) 
exchange columns either in tandem or as part of a mixed-bed column for increased 
separation efficiency. Havugimana et al. highlighted (2007) an improved number of 
identified proteins and higher quality of proteomics data using a "dual-colunm" 
approach with weak anion exchange (WAX) column coupled to a moderate cation 
ex change colunm for the analysis of mouse heart cytosol. Mo toyama et al. published, 
in the same year, a study with increased number of identified proteins in yeast using a 
mixed-bed weak cation/weak anion ex change (CA TW AX) column. The use of a 3D-
LC-MS approach incorporating CATW AX and SCX for protein and peptide 
fractionation was also reported by Zhang et al. (20 12) to facilita te in-depth prote in 
identification in mouse mammary tumor 4T1 celllysate. 
Liver pla ys a crucial role in the metabolism of xenobiotics through numerous 
enzymes involved in detoxification. A significant portion of these enzymes can be 
enriched in the microsomal fraction during subcellular fractionation (Van Summeren 
et al. , 2012) and therefore liver microsomes are often used in drug metabolism 
studies. Microsomes, in general, are rich sources of membrane proteins from 
endoplasmic reticulum, plasma membrane, mitochondria, and Golgi apparatus 
(Mathias et al., 2011). Integral membrane proteins (IMPs) represent the most 
pharmaceutically useful class of receptors (lm ming et al. , 2006), the targets of 
70- 80% of ail known drugs (Mathias et al., 2011 ), having strong implications in cell 
---- -----------------------, 
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survival (Helbig et al. , 2010). However, they are often tightly bound or physically 
integrated into the membrane and thus pose technical difficulties for proteomic 
analysis (Gilmore and Washbum, 2010). Liver S9 fraction, a mixture of microsomal 
and cytosolic fractions, is another important sample to study as it and is also often 
employed in toxicological and drug metabolism studies (Plant, 2004). Since an 
important goal in proteomics research aims at determining post-translational 
modifications (including covalent binding from reactive endogenous/exogenous 
species) (Zhou et al. , 2005), an ideal method would achieve very high sequence 
coverage of ali potentially-targeted proteins. 
We previously reported (Golizeh and Sleno, 2013) an approach for the 
proteomic analysis of rat liver microsomes examining different combinations of 
proteases and solubi lizing agents using single digestion, seriai dual digestion and 
parallel dual digestion workflows. An SDS-assisted parallel tryptic-peptic dual 
digestion method exhibited the highest proteome coverage with 768 proteins 
identified at 1% global false discovery rate (25% average protein sequence coverage) 
with a high proportion (19.3%) of integral membrane proteins. To further enhance 
proteome coverage, the present study compares severa! MDLC-based separations of 
rat liver microsomal and S9 fractions incorporating both protein-level and peptide-
leve! fractionation. Four strategies were devised to optimize the proteomic analysis of 
rat liver samples combining ion exchange with reversed-phase chromatography 
coupled to high resolution quadrupole-time-of-flight (QqTOF) mass spectrometry. 
The approach with the best overall performance was then selected to carry out a 
cross-species proteomics comparison of rat, mou se and human li ver fractions . 
The main goal of this work was to improve the proteome coverage for 
samples of specifie interest to drug metabolism and toxicology research, relatively 
rich in membrane proteins, where achieving high sequence coverage is particularly 
challenging. The increased coverage of individual proteins enhances the confidence 
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of their detection with a higher number of peptides per protein, therefore yielding a 
better potential for accurate protein quantitation. For instance, this study is 
particularly useful for applications involving the absolute quantitation and expression 
profiling of cytochrome P450 and UDP-glucuronosyltransferase enzymes 
(Langenfeld et al. , 2009; Bucher et al., 2011 ; Schaefer et al. , 2012). Moreover, when 
specifie protein modifications are studied, higher protein coverage would increase the 
chances of seeing such modifications in complex samples. 
3.3 Experimental 
3.3.1 Materials 
Male Sprague- Dawley rat, male ICR/CD-1 mouse, and human (M-50 donor) 
pooled liver microsomes (20 mg/ml protein) were purchased from Celsis In Vitro 
Technologies (Baltimore, MD). Rat liver S9 fractions (37.5 mg/ml protein) were from 
Moltox (Boone, NC), while male CD-1 mouse and human liver S9 fractions 
(20 mg/ml protein) were purchased from BD Biosciences (Franklin Lakes , NJ). 
Sequencing-grade modified trypsin was obtained from Promega (Madison, WI). 
Porcine gastric mucosa pepsin and all other chemical reagents were purchased from 
Sigma-Aldrich (St. Louis, MO). HPLC-grade ACN, methanol and isopropanol were 
from Caledon (Georgetown, ON), and ultra-pure water was from a Millipore Synergy 
UV system (Billerica, MA). 
3.3.2 Sample Digestion 
Liver microsomes or S9 fractions (0 .5-0.6 mg protein) were solubilized with a 
2% SDS solution (1: 1, v/v), heated at 95°C for 3 min, and diluted with 0.1 M 
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ammonium bicarbonate (pH 8.5) to 200 111. Reductive alkylation was performed using 
DTT (2.5 mM, 10 min, 25°C) and iodoacetamide (5 mM, 30 min, 37°C, dark). 
Samples were diluted with 150 111 of 0.1 M ammonium bicarbonate (pH 8.5) for 
trypsin digestions or 0.2% TFA in 20% methanol for pepsin digestions, and incubated 
at a 1:50 (w/w) enzyme : protein ratio for 18 h, at 37°C for trypsin and 25°C for 
pepsin with an additional 15 111 of 10% TF A prior to adding pepsin samples to 
maintain the required acidic digestion conditions (pH 1.5-2). CATW AX protein 
fractions were reconstituted in 150 111 of 0.1 M ammonium bicarbonate (pH 8.5), 
denatured and digested using 5 11g of the enzyme. Digestion was quenched by adding 
50 111 of 1% formic acid for trypsin or 1% ammonium hydroxide for pepsin. Samples 
were then diluted with 500 111 H20 prior to solid-phase extraction (SPE) on a 1 cc 
(30 mg) OASIS HLB cartridge (Waters, Milford, MA), eluting with 100% methanol 
(1 ml). Resulting samples were evaporated to dryness under vacuum (Thermo Fisher 
Scientific Universal Vacuum System, Asheville, NC) and stored at - 30°C. 
3.3.3 Protein Fractionation 
Solubilized protein samples (1.4 mg total) were diluted with buffer A (see 
below) to have a total volume of280 111 (5 mg/ml), sonicated (1 min) and then filtered 
using a Costar Spin-X 0.45 11m cellulose acetate centrifuge tube filter (Coming, 
Coming, NY) prior to injection (100 111, 0.5 mg protein) onto a PolyCATWAX 
200 x 2.1 mm column with 5 11m (1 000 A) particles (PolyLC, Columbia, MD) using 
an Agilent 1200 series HPLC (Agilent Technologies, Palo Alto, CA) equipped with a 
binary pump, degasser, diode array detector and fraction collector. Mixed-bed weak 
cation/weak anion ex change (WCX/W AX or CA TW AX) fractionation was 
performed at a flow rate of 200 111/min using a gradient of 100% A held for 1 min, up 
to 8% Bat 8 min, 85% Bat 9.5 min, then 100% Bat 12.5 min, and held at 100% B 
for an additional 17.5 min, where buffers A and B were 10 mM and 800 mM 
86 
ammonium acetate in 20% acetonitrile (pH 7.2), respectively. The stand-atone weak 
cation exchange (WCX) and weak anion exchange (WAX) separations were 
performed on PolyCA T and PolyW AX 100 x 2.1 mm columns with 5 )..LID (1 000 A) 
particles (PolyLC, Columbia, MD), respective! y. The WCX and WAX columns were 
also used in seriai WCX-WAX and WAX-WCX configurations for dual-colurnn 
weak cation/weak anion exchange experiments. ln all cases, the UV absorbance was 
monitored at 220 and 280 nm. From the CATWAX separation, six fractions were 
collected over 22 min. The fractions were collected at the following intervals: 0-2, 
2-4, 4-6, 6-14, 14-18 and 18-22 min, which were then evaporated to dryness under 
vacuum and kept at - 30°C prior to digestion. 
3.3 .4 Peptide Fractionation 
Protein digests were reconstituted in buffer A (120 )..Ll, see below), sonicated 
(10 min), and centrifuged (5 min, 14,000 g) prior to injection (100 )..Ll, 0.5 mg protein) 
onto a Zorbax 300-SCX 150 x 2.1 mm colurnn with 5 )..Lm (300 À) particles (Agitent 
Technologies, Palo Alto, CA) using the same HPLC system as for protein 
fractionation. SCX fractionation was performed at a flow rate of 250 J..Lllmin with a 
gradient of0- 50% B in 15 min, up to 100% Bat 25 min, then held for an additional5 
min at 100% B, where buffers A and B were 10 mM potassium dihydrogen phosphate 
in 25% acetonitrile (pH 2.75), and 1 M potassium chloride in buffer A (pH 2.75), 
respectively. UV absorbance was monitored at 220 and 280 nm. For trypsin samples, 
3 min (0 .75 ml) fractions were aliquoted into 1.5 ml tubes between 1.5 and 19.5 min, 
while for pepsin, 4 min (1.0 ml) fractions were collected between 1.5 and 25 .5 min. 
Fractions were evaporated to dryness under vacuum and kept at - 30°C. 
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3.3.5 RP-UHPLC-MS/MS Analysis of Peptide Fractions 
Dried samples were reconstituted in 10% acetonitrile (1 00 1-1l) and injected 
(20 1-1l) onto an Aeris PEPTIDE XB-C 18 100 x 2.1 mm column, with solid core 
1.7 1-1m particles (100 Â) (Phenomenex, Torrance, CA) on a Nexera UHPLC system 
(Shimadzu, Columbia, MD) with water (A) and acetonitrile (B), both containing 
0.1% formic ac id, at a flow rate of 300 j.lllmin ( 40 °C). The gradient started at 5% B, 
held for 2 min, and was increased linearly to 30% B at 24 min, to 50% B at 26 min, 
then to 85% B at 26.5 min. MS and MS/MS spectra were collected on a high-
resolution TripleTOF 5600 mass spectrometer (AB Sciex, Concord, ON) equipped 
with a DuoSpray ion source in positive ion mode. The instrument performed a survey 
TOF-MS acquisition from m/z 140- 1250 (250 ms accumulation time), followed by 
MS/MS on the 15 most intense precursor ions from mlz 250- 1250 (excluded for 20 
seconds after two occurrences) using information-dependent acquisition (IDA) with 
dynamic background subtraction. Each MS/MS acquisition bad an accumulation time 
of 50 ms and collision energy of 30 ± 10 V. The total cycle time was 1.05 s. 
3.3.6 Data Treatment 
MS/MS files from each workflow were combined and searched against the 
UniProt protein database (release date 26/06/2013) by ProteinPilot software (version 
4.1) for the specified species (rat, mouse, or human) using Paragon algorithm (Shilov 
et al. , 2007), including false discovery rate (FDR) analysis and detection protein 
threshold ofunused ProtScore > 0.05 (confidence > 10%). The search was perforrned 
for +2 to +4 charge states and MS tolerance was 0.05 Da on precursor ions and 
0.1 Da on fragments. All duplicates were frrst processed alone, then together and 
finally tryptic and peptic digest for each sample were co-processed together. All 
strategies were then combined into a "master" file to represent the total number of 
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proteins and peptides identified from ali methods. Pro teins were identified with a 1% 
global false discovery rate (FDR) using a target-decoy database search algorithm 
(Tang et al., 2008). 
The list of UniProt accession numbers from identified proteins was uploaded 
to NCBI Batch Entrez to ob tain the batch F ASTA file , which was subsequent! y 
submitted to ExP AS y for determination of isoelectric point and monoisotopic 
molecular weight and to Phobius (Krogh et al. , 2007) for prediction of IMPs, based 
on having at least one transmembrane domain (TMD 2: 1). GRA VY Calculator was 
used to calculate grand average of hydropathy (GRA VY) scores. The list of accession 
numbers was also uploaded to PANTHER (Thomas et al. , 2003) for gene ontology 
(GO) classification. Venn diagrams were created by Venny interactive Venn diagram 
piotter (BioinfoGP) (Oliveros, 2007) white Clustal Omega (Sievers et al. , 2014) was 
used for multiple sequence alignment (MSA) analysis of the proteins unique to each 
dataset. 
3.4 Results and Discussion 
Different sample fractionation methods were compared to achieve high 
proteome coverage for the analysis of rat liver microsomal (RLM) and S9 fractions 
(RLS). Several combinations of separation techniques including solid-phase 
extraction (SPE), peptide-leve! wn exchange fractionation, and protein-level ion 
exchange fractionation were evaluated (Figure 3.1). Each workflow was performed 
on pepsin and trypsin digested samples. The method with the best performance was 
then applied to the analysis of rat, mouse and human liver microsomal and S9 
fractions . This cross-species comparison unveiled large overlaps between the datasets 
obtained and further analysis of the results shed light on possible orthologs between 
the species. 
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Figure 3.1 MDLC-MS/MS proteomic analysis workflow 
3.4.1 Method Optimization 
For protein solubilization, SDS is often used, however, it is known to cause 
technical difficulties, interfering with downstream MS analysis, thus needs to be 
effectively removed prior to LC-MS (Griffin and Schnitzer, 2011). In previous work, 
SDS-assisted tryptic digestion yielded better results than severa! other solubilizing 
agents when peptide-leve! ion exchange fractionation was performed prior to LC-MS 
analysis (Goli zeh and Sleno, 2013). The current study also tested the effect of SDS on 
pepsin digestion efficiency with and without detergent removal by TCA precipitation. 
The SDS-solubilized peptic digestion without TCA precipitation yielded the highest 
number of identified pro teins at a 1% final SDS concentration (in 0.1 % TF A, 10% 
90 
methanol) (data not shown). During the SPE clean-up step, different elution 
conditions were tested on peptic digests (from RLM and RLS) using OASIS HLB 
cartridges (Waters, Milford, MA). Elution with 100% methanol yielded the highest 
number of identified peptides and proteins at 1% FDR, followed by a 60:40 mixture 
of ACN/isopropanol, and 100% ACN exhibited the )east favorable results 
(unpublished data). 
For LC-MS/MS acquisition, elution gradients and MS/MS parameters were 
assessed for the analysis of RLM digests (after SPE clean-up) . The LC method 
employed in previous work (Golizeh and Sleno, 2013) was further optimized by 
varying flow rates and gradient conditions slightly, with the goal of keeping a 
reasonable throughput (30-40 min per run). A flow rate of 300 ~-tVmin offered better 
separation efficiency compared to 250 and 350 ~-tllmin using the solid-core 1.7~-tm C18 
column. Based on the total ion chromatogram (TIC) of the TOF-MS survey scan; the 
gradient was modified to 5% B held for 2 min, gradually increased to 30% B at 
24 min, to 50% B at 26 min, then to 85% B at 26.5 min and held for 2 min. These LC 
conditions yielded extremely reproducible retention times between samples over the 
course of this study. In terms of IDA criteria, the maximum number of candidate ions 
for the MS/MS dependent scans per cycle was varied between 5 and 20 ions with an 
accumulation time ranging from 50 to 200 ms for each MS/MS. The intensity 
threshold of the IDA candidate ions was also varied from 200 to 500 eps and isotope 
exclusion was tested at 2 or 3 Da. Moreover, MS/MS acquisition of the precursor ion 
was excluded after two MS/MS scans for either 15, 20 or 30 seconds. Optimization of 
the IDA-MS/MS parameters resulted in 15 MS/MS with 50 ms accumulation time 
each, a 3 Da isotope exclusion and 20 s dynamic exclusion for selected precursor 
ions. This led to a significant improvement of the number of identified peptides, 
proteins and IMPs as well as higher average protein sequence % coverage and shorter 
total cycle time (summarized in Table 3.1). 
Table 3.1 lmprovements achieved by optimization of the IDA -MS/MS parameters 
Initial conditions" Optimized conditions h 
#Peptides (1% FOR) 7570 17566 
# Proteins (1% FOR) 768 1120 
A vg. Seq. % Coverage 25.0 29.9 
#IMP 147 217 
Acquisition speed 1.30 s/cycle 1.05 s/cycle 
• 10 MS/MS scans (! 00 ms accumulation ti me) without dynamic exclusion. 
b 15 MS/MS scans (50 ms accumulation time) with 20 s dynamic exclusion. 
3.4.2 2D-LC-MS/MS Using Protein-Level Fractionation 
A 
132% 
46% 
20% 
48% 
-19% 
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For protein pre-fractionation of microsomal and S9 fractions, five workflows 
were examined in this study, incorpora ting WCX and WAX in different 
combinations. Single WCX and WAX runs were compared to tandem WCX-WAX 
and WAX-WCX using two colurnns in series, as well as mixed-bed WCX/W AX 
(CATW AX) using identical gradient conditions. Judging by the LC-UV traces, single 
ion-exchange did not yield satisfactory separations, though WAX did perform better 
than WCX. Tandem combinations of WCX-WAX and WAX-WCX improved the 
separation, although CA TW AX provided more resolution due to the potential of 
retaining both negatively and positively charged proteins over the single colurnn in a 
homogeneous manner (Figure 3.2). 
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Figure 3.2 LC-UV traces at 220 nm for protein-level fractionation from mixed-bed 
WCX/WAX (CATWAX), tandem dual-colurnn WCX-WAX and WAX-WCX, stand-
alone WCX and WAX separations for RLM (left) and RLS (right) . The y-axis (signal 
intensity) has been magnified 5x for the region eluting from 10-30 min for clarity. 
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3.4.3 2D-LC-MS/MS Using Peptide-Leve! Fractionation 
LC-UV traces from SCX fractionation of the microsomal and S9 digested 
samples demonstrated a separation pattern similar to that of the protein-level 
fractionation (two elution zones) . Tryptic digests gave a more significant UV 
absorption in the second portion than the earlier elution zone at 2- 5 min, compared to 
pepsin, which seemed to have a wider elution profile overall . This is attributed to the 
tendency of trypsin to cleave after lysine and arginine residues resulting in more basic 
peptides strongly binding to the aromatic sulfonic acid groups of the SCX colurnn. 
The wider spread of elution for peptic digests was attributed to more variety possible 
in terms ofbasicity as pepsin cuts at non-charged (hydrophobie) amino acids (Figure 
3.3). 
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Figure 3.3 LC-UV traces at 220 nm from the SCX peptide-leve! fractionation ofRLM 
(left) and RLS (right) samples digested by trypsin (top) or pep sin (bottom) 
Previous work usmg 2D(SCX-RP)-LC-MS/MS for rat liver m1crosomes 
(Golizeh and Sleno, 2013) incorporated a protein precipitation step prior to digestion 
to remove membrane-associated impurities as well as excess reagents which may 
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hinder digestion or affect SCX separation efficiency (Westermeier and Naven, 2002) . 
This precipitation step was replaced by a SPE clean-up step prior to SCX 
fractionation, to achieve good separation efficiency. 
3.4.4 30-LC-MS/MS (Combined Protein- and Peptide-Leve! Fractionation) 
LC-MS/MS analysis with multiple dimensions of pre-fractionation has proven 
useful in proteomics research (Wu et al. , 2012), with reports of improved 
protein/peptide identification (Boichenko et al. , 2013; Li et al. , 2013; Rodriguez et 
al., 2012), higher peptide selectivity (Betancourt et ai. , 2013) and more efficient 
detection of modifications (McClintock et al. , 2013 ; Tousi et al., 2012). However, 
most of these have combined successive LC steps at the peptide level. In this study, 
the 3D-LC-MS/MS approach tested combined protein-level (CATW AX) with dual 
peptide-levet (SCX-RP) separations. Unfortunately, the results showed poor 
performance compared to both regular 10 (RP) and the 2D (SCX-RP) methods. All 
protein-level fractions, when subjected to peptide fractionation, yielded identical 
chromatographie traces. Severa! sample treatment workflows were tested 
incorporating SDS-assisted solubilization or acetone/TCA protein precipitation, 
however, no significant improvement was observed. 
3.4.5 Tryptic versus Peptic Digestion 
A parallel tryptic-peptic dual digestion was performed for the analysis of rat 
liver microsomes for increased proteome coverage due to the complementary 
cleavage sites between the two enzymes (Golizeh and Sleno, 20 13). Trypsin normally 
cleaves at basic amino acid residues such as arginine and lysine which are more 
abundant in water-soluble proteins. Pepsin, on the other band, targets residues with 
95 
hydrophobie and preferably aromatic side chains such as leucine, phenylalanine, 
tryptophan, and tyrosine (Dunn, 2002), likely found in Jess water-soluble regions, 
such as membrane proteins. Microsomes (and S9 fractions) are rich sources of 
membrane proteins and therefore a combined tryptic-peptic digestion enhances the 
proteome coverage as pepsin cleaves regions embedded inside (or associated witb) 
the membrane while trypsin cuts more solvent-exposed regions. Table 3.2 
sumrnarizes the results obtained from trypsin and pepsin digestions using four 
fractionation strategies. As expected, trypsin led to a higher number of identified 
proteins and peptides, while pepsin often yielded an increased %IMP. Moreover, 
replicate analysis showed that, overall, trypsin samples had better reproducibility 
compared to pepsin samples (see Table 3.3). It was also observed that 23- 51% of the 
identified proteins were shared between trypsin and pepsin, 37-72% were unique to 
trypsin, and 4- 12% were unique to peptic digestion. The pepsin-unique proteins 
included more IMPs (up to 40%) compared to trypsin-specific proteins (up to 20%). 
More details on the overlap analysis can be found in Table 3.4. 
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Table 3.2 Comparative results from the analysis of rat liver microsomes (RLM) and 
S9 fractions (RLS) using the four fractionation approaches (trypsin, pepsin, and the 
two enzymes combined) 
Sample" Approach Digestion Proteins h Peptides h A vg. sequence 
coverage (%) 
trypsin 543 4643 22.2 
ID pepsin 390 2453 16.0 
combined 586 7049 27. 1 
t rypsin 286 1384 16.1 
2D protein 
138 848 20.6 
(CATWAX) 
pepsin 
combined 297 2188 19.8 
RLM 
trypsin 1089 12111 24.8 
2D peptide 
pepsin 610 5251 20.9 
(SCX) 
combined 1120 17566 29 .9 
trypsin 365 1493 15 .0 
3D pepsin 177 737 13 .5 
combined 370 2 109 16.8 
trypsin 521 4721 22. 1 
lD pepsin 320 1817 13.4 
combined 569 6497 24.0 
trypsin 253 1190 17.8 
2D protein 
pepsin 74 541 24.1 
(CATWAX) 
combined 260 1707 20.1 
RLS 
trypsin 1015 11453 25 .0 
2D peptide 
pepsin 502 4291 18.4 
(SCX) 
combined 1037 15905 28.4 
trypsin 175 676 14.4 
3D pepsin 67 325 17.5 
combined 174 975 15.8 
• Data combined from duplicate samples 
b Total number of proteins/peptides identified (from duplicate samples) with 1% FDR 
c Percentage of integral membrane pro teins identified for each condition 
IMP 
(%1MP) c 
96 (17.7) 
90 (23.1) 
107 (18.3) 
23 (8.0) 
7 (5.1) 
20 (6.7) 
217(19.9) 
134 (22.0) 
212(18.9) 
39 ( 10.7) 
20(11.3) 
45 (12.2) 
51 (9.8) 
33 (1 0.3) 
52 (9.1) 
13(5.1) 
2 (2.7) 
10(3 .8) 
101 (10.0) 
51 (1 0.2) 
102 (9.8) 
15 (8 .0) 
4 (6.0) 
14 (8.0) 
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Table 3.3 Replicate analysis of tryptic and peptic digests for each LC-MS based 
approach 
Sample Approach Digestion Avg. # proteins Reproducibility ''' 
trypsin 492 77% 
l D 
pepsin 343 70% 
20 protein trypsin 223 52% 
RLM (CATWAX) pepsin 108 50% 
20 peptide trypsin 990 78% 
(SCX) pep sin 567 76% 
trypsin 316 70% 
3D 
pepsin 138 55% 
trypsin 463 74% 
lD 
pepsin 255 58% 
20 protein trypsin 192 50% 
(CATWAX) pepsin 59 54% 
RLS 
20 peptide trypsin 934 80% 
(SCX) pep sin 415 62% 
trypsin 143 57% 
3D 
pepsin 57 51 % 
• Ratio between nurnber of pro teins identified in technica1 rep1icates and total number of pro teins 
identified in corresponding treatment condition 
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Table 3.4 Number and % identified proteins and IMPs unique to and shared between 
tryptic and peptic digestions 
unique to trypsin unique to pepsin trypsin n pepsin 
Sam pie Approach Protcins IMP Protcins IMP Protcins IMP 
('Yo total) (% IMP) (% total) (% IMP) (% total) (% IMP) 
ID 227 35 74 29 316 61 (36.8) (15.4) (12.0) (38.7) (51.2) (19.3) 
2D protein 179 19 31 3 107 4 
(CATWAX) (56.5) (1 0.6) (9.8) (9.7) (33.8) (3.7) 
RLM 
2D peptide 529 103 50 20 560 113 
(SC X) (46.4) (19.5) (4.4) (40 .0) (49.2) (20.2) 
3D 234 29 46 10 131 10 (56.9) (12.4) (11.2) (21. 7) (31.9) (7.6) 
ID 268 28 67 10 253 23 (45 .6) (1 0.4) ( 11.4) (14.9) (43.0) (9.1) 
2D protein 193 12 14 1 60 1 
(CATWAX) (72.3) (6 .2) (5.2) (7.1) (22.5) (1.7) 
RLS 
2D peptide 553 63 40 13 462 38 
(SCX) (52.4) ( 11.4) (3 .8) (32.5) (43 .8) (8.2) 
3D 129 14 21 4 46 0 (65.8) (1 0.9) (10 .7) ( 19 .0) (23.5) (0.0) 
3.4.6 Comparison of the Four Workflows 
The results from ID-, 2D- and 3D-LC-MS/MS approaches showed 
significantly superior perfom1ance of the 2D-(SCX-RP) workflow. Based on previous 
research (Motoyama et al., 2007; Zhang et al., 2012), it was expected that the best 
performance would be seen with the 3D strategy, combining fractionation at both 
protein and peptide levels. Nevertheless, the 2D-(CATW AX-RP) and 3D-
(CATW AX-SCX-RP) methods led to less satisfactory results even compared to the 
99 
regular 1D-RP (Table 3.2). This is most likely related to sample loss related to protein 
fractionation. Proteins identified exclusively with sample preparation workflows 
involving protein fractionation were compared between RLM (94 proteins) and RLS 
(86 proteins). What was seen is that most (90%) of these 154 proteins (RLM+RLS, 
non-redundant) have negative GRA VY scores; bence they are more water soluble. 
This is in line with the assumption that recovery problems from protein fractionation 
workflows were caused by solubility issues. Separa ting complex mixtures of pro teins 
is challenging, especially for samples containing membrane proteins such as liver 
microsomes/S9 fractions . 
Using the 2D-SCX-RP method (combining trypsin + pepsin digestion results), 
17566 unique peptides were detected (1 % FDR) in RLM leading to 1120 identified 
proteins (1 % FDR), with ~ 30% average protein sequence coverage, out of which 212 
proteins (19%) were predicted to be transmembrane proteins (based on analysis using 
Phobius). From RLS samp1es, 15905 unique peptides and 1037 proteins were found 
with 28% protein sequence coverage. The S9 fractions also contained less 
transmembrane pro teins (1 02, equivalent to 1 0%), which was anticipated, since both 
cytosolic and microsomal proteins are present (Duffus et al. , 2007). Both sample 
types yielded the same ranking of performance between ID, 2D-CATWAX-RP and 
3D workflows (Table 3.2). The 2D-SCX-RP approach provided the highest number 
of these unique pro teins ( 486 in RLM, 440 in RLS) . A total number of 170 in RLM 
and 96 in RLS were common to all four workflows (Figure 3.4). Moreover, if average 
sequence coverage is compared for these shared proteins, the SCX-RP method was 
again superior (61 % vs 43% for ID, 22% for CATW AX-RP, and 23% for 3D). 
100 
20 (Peptide) 20 (Peptide) 
Rat Liver Microsomes (RLM} Rat Liver 59 Fractions (RLS} 
Figure 3.4 Venn diagrams representing the number of identified proteins in RLM 
(left) and RLS (right) using 1D-, 2D- and 3D-LC-MS/MS work:flows 
3.4.7 Rat Proteome Results 
The rat liver proteome bas been widely studied with the aim of improving 
existing knowledge on this specialized tissue. Severa] recent studies were performed 
to address questions in pathogenesis and development of liver cancer and chronic 
diseases (Low et al., 2013 ; Hu et al., 2013 ; Cao et al. , 2013), drug evaluation (Wang 
et al. , 2013) and drug-induced liver injury (van Swelm et al. , 2014; H. Zhang et al. , 
2013; A. Zhang et al. , 2013; Sharanova et al. , 2013), and understanding of cellular 
functions (Bakala et al., 2013; Chape] et al. , 2013 ; Gronemeyer et al. , 2013). Most 
recently, in an extensive study on whole rat liver homogenate, using an integrated 
"omics" approach on two rat strains (BN-Lx and SHR) combining multiple proteases 
(trypsin, Lys-C, Glu-C, Asp-N, and chymotrypsin), SCX fractionation and LC-
MS/MS analysis on two platforms (TripleTOF 5600 and LTQ-Orbitrap Velos), Low 
et al. (2013) obtained peptide evidence for 26463 proteins with an overall sequence 
coverage of 15 .6%. This impressive result was obtained based on searching a custom-
built database with the goal of achieving a complete inventory of genetic variation, 
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combining data from genome and RNA sequencmg, which includes genetic 
polymorphisms and post-transcriptional events . For comparative purposes, the 
analysis presented here was performed on Sprague-Dawley rat liver fractions with 
two proteases and one MS/MS platform, using the UniProt KB/Swiss-Prot database, 
comprising total of 7887 reviewed protein en tries. 
The current study incorporated a total of 491,615 (RLM) and 426,812 (RLS) 
high-resolution MS/MS spectra from the four strategies leading to the identification 
of 1185 (RLM) and 1081 (RLS) pro teins at 1% FDR, of which 796 pro teins (54%) 
were common between the two datasets, wb ile 674 proteins ( 46%) were unique to 
either microsomes or S9 fraction. Combining the two datasets and removing 
redundancies, a total number of 1400 proteins were identified in the studied rat liver 
fractions, ofwhich 1235 (88.2%) were also reported by Low et al. (2013). 
Using Phobius (combined transmembrane topology and signal peptide 
predictor) (Krogh et al. , 2007), 215 and 103 IMPs was found in RLM (18% identified 
proteins) and RLS (10% identified proteins), respectively. An average of 5 and 7 
peptides (confidence > 95%) were detected for eacb protein in RLM and RLS, 
respectively. However, the average protein sequence coverage was similar between 
RLM (31.4%) and RLS (29.9%) samples. Sequence coverage is of particular 
importance for studies involving protein modifications, since the higher the coverage, 
the better the chances of detecting covalent modifications on a target protein. Our 
group is particularly interested in elucidating novel protein targets of reactive 
molecules and therefore this was set as a high priority when optimizing the proteomic 
analysis workflow. 
Characterizing the overall distribution of pl, molecular weights, and GRA VY 
scores is of interest when optimizing sample preparation steps (ion exchange, SPE, 
etc.) for increasing coverage of the proteomic analysis . Therefore, an in-depth 
analysis of the identified proteins was performed on the rat liver samples. From the 
102 
compiled dataset, RLM and RLS proteins were analyzed in terms of severa! 
physicochemical properties. A comparison of protein pl revealed that the majority of 
rat liver proteins have a theoretical pl in the range of 4- 12 with 43.4% (RLM) and 
34.8% (RLS) with basic characteristics (pi > 7). Considering the MW distribution, 
2- 3% of proteins were below 10 kDa, 60- 62% in the range from 10 to 50 kDa, 
29- 30% in the range from 50 to 100 kDa, and 6- 7% above 100 kDa, with an average 
molecular mass of 48.2 and 50.1 kDa for RLM and RLS, respectively. The identified 
proteins were also analyzed in terms ofhydropathy (as measured by GRA VY scores) . 
With a GRA VY score distribution in the range from -2.0 to 1.1 , 16.8% of RLM and 
12.9% of RLS proteins were characterized as hydrophobie (GRA VY > 0), coinciding 
well with the %IMPs predicted by Phobius (Figure 3.5). The identified proteins in rat 
li ver samples were also analyzed in terms of biological properties using P ANTHER 
(Thomas et al., 2003). As depicted in Figure 3.6, GO analysis classified RLM and 
RLS proteins into 10 groups based on their molecular functions , over 45 % of which 
represent catalytic functions. 
Interestingly, there were more transporter and receptor proteins identified in 
the microsomes than in the S9 fractions , whereas the latter was richer in structural, 
molecule-binding, translation and enzyme regulator proteins. When classified by 
biological processes, 12 groups were identified with the highest proportion being 
involved in metabolic and cellular processes. However, a slightly higher proportion 
of the microsomal pro teins were involved in localization and multicellular organismal 
processes, while more proteins were associated to biological regulation, cellular, 
developmental and metabolic processes from the S9 fractions . Many of these pro teins 
play a crucial role in the metabolism of xenobiotics and thus are interesting for 
toxicology and drug discovery studies. 
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3.4.8 Cross-Species Comparison of Li ver Pro teins 
Rat and mouse are common animal models for various applications related to 
human metabolism, pharmacology and toxicology. Cross-species studies are 
informative for extrapolation of these models to humans (Benson and Giulio, 2006). 
Cross-species proteomics can also contribute to characterizing proteins of unknown 
function, especially between closely-related species which often have important 
sequence similarities (Wright et al., 2010). Using the workflow optimized for the 
analysis of rat samples, mouse and human liver fractions were also analyzed and the 
datasets were compared. Table 3.5 summarizes the results from the analysis of 
microsomal and S9 fractions of all three species. Overall, 1400 distinct proteins were 
identified at 1% FDR in rat, 1791 in mouse, and 1939 in human with an average 
sequence coverage of 23-30%, an average of 8-10 peptides (confidence > 95%) per 
protein, and a reproducibility of 62-80% (for separately-fractionated duplicate 
samples). Also, similar to rat, microsomes contained a higher number of IMPs than 
S9 fractions in both mouse and human. As expected, the proteins identified in the 
three species demonstrated a high amount of similarity in terms of both 
physicochemical and biological properties, as illustrated in Figure 3.7 and Figure 3.8. 
As for isoelectric points, 38.6-43.1% of the proteins have pl > 7, whereas 15 .6-16.4% 
could be classified as hydrophobie, coinciding well with the number of IMPs in each 
sample. Moreover, GO classification revealed that rat, mouse and human liver 
proteins are analogous in terms of function and involvement in biological processes, 
as expected. 
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As shown in Figure 3.9, when a cross-spec1es analysis was performed, 
comparing gene IDs only, on ali datasets, 31 .3% and 28 .0% orthologous proteins 
were found between the three species for microsomal and S9 fractions respectively, 
while approximately 44% were deemed as unique to one species. The combined 
results from microsomal and S9 fractions are shown in Figure 3.10. MSA analysis, 
performed to assess the non-orthologous proteins, demonstrated that for 22.6% 
(microsomal) and 24.6% (S9) of these proteins had reasonable sequence similarities, 
with at !east 10% inter-species homology (Figure 3.11 ). Taking into consideration all 
the identified proteins (microsomal and S9), MSA analysis revealed that the set of 
human proteins are slightly more homologous to rat than mouse (Figure 3.12). 
Percent identity matrices (PIMs) and phylogenetic trees from thi s analysis are 
available in Supplemental Table S4. 
HLM MLM HLS MLS 
RLM RLS 
Figure 3.9 Venn diagrams depicting the number of shared and umque proteins 
identified in rat, mouse and human liver rnicrosomal (LM) and liver S9 (LS) proteins 
110 
mou se human 
rat 
Figure 3.10 Venn diagrams depicting the number of shared and umque proteins 
identified in rat, mouse and human liver samples (microsomes and S9 fractions) 
* 
0.7 % 
:'llicrosomes 
* 
S9 Fraction 
• > 25% 
• lO - 25°'o 
• 5 -10°o 
Figure 3.11 Percent alignment of pro teins umque to rat, mou se or human li ver 
mtcrosomes (left) or S9 fraction (right). Labels (from the legend on right) are 
distributed in the pie charts from the * in a clockwise manner (The term NaN stands 
for "not a nurnber") 
* 
0.8% 
Human vs Rat 
* 
Human vs M ouse 
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• > 25% 
• 10 - 25% 
• 5 - 10% 
• < 5% 
• NaN 
Figure 3.12 Percent alignrnent of proteins unique to human with those unique to rat 
(left) and mouse (right). Labels (from the legend on right) are distributed in the pie 
charts from the* in a clockwise manner (The term NaN stands for "not a number") 
A complete list of the proteins identified (at 1% FDR) in each sample, and the 
distinct peptides detected for each protein is published as a Data in Brief article 
(Golizeh et al. , 2015b). In this related article, links to publicly accessible repositories 
are provided. In an effort to quantify the impact of making this data publicly 
available, the lists of peptides from tryptic digestion of human, mouse and rat 
samples were compared to the most recent database entries on PeptideAtlas (2013-11 , 
2014-12 and 2014-08 builds for rat, mouse and human, respectively) (Farrah et al. , 
2013). Remarkably, a relatively large proportion of our highly-confident peptides 
were not found in the most current version of PeptideAtlas (20.1 % of the human 
peptides, and 35 .8% for each of the mouse and rat peptide lists). Therefore, once 
incorporated, this large dataset would add a significant amount of additional 
information into this publicly accessible database. These data would be useful for 
subsequent studies involving quantitative proteomics applications as weil as further 
probing ofbiological information contained in these rich datasets . 
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Liver microsomes and S9 fractions are routinely used in drug metabolism 
studies and therefore, an in-depth characterization of the proteins contained in these 
fractions is of particular interest for probing protein modifications resulting via drug 
bioactivation (reactive metabolites). Severa! studies have been performed with the 
goal of identifying protein targets of reactive compounds in liver microsomes (Yang 
et al. , 2014; Tzouros and Pâbler, 2009; Rombach and Hanzlik, 1999; Shin et al. , 
2007), and we anticipate this comprehensive proteomic analysis of these three species 
will facilitate future work in this challenging area. 
3.5 Conclusions 
Sample preparation and emichment is a crucial step in the analysis of complex 
samples and direct! y affects the efficiency of any proteomic workflow. In this study, a 
parallel dual digestion method followed by a comparison of different fractionation 
strategies prior to UHPLC-MS/MS was employed in the analysis of rat liver 
microsomal and S9 fractions. Protein-level fractionation using mixed-bed weak 
cation/anion exchange (CATW AX) did not improve proteome coverage for these 
samples, compared to the lD(RP)-LC-MS/MS workflow and did not ameliorate 
results when combined with peptide-leve! SCX fractionation either. The 2D(SCX-
RP)-LC-MS/MS approach yielded the best results and was therefore chosen for the 
comparative analysis of rat, mouse and human liver fractions . Informative results 
including physicochemical properties and GO classification of the identified proteins, 
as well as an overall comparison of homology between the three species was 
performed. This study resulted in large sets of high-resolution MS/MS data yielding 
impressive proteome coverage for challenging liver fractions containing a relatively 
high number of membrane proteins. The results of this work are of particular interest 
to the drug discovery and toxicology communities. This information could be 
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specifically useful in several applications, for example cross-species extrapolation of 
toxicity, characterizing protein modifications, and developing targeted quantitative 
assays for verification of potential bi omar ker panels. 
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3. 7 Supporting Information 
Multiple sequence alignment (MSA) analysis results of the proteins unique to 
rat, mouse or human (available online). 
CHAPTER FOUR 
DATASET FROMPROTEOMIC ANALYSIS OF RAT, MOUSE, AND HUMAN 
LIVER MICROSOMES AND S9 FRACTIONS 
Makan Golizeh, Christina Schneider, Leanne B. Ohlund and Lekha Sleno 
Published in Data in Brief 2015, 3, 95-98. Supplementary data available online at 
doi: 10.10 16/ j.dib.20 15.02.007. 
Large amount of proteomics data are available via public data repositories. 
These data provide insight into mechanisms involved in biological processes and 
facilitate validation of findings across different areas of research. The analytical 
workflow developed in Chapter 3 enabled efficient proteomics analysis of liver S9 
and microsomal fractions in rat, mouse and human. Raw and processed data from this 
analysis were deposited onto two MS-based proteomics public data repositories. 
These data can be used in cross-species comparison between proteins found in the 
three species, extrapolation of toxicity data from rat and mouse to human, or more 
targeted analysis, such as MRM-based assays . 
Makan Golizeh, Christina Schneider, Leanne Ohlund and Lekha Sleno are co-
authors of this article. Makan Golizeh conducted the experiments, processed and 
submitted the data, and prepared the original manuscript. Christina Schneider and 
Leanne Ohlund participated in the analytical method development. Professor Lekha 
Sleno supported and supervised the project, verified data processing, revised and 
finalized the manuscript. 
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4.1 Abstract 
Rat, mouse and human liver microsomes and S9 fractions were analyzed 
usmg an optimized method combining ion exchange fractionation of digested 
peptides, and ultra-high performance liquid chromatography (UHPLC) coupled to 
high resolution tandem mass spectrometry (HR-MS/MS). The mass spectrometry 
proteomics data have been deposited to the ProteomeXchange Consortium 
(http://proteomecentral. proteomexcbange.org) v1a the PRIDE partner repository 
(Vizcaino et al. , 2013) with the dataset identifiers PXD000717, PXD000720, 
PXD000721 , PXD000731, PXD000733 and PXD000734. Data related to the 
peptides (trypsin digests only) were also uploaded to Peptide Atlas (Farrah et al. , 
2013) and are available with the dataset identifiers PASS00407, PASS00409, 
PASS00411 , PASS00412, PASS00413 and PASS00414. The present dataset is 
associated with a research article published in EuP A Open Proteomics (Golizeh et al., 
2015c). 
4.2 Value of the Data 
Liver proteins were identified in microsomal and S9 fractions with high 
sequence coverage. Comprehensive list of proteotypic peptides was reported for each 
identified protein enables more targeted analyses of these proteins. Data acquired 
from cross-species analysis of rat, mouse and human liver microsomes and S9 
fractions . Multiple-sequence alignment (MSA) analysis can be done between proteins 
exclusively found in each species . 
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4.3 Specifications Table 
Subject area Chemistry, biology 
More specifie subject area Proteomic analysis 
1) Raw and processed mass spectrometry data 
acquired by 2D-LC-MS/MS analysis of rat, mouse, 
Type of data and human liver microsomes and S9 fractions 
2) Ex cel datasheets with identified pro teins and 
corresponding peptides from each analyzed sample 
2D-LC-MS/MS using Agilent 1200 HPLC, Shimadzu 
How data was acquired Nexera UHPLC, and AB Sciex TripleTOF 5600 mass 
spectrometer 
. wiff, . wiff.scan (raw files) 
Data format 
.group, .xml (search files) 
. mgf (peak files) 
.xlsx (FDR analysis and processed results) 
Experimental factors No sample pre-treatment applied 
Li ver microsomes/S9 fractions were solubilized, 
denatured, and subjected to a trypsinlpepsin parallel 
Experimental features 
dual-digestion. Digested peptides were fractionated 
using strong cation exchange (SCX) chromatography 
pnor to UHPLC-MS/MS with subsequent data-
mining and bioinformatics analysis. 
Université 
Data source location 
du Québec à Montréal (UQÀM), 
Chemistry Department, Montréal, QC, Canada 
Data accessibility 
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The mass spectrometry proteomics data have been 
deposited to the ProteomeXchange Consortium via 
the PRIDE partner repository (Vizcaino et al., 2013) 
with the dataset identifiers PXD000717, 
PXD000720, PXD000721 , PXD000731, 
PXD000733 and PXD000734. Data related to the 
peptides (trypsin digests only) were also uploaded to 
Peptide Atlas (Farrah et al. , 2013) and are available 
with the dataset identifiers PASS00407, PASS00409, 
PASS00411 , PASS00412, PASS00413 and 
PASS00414. 
4.4 Experimental Design, Materials and Methods 
Rat, mouse, or human liver microsomes or S9 fractions (0.6 mg protein, n = 2) 
were solubilized in 2% SDS solution (1 :1 v/v ratio) and then diluted with 0.1 M 
ammonium bicarbonate (pH 8.5) prior to reductive alkylation with dithiothreitol 
(2 .5 mM) and iodoacetamide (5 mM) . Additional ammonium bicarbonate (for 
trypsin), or 0.2% trifluoroacetic acid in 20% methanol (for pepsin), was added for an 
overnight digestion at a 1:50 (w/w) enzyme/protein ratio. Digests were neutralized, 
diluted with water, and subjected to solid-phase extraction (SPE) on a 1 cc (30 mg) 
OASIS HLB cartridge (Waters, Milford, MA), eluting with 100% methanol (1 ml) . 
Eluates were evaporated to dryness under vacuum, reconstituted in SCX buffer A (see 
below), and injected (100 j..Ll, 0.5 mg protein) onto a Zorbax 300-SCX 150 x 2.1 mm 
column with 5 j.lm (300 À) particles (Agilent Technologies, Palo Alto, CA) using an 
Agilent 1200 series HPLC equipped with a binary pump, degasser, diode array 
detector and fraction collector. SCX fractionation was performed (250 j..Ll/min) with a 
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gradient of 0- 50% B in 15 min, up to 100% B at 25 min, then held for an additional 
5 min at 100% B, where buffers A and B were 10 mM potassium dihydrogen 
phosphate in 25% acetonitrile (pH 2.75), and 1 M potassium chloride in buffer A (pH 
2.75), respectively. UV absorbance was monitored at 220 and 280 nrn . For trypsin 
samples, 3 min (0.75 ml) fractions were aliquoted into 1.5 ml tubes between 1.5 and 
19.5 min, while for pepsin, 4 min (1.0 ml) fractions were collected between 1.5 and 
25.5 min. Fractions were evaporated to dryness under vacuum and kept at - 30°C. 
Dried fractions were reconstituted in 10% acetonitrile (100 11l) and injected 
(20 111) onto an Aeris PEPTIDE XB-C 18 100 x 2.1 mm colurnn, with solid core 
1.7 11m particles (100 Â) (Phenomenex, Torrance, CA). RP-LC was performed 
(300 111/min, 40°C) on a Nexera UHPLC system (Shimadzu, Columbia, MD) with 
water (A) and acetonitri1e (B), both containing 0.1% formic acid with a gradient of 
5% B held for 2 min, increased linearly to reach 30% B at 24 min, to 50% B at 
26 min, then to 85% Bat 26.5 min and held for 2 min. MS and MS/MS spectra were 
collected on a high-resolution hybrid quadmpole-time-of-flight (QqTOF) TripleTOF 
5600 mass spectrometer (AB Sciex, Concord, ON) equipped with a DuoSpray ion 
source in positive ion mode. The instmment performed a survey TOF-MS acquisition 
from m/z 140- 1250 (250 ms accumulation time), followed by MS/MS on the 15 most 
intense precursor ions from m/z 250- 1250 (precursors excluded for 20 seconds after 
two occurrences) using information-dependent acquisition (IDA) with dynamic 
background subtraction (DBS). Each MS/MS acquisition (m/z 80- 1500) had an 
accumulation time of 50 ms and collision energy of 30 ± 10 V. The total cycle time 
was 1.05 s. 
MS/MS files were combined and searched against the UniProt protein 
database (http ://www.uniprot.org, release date 26/06/2013) by ProteinPilot software 
(version 4.1) using Paragon algorithm (Shilov et al., 2007) using a thorough ID 
search with no specified enzyme and carbamoy1ation as a fixed cysteine modification. 
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The search was performed for +2 to +4 charge states and MS tolerance was 0.05 Da 
on precursor ions and 0.1 Da on fragment ions. Ali duplicates were first processed 
alone, then togetber and finally tryptic and peptic digest for each sample were co-
processed to ob tain the total number of pro teins and peptides. Pro teins were identified 
with a 1% global false discovery rate (FDR) using a target-decoy database search 
algorithm (Tang et al. , 2008) in ProteinPilot Descriptive Statistics Template (version 
3.001p) (http: //www.absciex.com/PDST). ProteinPilot Protein Alignment Template 
(version 2.000p) was also used for replicate analysis . The list of UniProt accession 
numbers from identified proteins was uploaded to NCBI Batch Entrez 
(http ://www.ncbi.nlm.nih.gov/sites/batchentrez) to obtain the batch FASTA file, 
wbich was subsequently submitted to ExPASy (http: //www.expasy.org) for 
determination of isoelectric point and monoisotopic molecular weight, to Phobius 
(http://phobius.sbc.su.se) (Krogh et al., 2007) for prediction of integral membrane 
proteins, and to GRA VY Calculator (http ://www.gravy-calculator.de) to compute 
grand average of hydropathy (GRA VY) scores. Lists of the identified proteins and the 
corresponding proteotypic peptides in rat, mouse, and human liver microsomes and 
S9 fractions can be found in Supplemental Tables S 1 and S2 (see Table 4.1 for 
details). The related MS data are also available via public proteomics data 
repositories (see Table 4.2 for the accession numbers) . 
4.5 Acknowledgements 
Authors would like to thank Dr. Sean Seymour (AB Sciex), Dr. Eric Deutsch 
(Institute for System Biology 1 PeptideAtlas) and the PRIDE team for their kind and 
timely support. 
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4.6 Supporting Information 
Table S 1, final list of the pro teins identified in rat, mouse and hum an li ver 
microsomes/S9 fractions at 1% FDR; Table S2, final list of the prototypic peptides 
identified in rat, mouse and human li ver microsomes/S9 fractions at 1% FDR. 
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CHAPTER FIVE 
IDENTIFICATION OF ACETAMINOPHEN ADDUCTS OF RAT LIVER 
MICROSOMAL PROTEINS USING 2D-LC-MS/MS 
Makan Golizeh, André LeBlanc and Lekha Sleno 
Published in Chemical Research in Toxicology 2015, 28, 2142-2150. Supporting information 
included in Appendix A and Appendix 8 (also availab1e online at 
doi : 10. 1 021 /acs.chcmrcstox.5b00317). 
The ultimate goal of this dissertation was to develop an analytical method for 
the identification of reactive metabolite protein targets using LC-MS/MS. In this 
chapter, rat liver microsomes were treated with acetaminophen, a well-studied mode! 
in liver proteins adduction research, and then subjected to a 2D-LC-MS/MS 
workflow. An extensive data processing approach was later established to detect 
potential covalent modifications, efficiently remove false positives, and characterize 
the adducted peptides. The results presented in this chapter can potentially improve 
the existing knowledge of the mechanisms goveming acetaminophen-induced liver 
injury, and the developed metbod can be used in similar studies involving protein 
adduction and drug-related toxicity. 
Makan Golizeh, André LeBlanc and Lekha Sleno are co-authors of this 
article. Makan Golizeh conducted the literature survey, prepared experimental 
protocols, conducted the experiments, processed the data, and prepared the original 
manuscript. André LeBlanc developed the microsomal incubation procedure and 
participated in interpretation of the results. Professor Lekha Sleno supported and 
supervised the project, verified data analysis and interpretation of the results, revised 
and finalized the manuscript. 
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5.1 Abstract 
Xenobiotic metabolism in the liver can give rise to reactive metabolites that 
covalently bind to proteins, and determining which proteins are targeted is important 
in drug discovery and molecular toxicology. However, there are difficulties in the 
analysis of these modified proteins in complex biological matrices due to their low 
abundance. In this study, an analytical approach was developed to systematically 
identify target pro teins of acetaminophen (AP AP) in rat li ver microsomes (RLM) 
usmg two-dirnensional chrornatography and high-resolution tandem mass 
spectrometry. ln vitro microsomal incubations, with and without AP AP, were 
digested and subjected to strong cation exchange (SCX) fractionation prior to 
reversed-phase UHPLC-MS/MS. Four data processing strategies were combined into 
an efficient label-free workflow meant to eliminate potential false positives, using 
peptide spectral matching, statistical differentiai analysis, product ion screening, and 
a custom-built delta-mass filtering tool to pinpoint potential rnodified peptides. This 
study revealed four proteins, involved in important cellular processes, to be 
covalent! y rnodified by AP AP. Data are available via ProteomeXchange with 
identifier PXD002590. 
5.2 Introduction 
Drug-induced liver injury (DILI) is a major obstacle in drug development 
which often leads to drug use restriction, post-market withdrawal, and attrition due to 
toxicity (Kaplowitz, 2005) . Approximately 1000 drugs, herbal products, dietary 
supplements and illicit compounds are known to be associated with liver injury (Chen 
et al. , 2014). However, although intrinsic hepatotoxicity is reasonably predictable 
from pharmacology and chemical structures, the pathophysiological mechanisms of 
DILI are poorly understood (Fontana, 2014). Several therapeutic drugs with different 
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structures and mechanisms of action have been used in preclinical tests to identify the 
risk ofliver injury in humans (Chen et al., 2014). Acetaminophen (APAP) is a widely 
used analgesie and antipyretic drug which is safe and effective at therapeutic doses 
but can act as a potent hepatotoxin at high doses, and thus is cornmonly used as a 
mode! to study DILI. The APAP mode! has severa! advantages, including being dose-
dependent and reproducible in animal models for clinically-relevant studies (Jaeschke 
et al. , 2011). Moreover, extensive research over the past 40 years has provided 
substantial information on the mechanisms of AP AP-mediated hepatotoxicity 
(Abdelmegeed et al. , 2013 ; Jaeschke et al., 2003; Jaeschke et al. , 2012; Jiang et al., 
2015 ; Xie et al. , 2015). 
One of the liver ' s main physiological roles is the metabolism of xenobiotics 
into hydrophilic metabolites to facilitate their excretion from the body. The liver is 
therefore exposed to higb concentrations of drugs and tbus is a primary target for 
chemical-induced toxicity. At therapeutic doses, APAP ts detoxified via 
glucuronylation and sulfation. However, a proportion of the drug undergoes 
bioactivation to N-acetyl-p-benzoquinoneimine (NAPQI), a reactive electrophile, 
which rapidly reacts with free thiol groups, and if not completely quenched by 
hepatic GSH, can covalently bind to protein thiols (Figure 5.1) (Yuan and Kaplowitz, 
2013). Altbough protein covalent binding does not always lead to toxicity, 
modification of certain proteins by reactive drug metabolites cao potentially alter 
critical cellular pathways causing or contributing to the extent and direction of 
toxicity (Liebler, 2008). Therefore, identification of the proteins targeted by reactive 
metabolites can belp better understand the mechanism of drug-induced toxicity. 
However, since protein adducts are typically much less abundant compared to non-
adducted proteins, tbeir detection and identification in complex mixtures often pose 
serious analytical challenges (Tzouros and Pàbler, 2009). 
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0 0 0 
HNA CH3 NA CH 
.. 
HN A CH3 Q' HS Q CYP450 Çt 1 NADPH 102 s 
OH 0 OH 
APAP NAPQI AP AP-Protein Adduct 
Figure 5.1 Covalent binding of NAPQI to the free thiol group of cysteine residues in 
proteins. NAPQI forms via phase 1 biotransformation of AP AP by cytochrome P450 
enzymes through NADPH-dependant oxidation. 
In 1973, Jollow et al. showed that AP AP-protein adducts accumulate in 
hepatocytes causing extensive necrosis after acetaminophen administration. Previous 
attempts to separate and identify AP AP-modified pro teins have employed 
immunohistochemical (Bartolone et al., 1989; Roberts et al., 1991), electrochemical 
(Muldrew et al. , 2002), or radiochemical (Qiu et al. , 1998) methods, which although 
they provided valuable information on the possible targets and mechanisms, required 
intensive labour, were unsuitable for the analysis of complex samples, and yielded no 
or little insight on the position of the modifications (Zhou, 2003 ; Park et al. , 2005). 
The development of MS-based proteomics and multidimensional 
chromatographie separation in the late 1990s and early 2000s (Aebersold and Mann, 
2003 ; Washburn et al., 2001) bas enabled high-throughput analysis of modified 
proteins with higher sensitivity and better selectivity. Mass spectrometry is currently 
the method of choice for identifying proteins and studying their post-translational 
modifications (Altelaar and Heck, 2012). The emergence of high-resolution MS (BR-
MS) (Mehmood et al. , 2015), modern data acquisition techniques (Bern et al. , 2010; 
Gillet et al. , 2012), and multidimensional (Di Palma et al. , 2012) liquid 
chromatography, in conjunction with novel sample preparation (Feist and Hummon, 
2015) and data analysis (Titz et al. , 2014) approaches have allowed significant 
enhancements to MS-based proteomics for the detection of low-abundance and less 
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soluble proteins and their post-translational modifications. In the present study, an 
analytical approach was developed combining solid-phase extraction (SPE) with 
strong cation exchange (SCX) and reversed-phase (RP) LC for sample preparation 
and an extensive data analysis workflow to identify the covalent binding target 
pro teins of AP AP in RLM. Four proteins were confirmed to be AP AP-modified 
based on their accurate mass and high-resolution MS/MS peptide spectra. 
5.3 Experimental 
5.3 .1 Chemicals and Reagents 
Aroclor-induced male Sprague- Dawley RLM were purchased from 
Bioreclamation NT (Baltimore, MD). Trypsin (TPCK-treated, from bovine 
pancreas), AP AP, n-dodecyl-P-D-maltoside (DDM) and ali other chemical reagents 
were purchased from Sigma-Aldrich (St. Louis, MO). Synthetic peptides were 
purchased from Biomatik (Cambridge, ON). HPLC-grade acetonitrile (ACN), and 
methanol were from Caledon (Georgetown, ON), and ultra-pure water was from a 
Millipore Synergy UV system (Billerica, MA). 
5.3.2 Drug Metabolism 
RLM (0.5 mg protein) were incubated (3 h, 37°C) ± APAP (0.1 mM), in the 
presence of NADPH (2 mM), in 100 mM phosphate buffer pH 7.4 (total volume 
0.4 ml) . GSH (0.12 mM) was then added to remove any excess reactive metabolite. 
Samples were prepared in triplicate. 
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5.3.3 Protein Digestion 
DDM (0.1 %, 15 mm sonication, 25 °C) was added to help solubilize 
microsomal proteins and reductive alkylation was performed using dithiothreitol 
(DTT, 5 mM, 20 min, 37°C) and iodoacetamide (lAM, 15 mM, 30 min, 37°C, dark), 
after adding 250 I-ll of 100 mM ammonium bicarbonate (pH 8.5). Samples were then 
diluted with ammonium bicarbonate buffer to a total volume of 0.75 ml and incubated 
with trypsin ovemight (18 h, 37°C) at a 1:25 (w/w) enzyme-to-protein ratio . Digests 
were then cleaned-up by solid-phase extraction on 1 cc (30 mg) OASIS HLB 
cartridges (Waters, Milford, MA) with 100% methanol elution (1 ml) . Eluate was 
dried under vacuum and stored at - 30°C. 
5.3.4 SCX Chromatography 
Dried SPE extracts were reconstituted in buffer A (120 !-ll, see below) for 
injection (100 !-ll) onto a Zorbax 300-SCX 150 x 2.1 mm column with 5 !-lill (300 Â) 
particles (Agilent Technologies, Palo Alto, CA) using an Agilent 1200 series HPLC 
equipped with a temperature-controlled autosampler, binary pump, degasser, diode 
array detector and refrigerated fraction collector. SCX fractionation was performed at 
a flow rate of 250 I-ll/min with a gradient of 0- 8% B in 6 min, increasing to 30% at 
11 min, 65% at 20 min, 95% at 25 min, and held for 10 min at 95% B, where buffers 
A and B were 10 mM KH2P04 in 25% ACN (pH 2.75), and 1 M KCl in buffer A 
(pH 2.75), respectively. UV absorbance was monitored at 220 and 280 mn. Eighteen 
(1.25 min) fractions were aliquoted from 1- 23.5 min. Fractions were dried and 
reconstituted in 100 !-lll 0% ACN prior to LC-MS/MS analysis . 
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5.3.5 Microsomal Trapping Experiments with Standard Peptides 
Glutathione, QACLFK, ILISDFGLCK, LQQCPFEDHVKL, MPFTSSCLII, 
FIDLIPTNLPHAVTCDIK, GKEGAHAPCASE and VFANPEDCAGFGK peptides 
were incubated (0.125 mM, 90 min, 37°C) with APAP (0.02 mM), NADPH (1 mM), 
and RLM (1.25 mg/ml protein) in 100 mM phosphate buffer pH 7.4 (total volume 
0.4 ml). The reaction was quenched with 1:1 (v/v) ice-cold ACN, centrifuged 
(10 min, 14,000 g, 4°C), and supematant was evaporated under vacuum and 
reconstituted in 200 1-1110% ACN prior to LC-MS/MS analysis . 
5.3 .6 RP-UHPLC-MS/MS Analysis 
Samples were injected (20 Ill) onto an Aeris PEPTIDE XB-C 18 100 x 2.1 mm 
column, with solid core 1.7 !lill particles (100 Â) (Phenomenex, Torrance, CA) using 
a Nexera UHPLC system (Shimadzu, Columbia, MD) with water (A) and ACN (B), 
both containing 0.1 % formic acid, at a flow rate of 300 1-11/min (40°C). The gradient 
started at 5% B, held for 2.5 min, and was linearly increased to 30% B at 40 min, to 
50% B at 50 min, then to 85% B at 55 min. MS and MS/MS spectra were collected 
on a high-resolution quadrupole-time-of-flight TripleTOF 5600 mass spectrometer 
(AB Sciex, Concord, ON) equipped with a DuoSpray ion source in positive mode set 
at 5 kV source voltage, 500°C source temperature and 50 psi GS l/GS2 gas flows , 
with declustering potential of 80 V. The instrument performed a survey TOF-MS 
acquisition from m/z 140-1250 (250 ms accumulation time), followed by MS/MS on 
the 15 most intense precursor ions from m/z 250- 1250 (excluded for 20 seconds after 
two occurrences) using information-dependent acquisition (IDA) with dynamic 
background subtraction. Each MS/MS acquisition bad an accumulation time of 50 ms 
and collision energy of30 ± 10 V. The total cycle time was 1.05 s. 
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An IDA inclusion list was later generated in order to obtain MS/MS data on 
potential bits from non-spectral matching approaches. The method included a survey 
TOF-MS acquisition from m/z 250- 1250, followed by MS/MS for the top ten 
precursor ions, with a total cycle time of 1.25 s. A representative UV trace (220 nm) 
from the SCX fractionation and the total ion chromatogram for a chosen fraction are 
displayed in Figure 5.2. 
5.3.7 Data Analysis 
LC-MS/MS files from each sample (18 SCX fractions combined) were 
searched against the UniProtKB/Swiss-Prot protein database (release date 
07/0112015) by ProteinPilot software for rattus norvegicus using the Paragon 
algorithm (Shilov et al., 2007). In order to find potential AP AP adducts, the protein 
search algorithm was changed to consider a probability of 0.85 for APAP 
modification on cysteine residues . The search was performed for +2 to +4 charge 
states at a MS tolerance of 0.05 Da on precursor ions and 0.1 Da on fragments. 
Proteins were identified with a 1% global false discovery rate (FDR) using a target-
decoy database search algorithm (Tang et al. , 2008). MarkerView software was used 
to generate peak lists and to find features (mlz > 300) showing a fold-change > 3 in 
the AP AP-treated sample compared to the control (- AP AP), corn bining ali fractions 
for each sample. MetabolitePilot software was employed to find LC-MS peaks with a 
sample-to-control signal ratio > 20 (one fraction at a ti me) including at !east one of 
the four APAP-cysteine adduct-related diagnostic product ions (m/z 166.0321 , 
182.0270, 208.0427 and 225.0692). 
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A stand-alone java application (MassBox) was also developed to remove 
redundancies in peak lists and to filter peak pairs based on a delta-mass equal to the 
mass of APAP (considering +1 to +4 charge states) . Jvenn interactive Vem1 diagram 
viewer (Bardou et al., 2014) was used for overlap analysis and MultiQuant software 
was used for the final verification of modified peptides based on their absence in the 
control samples. The mass spectrometry proteomics data have been deposited to the 
ProteomeXchange Consortium (Vizcaino et al. , 2014) via the PRIDE partner 
repository with the dataset identifier PXD002590. 
5.4 Results and Discussion 
A high resolution 2D-LC-MS/MS method was applied to APAP-treated and 
control (no drug) RLM incubations followed by extensive data mining to assess the 
presence of APAP-modified peptides. Data processing included (1) high-resolution 
peptide spectral matching, (2) differentiai analysis (following generic peak finding) 
between control and drug-treated sample, (3) detection of AP AP-cysteine adduct-
related diagnostic fragment ions, and ( 4) accurate mass difference filtering between 
treated and control samples. 
5 .4.1 Proteome Analysis of the Microsomal Samples 
LC-MS/MS data from contro l and treated samples were subjected to generic 
proteomic searching to ascertain that our overall proteome coverage was consistent 
between all samples. An average number of 869±13 and 862±38 proteins (from 
9661± 145 and 9950±875 peptides) were identified at 1% FDR from the APAP-
treated and control samples, respectively (n = 3). This comparison shows that results 
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for all samples were highly reproducible and therefore no bias would have been 
introduced simply by the treatment of li ver microsomes with AP AP. 
5.4.2 Peptide Spectral Matching 
An initial list of potential adducts was generated using ProteinPilot software 
where raw (. wif.f) files from the SCX fractions were combined and searched against 
UniProtKB/Swiss-Prot (reviewed) database using peptide spectral matching (PSM). 
APAP modification was added as a custom modification (addition of C8H8N02 
replacing H) on cysteine residues with a probability of 0.85. This increase in the 
probability of APAP-modification can lead to a relatively high bias towards the 
detection of APAP-modified peptide spectral matches and thus an increased number 
of potential false positives, needing to be subsequently removed using paralle1 
complementary data mining strategies. 
Using the custom PSM algorithm, 7666 distinct peptides (from 1% FOR 
proteins) were detected in the drug-treated sample, out of which 455 were identified 
to be potentially APAP-modified. Applying the same search parameters to the control 
sample, 134 of this list were rejected and were thus deemed false positives. The 
remaining 321 peptides were later subjected to an overlap analysis with the lists of 
putative AP AP-modified peptides from other data mining workflows. 
5.4.3 Statistical Differentiai Analysis 
For differentiai ana1ysis, MarkerView software was ernployed to generate 
peak lists from AP AP-treated and control sarnp1es. After rernoving peak redundancies 
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within the range of 0.02 mlz and 0.5 min RT, 7491 peaks were considered potential 
bits and subjected to the overlap analysis with the lists of candidates from other data 
mining strategies. 
5.4.4 Peak-Pair Finding 
Peak lists (from MarkerView) from the treated and control samples were 
compared using MassBox Peak Picker to find peak-pairs with a delta-mass 
corresponding to the difference between AP AP and lAM modification of a cysteine 
residue (149.0477 - 57.0215 = 92.0262 Da) for z = 1-4 within a mass accuracy of 
25 ppm. Since AP AP-modification should, in theory, increase hydrophobicity, peak 
pairs were considered valid only if the peak with the larger mlz value (in the treated 
sample) eluted later on the RP-LC column. The search yielded a totalnumber of 181 
peak pairs, which were later subjected to overlap analysis with results from other data 
mining strategies. 
MassBox is an in-bouse custom-built open-source Java package for routine 
MS-based omics applications including molecular weight calculation, exact mass to 
m/z conversion, formula frnding, redundancy removal, and peak-pair finding. The 
package bas been deposited to SourceForge public source code repository and can be 
downloaded at http://massbox. ourceforge.net. 
5.4.5 Differentiai Analysis Combined with Diagnostic Ion Screening 
MetabolitePilot software was used to process chromatograms from each 
fraction to frnd peaks unique to AP AP-treated samples for ali LC-MS peaks elu ting 
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from 3- 60 min within m/z 400- 1250. For a feature to be reported, the software 
needed to detect at 1east one of the four diagnostic (Sleno et al. , 2007) AP AP-cysteine 
adduct-related product ions with an m/z tolerance of 25 ppm. As illustrated in 
Figure 5.3, these ions were detected from microsomal incubations witb APAP and 
standard peptides. After the redundant features within the range of 0.02 m/z and 0.5 
min RT were removed (using MassBox Redundancy Remover), a final list of 368 
features of interest were subjected to overlap analysis with other data mining 
strategies. 
5.4.6 Data Verification and Comparison of Data Mining Workflows 
The final lists of potential AP AP-modified peptides from each data treatment 
strategy were compared by mlz, RT and charge state (within 0.1 m/z and 1.5 min RT). 
As illustrated in Figure 5.4, out of the 7457 total features, 324 (4.3%) were detected 
by more than one data mining approach. Differentiai analysis with diagnostic ion 
screenmg (MetabolitePilot) resulted in the highest overlap (70%) with other 
strategies, most significantly with statistical differentiai analysis (MarkerView), 
which accounts for the highest number of candidates, but with only 5% of them 
shared with other workflows. Table 5.1 summarizes the number of putative APAP-
modified peptides from each data analysis and the number of bits shared with other 
workflows. 
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Features shared between the two differentiai analyses (233 peaks) were 
subjected to a second LC-MS/MS analysis using an inclusion list for a more targeted 
MS/MS acquisition to help characterize corresponding peptide sequences through 
PSM. Two additional putative AP AP-modified peptides were found, which were then 
added to the list of previously characterized candidates from the PSM workflow that 
either were shared with other strategies or had a spectral confidence > 95%. The 41 
hits which overlapped between peak pair-finding (MassBox) and differentiai analysis 
(MarkerView) data analysis workflows were eliminated based on being present in the 
control samples upon further verification (not included in inclusion list). The final list 
of 55 peptides was then visually inspected in terms of accurate mass (within 25 ppm), 
charge state and presence in the control samples. More specifically, potential hits 
were reduced to 46 upon mass accuracy verification (within 25 ppm), and then to 33, 
after filtering based on isotope pattern and charge state. 
Five peptides were ultimately confirmed as AP AP-modified based on their 
high-resolution LC-MS/MS data and being unique to the drug-treated sample. 
Table 5.2 lists the identified adducted peptides, their representative proteins and sites 
of APAP modification. Extracted ion chromatograms, high-resolution MS and 
MS/MS spectra from the confirmed AP AP-modified peptides related to these pro teins 
can be found in Appendix A. 
During data verification, severa! highly confident (peptide 
confidence 99%) false positives were removed. For example, 
LKVFVDLLP AAQCTQFINQLLGVVPLST, Asn-deamidated versiOn of 
VFANPEDCAGFGKGENAK and N-terminal carbamoylated LAGIVSWGDACGAP 
were ail found to be AP AP-modified within 25 ppm by both PSM and statistical 
differentiai analysis . However, the first peptide had a wrong charge state; the second 
was not a mono-isotopie peak, and the third was found to also be present in the 
control, and thus ail three were rejected. 
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Multiple comparison procedures generally help reduce false discovery rate 
thus increasing the validity of results (Bate and Clark, 2014). The probability of the 
same feature being detected by more than one data processing strategy decreases the 
risk of that feature being a false positive. In the present study, initial hits were 
considered a "potential" candidate only if bigh-quality MS/MS data supported the 
peptide spectral match (PSM confidence > 95%) or they were detected by at least one 
additional detection method otber than the PSM workflow, which is often the basis of 
MS-based target protein identification studies (Qiu et al., 1998; Jan et al. , 2014; Yang 
et al., 2014). Although no real bits resulted from delta mass filtering, this remains an 
interesting tool to search for specifie modifications in complex proteomic samples. 
Also, the inclusion list of 233 ions, only 2 PSM bits were added to the list of 
previously characterized peptides resulting from the initial IDA method employed. 
This fact reassured us that the IDA parameters were optimized as to trigger a very 
large majority of interesting ions in these samples even considering their low 
abundance relative to the other peptides present in these complex samples. This 
model bad been optimized previously for proteome coverage in rat liver microsomal 
samples (Golizeh et al. , 2015c). 
To further confirm the structure of the detected APAP-modified peptides, 
synthetic standards of target peptides were purchased, subjected to microsomal 
incubations with APAP, and analyzed using the same LC-MS/MS method. Co-elution 
of the extracted ion chromatograms, as well as MS and MS/MS spectral matching 
between AP AP-modified synthetic peptides and those found from digested rat li ver 
microsomes proved that these modification sites were accurately characterized (see 
Appendix B). 
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5.4.7 APAP Covalent Binding Target Proteins 
Over 30 pro teins have been found to be covalently modified by AP AP in vivo 
in mouse, rat, and human (Qiu et al. , 1998; Jan et al. , 2014; Streeter et al., 1984; 
Axworthy et al. , 1988; Dietze et al. , 1997; Cohen et al. , 1997; James et al. , 2003 ; 
Copple et al. , 2008; Damsten et al. , 2007; Senter et al., 2002; Wendel and Cikryt, 
1981 ; Zhou et al., 1995). A comprehensive list of these pro teins can be obtained from 
the reactive metabolite target protein database (TPDB) (Hanzlik et al. , 2007). In the 
present study, four proteins were identified as AP AP-modified, three of which were 
not previously reported as in vivo targets of drug-induced covalent modification. 
Microsomal glutathione S-transferase 1 (MGSTl) is a multi-pass integral 
membrane protein in ER and mitochondria outer membrane, which is involved in 
conjugation of GSH to a wide number of exogenous and endogenous hydrophobie 
electrophiles and is a crucial part of the cellular response to drugs, toxins, and other 
xenobiotics. It is known that the Cys-50 residue of this protein acts as a switch for 
enzyme activation if being attacked by electrophilic species including NAPQI (Shin 
et al. , 2007). In this study, two Cys-50-containing tryptic peptides were APAP-
modified at 99% spectral confidence. VFANPEDCAGFGK (m/z 752.3323 , 21.9 min, 
2+) and VFANPEDCAGFGKGENAK (m/z 668.3036, 19.3 min, 3+) were detected in 
ali three technical replicates by both peptide spectral matching and differentiai 
analysis. The latter also showed an APAP-cysteine adduct-related diagnostic ion at 
m/z 208.04. Excessive modification ofMGST1 by NAPQI can accelerate depletion of 
the protective GSH reservoir rendering other potential cellular targets vulnerable to 
covalent additions. The primary structure of MGST1 is highly homologous in rat, 
mouse and human and it is possible that a similar modification occurs in AP AP-
induced human liver injury. 
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Cytochrome P450 2C6 (CP2C6) is a liver microsomal heme-thiolate 
monooxygenase involved in NADPH-dependent electron transport and oxidizes a 
variety of hydrophobie compounds, including steroids, fatty acids, and xenobiotics . 
The CP2C subfamily is the most complex subfamily of the P450s found in human 
and animal species with severa! different isoforms, and is involved in the metabolism 
of a large number of drugs on the market. The human ortholog of rat CP2C6 is 
CP2C9, which is the major form of the 2C subfamily and accounts for 60% of total 
hum an CP2C. The mou se counterpart of this prote in is CP2C29, which is also the 
most abundant CP2C in this species (Martignoni et al. , 2006). These results 
demonstrate that the highly conserved Cys-372 of this protein has been modified by 
AP AP. The tryptic peptide containing this modification site, 
FIDLIPTNLPHAVTCDIK (m/z 720.3784, 33 .7 min, 3+), was detected at 99% 
spectral confidence in all three technical replicates, and was only found by peptide 
spectral matching. Although strongly involved in drug metabolism, CP2C6 has not 
been reported as a covalent target before. The only members of the CP2C subfamily 
reported to be modified by reactive metabolites are 2C7 and 2Cll that were both 
identified in rat in vivo in relation to teucrin A (Druckova et al., 2007) and diclofenac 
(Shen et al. , 1997), respectively. Moreover, in addition to liver, CP2C9 and its 
orthologs have also been detected in severa! other tissues such as kidney, testes, 
adrenal gland, prostate, ovary and small intestine (Martignoni et al., 2006). 
NADH-ubiquinone oxidoreductase chain 5 (NU5M) is a core subunit of the 
respiratory chain NADH dehydrogenase (Complex I) that translocates electrons and 
protons across the inner mitochondrial membrane helping to maintain the 
electrochemical potential difference required to produce ATP. This enzyme is the 
first and largest component of the electron transport chain and, due to its structural, 
functional and regulatory complexity, is particularly vulnerable to genetic and 
sporadic pathological factors (Papa et al., 2012). Complex I couples the oxidation of 
NADH to the reduction ofubiquinone. During this process, electrons can escape from 
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the complex and react with ambient 0 2 to produce 0 2- and the subsequent reactive 
oxygen species (ROS) (Koopman et al. , 2010). Covalent modification of this protein 
can impact the efficiency of the enzymatic process and potentially play a role in the 
initial mitochondrial oxidative stress triggered by protein adduct formation observed 
in APAP hepatotoxicity (Jaeschke et al., 2003 ; Jiang et al. , 2015). From the present 
study, Cys-3 71 of NU5M was identified as APAP-modified. The non-tryptic peptide 
MPFTSSCLII (m/z 630.8038, 5.3 min, 2+) was detected by both peptide spectral 
matching and differentiai analysis with an APAP-cysteine adduct-related diagnostic 
ion at m/z 182.03. Cys-371 lies on one of the 15 transmembrane demains of the 
Complex l subunit and, although conserved in mouse, this cysteine is replaced with a 
serine residue in the human ortho log, and thus cannot exp lain the AP AP-induced 
mitochondrial dysfunction seen in human hepatocytes (Jiang et al., 2015 ; Jaeschke et 
al., 2012). Although microsomal fractions should in theory be composed mainly of 
proteins from the ER membrane, they are often not free of cell debris, nuclei and 
mitochondria. For instance, in our previous analyses of rat, mouse and human liver 
microsomes (Golizeh et al. , 2015c), 13.3, 13 .6 and 12.4% of the proteins were 
identified as mitochondrial, respectively. Therefore, the identification of NU5M, a 
mitochondrial membrane protein, as a covalent target of APAP in the studied samples 
should not be surprising. 
Mitogen-activated protein kinase (MAPK)- activating death domain protein 
(MADD) plays a crucial role in regulating cell proliferation, survival and death 
through alternative mRNA splicing. MADD converts GDP-bound inactive Rab3 (A, 
C and D) to its GTP-bound active form (Del Villar and Miller, 2004). This protein 
was found to be APAP-modified on Cys-125 . The non-tryptic peptide 
GKEGAHAPCASE (mlz 653.2800, 8.4 min, 2+) containing this modification site 
was detected by the peptide spectral matcbing and statistical data analysis strategies. 
Cys-125 is located on the region that connects uDENN and DENN demains. The 
DENN (differentially expressed in normal versus neoplastic) domain is thougbt to be 
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involved in GTP/GDP exchange activity and thus essential to the function of the 
protein (Levivier et al. , 2001). This cysteine is replaced by a glycine residue in 
mouse, but is conserved in the human ortholog. Jaeschke et al. (20 13) proposed that 
APAP-induced mitochondrial dysfunction and oxidative stress activates apoptosis 
signal-regulating kinase 1 (ASK1) and c-Jun N-terminal kinase (JNK) leading to 
enhanced ROS formation. The resulting damage to the mitochondrial membrane leads 
to the release of mitochondrial endonucleases (AIF, EndoG) causing nuclear DNA 
fragmentation and eventually cell necrosis. MADD is known to also promote JNK 
activation through a series of death domain interactions enabling TRAF2-mediated 
activation of ASK1 (Del Villar and Miller, 2004) therefore, its APAP-modification at 
its DENN domain region can potentially play a rote in the suggested cell death 
mecbanism. Figure 5.5 places each of the identified AP AP-modified proteins in the 
grand scheme of previously suggested mechanisms for APAP-induced hepatotoxicity 
(Jaeschke et al., 2013). 
Generally, rats are deemed to be more resistant to AP AP toxicity than mice, 
and althougb the overall AP AP metabolism is similar in both species, the extent of 
drug-induced oxidative stress and hepatocyte necrosis due to mitochondrial 
dysfunction are significantly lower in rats (McGill et al., 20 12). For this reason, very 
few reports exist on the study of AP AP-induced hepatotoxicity in rats. However, 
acetaminophen toxicity in rat bas been the subject of severa! recent studies 
(Mahmoud et al. , 2015 ; Mast et al., 2015 ; Yao et al. , 2015 ; içer et al. , 2016). The 
APAP-modification of rat proteins identified in this study will be compared to other 
species in the future. 
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5.5 Conclusions 
An approach was developed to identify protein targets of AP AP covalent 
binding from rat liver microsomes using 2D-LC-HR-MS/MS and multiple 
complementary data mining workflows. SCX fractionation was employed to decrease 
sample complexity and increase the potential for detecting modified peptides. The 
detailed data processing strategy was aimed at removing any false positives, an 
important drawback of generic methods employed for identification of target pro teins 
using LC-MS/MS. Four proteins were confidently identified to be adducted by the 
reactive metabolite of APAP (NAPQI), namely MGSTl , CP2C6, NU5M and MADD. 
These proteins are ali known to be involved in critical biological pathways that 
govem cell survival under xenobiotic-induced oxidative stress and their modification 
can be potentially linked to the mechanisms proposed for APAP-induced 
hepatotoxicity. 
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CHAPTER SIX 
COY ALENT BINDING OF 4-HYDROXYNONENAL TO MATRIX 
METALLOPROTEINASE 13 STUDIED BY LIQUID CHROMATOGRAPHY-
MASS SPECTROMETRY 
Makan Golizeh, Jamilah Abusarah, Mohamed Benderdour and Lekha Sleno 
Published in Chemical Research in Toxicology 2014, 27, 1556-1565. Supporting information 
included in Appendix C ( also available online at doi : 1 0.1 021 /tx5002095). 
Covalent modification of proteins by reactive metabolites is not limited to 
xenobiotics. Numerous endogenous metabolites are chemically reactive and readily 
undergo covalent reactions with macromolecules, such as proteins, to form stable 
adducts affecting the biological function of the substrate, potentially inducing 
toxicity. In this chapter, an analytical workflow was developed for the detection of 
covalent adduction of matrix metalloproteinase 13 by 4-hydroxynonenal, an 
endogenous reactive metabolite, believed to be involved in the pathogenesis of 
osteoarthritis. The method was first applied to in vitro incubations and then optimized 
for the analysis of clinically-relevant samples. 
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analysis and interpretation of the results, revised and finalized the manuscript. The 
second and third au thors of this article were, at the time of publication, affiliated with 
Orthopaedic Research Laboratory of Hôpital du Sacré-Cœur, Université de Montréal, 
Montreal, Quebec. 
6.1 Abstract 
Osteoarthritis (OA) is caused by the degradation of articular cartilage and 
affects approximately 80% of people over the age of 65. Matrix metalloproteinases 
(MMPs) belong to a group of zinc endopeptidases that degrade extracellular matrix 
(ECM) proteins in cartilage. MMP-13 , also known as collagenase 3, cleaves type II 
collagen more rapidly than other MMPs and therefore is an important target for the 
treatment of OA. The lipid peroxidation product 4-hydroxy-2-(E)-nonenal (HNE), 
generated under oxidative stress, is known to play a crucial role in cartilage 
degradation, however the mechanism is not yet fully understood. An approach has 
been developed to monitor HNE modification sites by incubating rhMMP-13 ± HNE 
in vitro followed by analysis of tryptic digests by UHPLC coupled to high resolution 
(HR) quadrupole-time of flight (QqTOF) tandem mass spectrometry (MS/MS). The 
analysis elucidated severa! covalently-modified histidine and cysteine residues. The 
reaction was monitored using different HNE concentrations and incubation times. A 
targeted assay, using multiple-reaction monitoring (MRM), was then optimized to 
increase the sensitivity of detecting these modification sites in biological samples. 
HNE-related covalent modifications of MMP-13 were confirmed in enriched extracts 
from interleukin 1 ~-activated chondrocytes from OA patients using high resolution 
MS/MS and MRM analysis. 
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6.2 Introduction 
Biologically-active electrophiles are a diverse set of compounds that are 
produced in living organisms and tend to covalently bind to nucleophilic centers 
present in biomolecules such as nucleic acids and proteins, and therefore can interfere 
with a wide range of biological functions (Gersch et al. , 2012). a,B-Unsaturated 
carbonyls represent an important group of such reactive species and have been shown 
to exhibit important toxicity (Kalgutkar, 2011). 4-Hydroxy-2-(E)-nonenal (HNE) is 
an a,B-unsaturated aldehyde and reactive oxygen species (ROS) endogenously 
generated by peroxidation and breakdown of both w-3 and w-6 polyunsaturated fatty 
acids (PUF A) under oxidative stress. This electrophilic species has been linked to a 
number of adverse biological effects, affecting cell proliferation and gene expression 
through carbonylation of essential biomolecules (Esterbauer et al. , 1991 ). HNE is 
highly reactive and has the ability to covalently bind to carbohydrates, lipids, nucleic 
acids, amino acids and proteins as well as low molecular weight metabolites, such as 
glutathione. Covalent binding of HNE to protein yields adducts which can alter the 
protein' s structure and function causing cell damage as well as adverse Immune 
responses (Niemelii, 1999). In a recent review article on protein damage 
(Chondrogianni et al. , 2014), the mechanism of this impairment is classified under 
"secondary oxidative protein modifications" occurring when proteins are indirectly 
modified through secondary reactions with by-products of oxidative stress. This is in 
contrast to other types of ROS, such as free radicals, that directly bind to proteins. 
The addition of HNE onto proteins often occurs on free thiol groups of cysteine 
residues as well as the imidazole ring nitrogen of histidine, forming stable adducts 
through a 1,4-addition via the Michael reaction. However, the E-amino group of 
lysine, guanidine nitrogen of arginine and the N-terminal amine may also generate 
less stable and potentially reversible HNE adducts via Schiff base formation 
(Grimsrud et al., 2008). Although sorne studies show that the reactivity of these 
amino acids to HNE occurs in the following order: Cys > His > Lys > Arg (Sayre et 
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al., 2006; Doom and Petersen, 2003 ), preference of the reaction sites also depends on 
the protein' s structure (Uchida and Stadtrnan, 1992). It has been shown that histidine 
residues are often the primary targets for HNE (Roe et al., 2007). Michael adducts 
represent 99% of HNE protein modifications, while Schiff base formation is much 
Jess prevalent, even in the presence of excess HNE (Bruenner et al., 1995). 
Matrix metalloproteinases (MMPs) are a family of zinc endopeptidases m 
humans that enable extracellular matrix (ECM) breakdown under normal and disease 
conditions (Kevorkian et al. , 2004). Unusual expression or activity of MMPs is 
known to be associated with severa! disorders such as metastasis, angiogenesis, and 
cardiovascular diseases, as well as rheumatoid arthritis (RA) and osteoarthritis (OA) 
(Engel et al., 2005). It bas been reported that HNE is involved in accelerated 
production and increased activity of severa! MMPs including MMP-1 (Akiba et al. , 
2006; Chapple et al. , 2013 ; Zamara et al., 2004), MMP-2 (Chapple et al. , 2013 ; 
Zamara et al. , 2004; Lee et al. , 2008), MMP-9 (Lee et al. , 2010; Minami et al. , 2009), 
and MMP-13 (Marquette et al. , 2006). It is suggested that this reactive species 
degrades cartilage through either oxidation of ECM macromolecules or covalent 
binding to MMPs resulting in their activation via a "cysteine-switch" mechanism (Gu 
et al. , 2002; Fu et al. , 2001). MMP-13, or collagenase 3, is produced by the 
chondrocyte and preferentially cleaves type II collagen and is essential in the 
development of degenerative joint disease (Engel et al. , 2005). Collagenases, such as 
MMP-13, are the only mammalian proteinases that can specifically degrade fibrillar 
collagens at neutra! pH, and thus play a crucial role in cartilage homeostasis 
(Kevorkian et al., 2004) . The nature of the interaction between HNE and MMP-13 
and its biological relevance with collagen degeneration, if better understood, could 
present a new avenue for the treatment of OA. 
Mass spectrometry (MS)-based proteomic analysis IS one of the most 
commonly used analytical techniques for studying protein adducts and covalent 
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binding (Liebler, 2008). The analytical workflow is usually based on a bottom-up 
approach, where proteins are digested with proteases, and peptides are then separated 
(by electrophoresis or chromatography) prior to peptide sequencing by tandem mass 
spectrometry, most often using high-resolution mass analyzers (Khan et al. , 2011 ). 
On the other band, triple-quadrupole (QqQ) systems have lower resolving power but 
offer higher sensitivity in targeted assays and thus are often applied to complex 
biological samples, where specifie peptides are monitored using multiple-reaction 
monitoring (MRM) with the capacity for the simultaneous analysis of hundreds of 
peptides (Walther and Mann, 2010). Whereas high-resolution mass spectrometry 
(HR-MS) enables comprehensive profiling and structural analysis, MRM assays are 
reliable tools for targeted analyses (Liebler and Zimrnerman, 2013). 
In the present study, a proteomics approach was employed using UHPLC 
coupled to HR-MS/MS to characterize HNE-related covalent modifications of 
MMP-13 , and to screen the extent of protein covalent binding under different 
treatment conditions, such as time of reaction and HNE concentration. This method 
was subsequently applied to confirm these modifications in an enriched chondrocyte 
extract from patients with OA, in conjunction with a targeted LC-MRM analysis to 
detect the corresponding HNE-modified peptides with higher sensitivity. 
6.3 Experimental 
6.3.1 Materials 
Recombinant human matrix metalloproteinase 13 was purchased from R&D 
Systems (Minneapolis, MN), sequencing-grade trypsin was from Promega (Madison, 
WI) and 4-hydroxy-2-(.E)-nonenal was obtained from Cayman Chemicals (Ann 
Arbor, MI) . Dulbecco's modified Eagle' s medium, fetal bovine serum, penicillin and 
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streptomycin were from Life Technologies (Burlington, ON, Canada) whereas 
interleukin-1~ was from R&D System (Minneapolis, MN). Streptomyces griseus 
pronase, type IV collagenase and all other chemical reagents (analytical grade) were 
purchased from Sigma-Aldrich (St. Louis, MO). HPLC-grade solvents were acquired 
from EMD Chemicals (Gibbstown, NJ). All aqueous solutions were prepared using 
nanopure water purified by a Millipore Synergy UV system (Billerica, MA). 
6.3.2 Incubation of Recombinant Human MMP-13 with HNE 
Recombinant human MMP-13 (2.5 flg) was incubated in the presence ofHNE 
at 0, 8, 40, 200, 1000 and 2400 f1M (total vo lume of 150 f1l in 100 mM phosphate 
buffer pH 7.4) for 2 h at 37°C, followed by an additional 30 min with cysteine (fmal 
concentration 0.4 mM) to deactivate the excess HNE. For the time-course 
experiment, MMP-13 was incubated with HNE at 200 11M for up to two hours . 
6.3.3 Specimen Selection, Chondrocyte Culture and Treatment 
Post-surgery discarded human OA articular cartilage was obtained from OA 
patients (aged 67 ± 9 years, n = 4) and informed consent was obtained for the use of 
tissues. AU patients were evaluated by rheumatologists who followed American 
College of Rheumatology criteria (Altman et al. , 1986). The protocols and use of 
human tissues were approved by the Research Ethics Board of Hôpital du Sacré-
Cœur de Montréal. OA knee cartilage specimens were spliced and rinsed, and 
chondrocytes were extracted by sequential enzymatic digestion, as described 
previously (Marquette et al. , 2006). Cartilage samples were digested with pronase 
(1 mg/ml, 1 h, 37°C) and type IV collagenase (2 mg/ml, 6 h, 37°C) in Dulbecco ' s 
- - ------------·· 
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modified Eagle 's medium (DMEM) supplemented with 10% heat-inactivated fetal 
bovine serum (FBS), 100 units/ml of penicillin and 100 f.!g/ml of streptomycin. The 
cells were seeded at high density in culture flasks at 37°C in a humidified atmosphere 
of 5% C02/95% air until they were confluent. Chondrocytes were then incubated 
( 48 h) in DMEM (1 0 ml) with 0.1% FBS in the presence of 1 ng/ml interleukin-1 be ta 
(IL-l~). The medium was then collected and subjected to either ion exchange 
chromatography or immunoprecipitation (IP) . 
6.3.4 Immunoprecipitation 
The culture medium was passed over a colurnn containing aldehyde-activated 
beaded agarose (Pierce, Rockford, IL) to which mouse anti-human MMP-13 
antibodies were covalently attached through primary amines. After washing with 
PBS, human MMP-13 was eluted with 100 mM glycine buffer (pH 3). The eluate was 
dialyzed ovemight at 4°C against PBS and concentrated using Amicon 30 kDa ultra-
centrifugai filter deviees (EMD Millipore, Etobicoke, ON, Canada) . Purified 
MMP-13 was quantified with a commercial ELISA kit from R&D Systems and 
HNE/MMP-13 adduct was detected by Western blot using anti-HNE antibody as 
primary antibody. MMP-13 concentration was 2.5 and 1 J.lg/ml before and after IP, 
respective! y. 
6.3.5 Protein Fractionation by lon Exchange Chromatography 
The culture media was concentrated using Ami con 10 kDa ultra-centrifugai 
filter deviees to remove low-MW impurities. The sample (~20 f.ll) was then diluted in 
100 J.ll of buffer A and injected (1 00 J.ll, 1.25 J.lg protein) onto a PolyCATW AX 
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200 x 2.1 mm column with 5 J.lm (1 000 Â) partiel es (PolyLC, Columbia, MD) using 
an Agilent 1200 series HPLC (Agilent Technologies, Palo Alto, CA) equipped with a 
binary pump, degasser, diode array detector and fraction collector. Fractionation was 
performed at 200 J..Lllmin using a gradient of 100% A held for 1 min, up to 8% B at 8 
min, 85% B at 9.5 min, then to 100% B at 12.5 min and held for an additional 17.5 
min, where buffers A and B were 10 mM and 800 mM ammonium acetate in 20% 
acetonitrile (pH 7.2), respectively. UV absorbance was monitored at 280 nm. Eight 
fractions were collected at the following intervals: 2-4, 4-6, 6-10, 10-14, 14-18, 
18-22, 22-26 and 26-30 min. Collected fractions were evaporated to dryness under 
vacuum (Thermo Fisher Scientific Universal Vacuum System, Asheville, NC) and 
then reconstituted in 100 mM ammonium bicarbonate (ABC) pH 8.5 (100 J.ll) prior to 
digestion. 
6.3 .6 Prote in Digestion 
Reductive alkylation was performed with dithiothreitol (DTT) (10 min, 25 °C) 
and iodoacetamide (lAM) (30 min, 37°C, in the dark) at a final concentration of 10 
and 40 mM, respectively. Samples ( containing 0.1-1 J.lg protein) were diluted in ABC 
(200 J.ll) and digested using trypsin at a 1:15 (w/w) enzyme : protein ratio for 16 h at 
37°C. Samples were cleaned-up using solid-phase extraction (SPE) on OASIS HLB 
(Waters, Milford, MA) cartridges (1 cc, 30 mg) and eluted with 100% methanol 
(1 ml) . Dried extracts were reconstituted in 10% acetonitrile (50 J..Ll) prior to analysis. 
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6.3.7 LC-HR-MS/MS Analysis 
Samples were injected (20 ~-tl) onto a Kinetex XB-C 18 2.1 x 100 mm column, 
with solid core 1.7 ~-tm particles (100 A) (Phenomenex, Torrance, CA) using a Nexera 
UHPLC system (Shimadzu, Columbia, MD). Reversed-phase liquid chromatography 
was performed using water (A) and acetonitrile (B), both containing 0.1% formic 
acid, with a gradient of 5-30% B in 15 min, to 40% B at 24 min, followed by a sharp 
increase to 80% B at 25 min and held for an additional 3 min prior to re-equilibration 
of the column, with a flow rate of 300 ~-tllmin and column temperature of 40°C. MS 
and MS/MS spectra were collected on a hybrid quadrupole-time-of-flight (QqTOF) 
TripleTOF 5600 mass spectrometer (AB Sciex, Concord, ON, Canada) equipped with 
a DuoSpray ion source in positive ion mode set at 5 kV source voltage, 500°C source 
temperature and 50 psi for GS l/GS2 gas flows , with a declustering potential of 80 V. 
Data were acquired in IDA (information-dependent acquisition) mode, with a survey 
TOF-MS acquisition from m/z 140-1250, followed by MS/MS on the ten most intense 
ions (+1 to +4 charge states) from m/z 100-1500 with dynamic background 
subtraction (DBS) with a total cycle time of 1.3 s. MS/MS of precursor ions was 
performed at a collision energy of 30 ± 10 V. 
6.3.8 LC-MRM Analysis 
Samples were injected (5 J .Ll) and eluted usmg the same chromatographie 
method as above. Multiple-reaction monitoring (MRM) was performed on a hybrid 
quadrupole-linear ion trap QTRAP 5500 mass spectrometer (AB Sciex, Concord, 
ON, Canada) equipped with a Turbo V ion source in positive mode. Nine peptides 
were monitored in modified and unmodified forms (different charge states) with 87 
MRM transitions in total , with optimized collision energies and a total cycle time of 
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1.2 s. Ion spray voltage was set to 5 kV with a temperature of 450°C, declustering 
potential of 80 V and GS l/GS2 at 50 psi . 
6.3 .9 Data Processing 
LC-HR-MS/MS data were processed using ProteinPilot (version 4.1) and 
MetabolitePilot (version 1.5) software for finding HNE-related modifications. 
MS/MS files were searched, with no enzyme specification, against the F ASTA file 
obtained from the MMP13_HUMAN entry (accession number P45452) of UniProt 
knowledgebase (last modified April 3, 2013 , version 138) by ProteinPilot software 
using Paragon search algorithm (Shilov et al. , 2007). For cell culture samples, the 
MS/MS data were searched against the (reviewed) human subset of 
uniprot_sprot.FASTA from UniProt. Proteins were identified with a 1% global false 
discovery rate (FDR) with a target-decoy database search algorithm (Tang et al. , 
2008) using ProteinPilot Descriptive Statistics Template (version 3.001 p) 
(http ://www.absciex .com/PDST). Mass tolerance was 0.05 Da on precursor ions and 
0.1 Da on fragments and the search was perfom1ed for +2 to +4 charge states. In 
order to find potential HNE adducts, the Paragon protein search algorithm was 
changed to include higher probability (0 .99) for HNE adducts on cysteine, lysine and 
histidine. MetabolitePilot software was employed to compare HNE-treated sample 
with the control (-HNE) to find unique peaks in the treated sample, while PeakView 
software (version 1.2) was used to visually inspect and verify extracted ion 
chromatograms (XICs), MS and MS/MS spectra of the potential adducts. Given the 
accurate mass and retention times (RT) of the modified and unmodified peptides, 
MultiQuant software (version 2.1) was employed for peak area integration. 
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6.4 Results and Discussion 
6.4.1 Covalent Modification ofMMP-13 by HNE 
In order to determine possible HNE modification sites on MMP-13, 
recombinant human matrix metalloproteinase 13 (MMP-13) was incubated with HNE 
in vitro and the digested protein was then subjected to LC-HR-MS/MS analysis. 
Based on high resolution MS and MS/MS data, MMP-13 was identified with over 
99% sequence coverage in the control and over 97% in the HNE-treated sample. The 
protein sequence was identified based on a total number of 276 and 147 peptide 
features with over 95% confidence for the control and treated samples, respectively. 
Peptide features includes all the tryptic and non-tryptic peptide sequences with 
different post-translational modifications and charge states. Since each peptide 
sequence may be detected multiple times as different features, this number is higher 
than the number of unique protein sequences, known as the proteotypic peptides. 
Two different but complementary strategies were used to examme HNE-
associated covalent modifications on the MMP-13 sequence using ProteinPilot and 
MetabolitePilot software packages. The Paragon search algorithm was slightly altered 
to allow ProteinPilot to detect HNE modifications on histidine, cysteine and lysine 
residues with higher probabilities, leading to the identification of several HNE-
modified histidine- and cysteine-containing peptides. Since there is a possibility that 
sorne HNE-modified peptides could be neglected by the search engine as a result of 
their law-confidence or missing MS/MS data, the HNE-treated sample was also 
compared to the control (-HNE) in MetabolitePilot software to find unique features 
and a complementary list was compiled after visual inspection of peaks . Potential 
adducts found via this search were then added to the list of modified peptides found 
with ProteinPilot. 
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Once a final list was compiled, the HNE-treated sample was verified for the 
unique peaks using PeakView software. Extracted ion chromatograms (XICs), as weil 
as MS and MS/MS spectra, were reported for all unique potential adducts for further 
investigation. With the final confirmed list of interesting peaks, each potential adduct 
was used to calculate the theoretical non-adducted peptide. This final list of adducted 
and non-adducted peptides was then used to generate an inclusion list (as IDA 
criteria) for a second round of LC-MS/MS analysis through which each pair of 
adducted/non-adducted peaks were compared in terms of accurate mass, retention 
time shift and MS/MS behavior. Covalent modification by HNE was detected on 
seven histidines (His-48, His-187, His-251 , His-312, His-340, His-343, and His-387) 
as weil as two cysteines (Cys-96 and Cys-284). The sequence ofhuman MMP-13 and 
the location of the detected HNE modifications are illustrated in Figure 6.1. 
MHPGVLAAFL 0 FLSWTHCRAL 20 PLPSGGDEDD30 LSEEDLg FAE 40 RYLRSYYHPT~0 NLAGILKENA60 
ASSMTERLRE 70 M SFFGLEVT80 GKLDDNTLDV90 MKKPRCGVPD1 0 VGEYNVFPRT11 LKWSKMNLTY' 21 
RIVNYTPDMT1 30 HSEVEKAFKK1 40 AFKVWSDVTP' 5 LNFTRLHDGI 160 ADIMISFGIK EHGDFYPFDG"81 
PSGLLAHAFP1 90 PGPNYGGDAH200 FDDDETWTSS21 SKGYNLFLVA 220 AHEFGHSLGL 2 10 DHSKDP~40 
FPIYTYTGKS25 HFMLPDDDV~260 GI~SLYGPGD2 EDPNPKHPKT281 PDKCDPSLSL 29 DAITSLRGET301 
MIFKDRFFWR LHP~~VDAEL 320 FLTKSFWPEL 3 PNRIDAAYEH3 40 PSHDLIFIFR 5 GRKFWALNGY36 ' 
DILEGYPKKI37 SELGLPKEVK380 KISAAVHFED 9 TGKTLLFSGN4110 ~VWRYDDTNH41 IMDKDYPRLI 42 
EEDFPGIGDK430 VDAVYEKNGY440 IYFFNGPI~F450 EY S IWSNRIV4 60 RVMPANSILW47 c 
• Signal Peptide • Pro-domain • Cysteine Switch Specificlty Loop • Catalytic Domain • Hemopexin-like Domain 
Figure 6.1 Sequence annotation of human MMP-13 (UniProt accession P45452) and 
the identified HNE modification sites (catalytic sites colored in blue and HNE-
modified sites in red) 
The chemistry of HNE modification involves a 1,4 Michael addition of the 
imidazole ring ' s non-acidic nitrogen to the gamma carbon (C-3) of HNE, followed by 
an intramolecular cyclization to form an a-tetrahydrofuryl alcohol (Uchida and 
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Stadtman, 1992). ln this study, a subsequent dehydration of the alcohol into a 
substituted dihydrofuran was also detected in the case of histidine modification. It is 
presumed that the thiol group ' s sulfur of cysteine would also react with HNE in a 
similar way; however, additional dehydration was not detected for any of the 
modified cysteines (Figure 6.2). Considering the formerly reported (Bruenner et al. , 
1995) 99:1 ratio of HNE Michael adduct formation over its Schiff base counterpart, 
and also the high probability of imine hydrolysis, formation of HNE-Schiff bases was 
neither expected nor detected. HNE modification of the targeted residues was 
confirmed using accurate mass data of the corresponding peptides as well as high-
resolution MS/MS spectra coliected from the HNE-treated samples. 
Ali high resolution MS/MS spectra for HNE-modified peptides contained the 
previously reported (Roe et al. , 2007) diagnostic fragment ions at m/z 139.11 and 
266.19 (in the case of histidine modification), representing the dehydrated protonated 
molecule of HNE and the immonium ion of HNE-modified histidine, respective! y, as 
weil as occasional neutralloss of HNE (156.1150 Da) (Figure 6.3). ln searching for 
HNE-related (M+l56.1) modifications, it is important to be able to distinguish 
between an Arg residue (156.1011 Da) and HNE addition (156.1150 Da) , which can 
easily be achieved by high-resolution mass spectrometry. Figure 6.4 illustrates 
representative MS/MS spectra from the peptide containing His-48 with and without 
HNE modification. This example also depicts the case of the HNE adduct losing an 
additional molecule of water. Ali high-resolution MS/MS spectra for peptides 
characterized in their unmodified and HNE-modified forms are included in 
Appendix C. 
- His -
P~! 
~0 
OH 
160 
-H20 
Figure 6.2 Mechanism of reaction for the nucleophilic addition of histidine (above) 
and cysteine (below) to HNE 
(a) (b) HN~:) (d) HN~N 
N--V' 
~ ~ N--V' ~0 ~ OH OH 
C9H140 C9H1s0 2 C14H23N30 2 C14H21N30 
HNE-H20 NL HNE His(HNE)-HC02H His(H NE)-H20 -HC02H 
m/ z 139.1118 (MH+) 156.1150 Da m/ z 266.1863 (MH+) ml z 248.1758 (MH+) 
Figure 6.3 HNE adducts CID-generated diagnostic products corresponding to (a) 
cleaved dehydrated HNE, (b) neutral loss of HNE, (c) cleaved immonium ion of 
HNE-modified histidine, and ( d) cleaved dehydrated immonium ion of HNE-
modified histidine 
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Figure 6.4 MS/MS spectra from the His-48-containing peptide (+3 charge state) in 
unmodified (a) and HNE-modified (b) forms . The m/z 139.11 and 266.18 are 
characteristic fragment ions associated with dehydrated protonated molecule of HNE 
and the immonium ion of HNE-modified histidine, respectively. In this example, a 
dehydrated modified peptide was also found, with a diagnostic ion at m/z 248 .17 (c) . 
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Table 6.1 lists the peptides found to contain HNE-modification sites. Among 
the identified HNE-modified peptides, three were non-tryptic (YYH48PTN, 
LLAH 187AFPPGP and SH25 1FMLPDDDVQG), while IDAA YEH340PSH343DLIFIFR 
represented the sole peptide containing two modification sites. Tryptic miscleavages 
were also detected in the case of TPDKC284DPSLSLDAITSLR which could 
potentially be related to decreased enzyme efficiency due to the steric hindrance 
caused by the addition of HNE in the vicinity of the cleavage site. An example of 
multiple HNE additions on a single modification site was also observed on His-187, 
where doubly and triply HNE-modified peptides were detected at m/z 666.4023 
(16.9 min) and m/z 744.4598 (21.5 min), respectively, due to a previously reported 
(Annangudi et al., 2008) "domino-like multiple Michael adduction of HNE" to 
histidine. However, the singly modified peptide represented the most abundant 
species (in terms of MS sensitivity). All modified and unmodified peptides have been 
identified within 5 ppm mass accuracy. 
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From a biochemical point of v1ew, ali the adducted ammo acids play 
important roles in MMP-13 enzymatic function and are in regions of biological 
significance. More precise! y, His-48 and Cys-96 are located on the pro-peptide (or 
activation peptide) which must be removed from the zymogen in order for the 
enzyme to be activated. Cys-96 is also a strictly conserved residue involved in the 
"cysteine switch" mechanism of activation (Van Wart and Birkedal-Hansen, 1990). 
Together with the three catalytjc histidines (His-222, His-226 and His-232) and the 
"catalytic water" stabilized by Glu-223, Cys-96 forms a relatively stable complex 
with the catalytic zinc (Zinc 2), a structure known as the "metzincin-type zinc-
binding consensus", preventing binding and cleavage of the substrate and is therefore 
essential for keeping the enzyme in its inactive form (Overall, 2000). HNE 
modification of this cysteine disrupts the zinc complex structure and could potentially 
lead to the unusual activation of MMP-13 in fa v or of type II collagen breakdown and 
therefore undesired cartilage degradation. His-251 is located within the specificity 
Joop, giving MMP-13 a higher affmity towards type II collagen and is thought to be 
involved in an increased proteolytic activity if covalently modified (Aure li et al. , 
2008). His-187 is one of the four residues (together with His-172, Asp-174 and 
His-200) extremely tightly bound to the structural zinc (Zinc 1) (Overall, 2000). AU 
the other modification sites are part of the hemopexin-like domains, which play a key 
role in activation, inhibition and substrate-binding properties of all MMPs (Piccard et 
al., 2007) . 
6.4.2 Reactivity ofHNE Modification Sites 
To compare the relative reactivity of the identified modification sites, 
rhMMP-13 (100 nM) was incubated with different HNE concentrations (0, 8, 40, 200, 
1000 J..lM), and in a second test, with varying reaction times (1-120 min) . The extent 
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of modification was measured by the ratio of modified-to-unmodified peak areas 
from high-resolution extracted ion chromatograms. These data are illustrated in 
Figure 6.5. From these experiments, exposure to HNE was found to have more of an 
effect on histidine adduction than cysteine modification. ln particular, the 
modification of His-251 (in the specificity loop) as well as His-340 and His-343, 
located on a hemopexin-like domain, exhibited the highest dependence on both HNE 
concentration and reaction time. His-48, located in the pro-peptide region, is less 
concentration-dependent but is modified at high rates even after long incubation 
times. On the other band, the extent of His-387 modification reaches a plateau after 
30 minutes; however the reaction continues to increase at very large excess HNE. 
His-187 and His-312 both demonstrate less dependence on exposure to HNE than 
otber histidines . The two cysteine modification sites (Cys-96 and Cys-284) were less 
affected by the reaction conditions tested, with Cys-284 being the least reactive of ail 
found sites. 
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Figure 6.5 Graphie representation of modified/um11odified peak area ratios under 
different HNE concentrations (left) and incubation times at [HNE] = 200 ).lM (right) 
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6.4.3 Targeted MRM-Based Assay 
Multiple-reaction monitoring (MRM) is a targeted technique enabling the 
selective detection of specifie peptides with enhanced sensitivity, therefore is useful 
for monitoring specifie peptides of interest in complex samples. An MRM-based 
method was developed for directly monitoring each of the peptides which were 
previously found to be modified by HNE, in both unmodified and modified forms. 
This enables higher sensitivity for confirming the presence of modified peptides from 
complex samples. Collision energies were optimized for the most sensitive MRM 
transitions (most abundant productions for each peptide) . Detailed information on the 
optimized MRM method can be found in Table 6.2. This targeted method was useful 
for the analysis of biological samples due to decreased interfering signais present in 
complex matrices. 
6.4.4 Analysis of Cell Culture Samples 
Complexity of biological samples is one of the major current limitations of 
proteomic investigations affecting both the quality and quantity of the MS-acquired 
data (Chandramouli and Qian, 2009). However, recent advancements have improved 
protein identification for even the !east abundant proteins in biological samples. 
Modem fractionation techniques, high resolution LC separations, sophisticated search 
algorithms, and most importantly, the advancement of high-resolution and high-speed 
MS instruments have enabled in-depth analysis of the proteome (Mann et al., 20 13). 
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In the present study, three different workflows were employed to enrich the 
culture media extracted from chondrocytes of OA patients : molecular weight eut-off 
(MWCO) filtration, protein pre-fractionation and immunoprecipitation. The LC-
MS/MS analysis of the MWCO sample (1.5 ml, 2.5 1-lg/ml) filtered to include on! y the 
molecules larger than 30 kDa led to the identification of 24 proteins; however, 
MMP-13 was not present in this list. By extracting accurate masses from the list of 
target peptides, a few unmodified peptides were detected as well as a prominent 
signal for the HNE-modified peptide containing His-48 (YYH48PTN, m/z 475.7339 at 
8.2 min). 
In a second experiment, the MWCO-filtered sample was separated into 8 
fractions using mixed-bed weak cation/anion exchange (CATW AX) to further reduce 
complexity. Mixed-bed and dual-colunm cation/anion exchange fractionations have 
been previously reported (Zhang et al., 2012; Havugimana et al., 2007; Motoyama et 
al. , 2007) as efficient prote in separation methods. Using ProteinPilot, 110 pro teins 
were found, with the majority concentrated in fractions 5-6 (Table 6.3). The average 
sequence coverage of the identified proteins was 13 .6% with an average of 5 
confident peptides per protein. Although MMP-1 , MMP-2 and MMP-3 were 
detected, the ProteinPilot search did not result in the identification ofMMP-13 . 
Immunoprecipitation (IP) is an efficient and highly specifie technique to 
isolate and concentrate a particular protein from a complex biological matrix (Wilson 
and Walker, 2010). When IP was performed on the cell culture sample, LC-MS/MS 
analysis led to improved results with a total number of 6 identified proteins (as weil 
of a few contaminating keratins) with MMP-13 having the highest protein coverage 
(45.9%), and the formation of HNE/MMP-13 adduct was confirmed by Western blot 
using an anti-HNE antibody (Figure 6.6). Similar to the results from CATW AX 
fractions, MMP-1 and MMP-3 were also detected. A list of proteins found in the IP-
enriched sample is given in Table 6.4. 
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Chondrocytes 
IL-1P (ng/ml) 
0 1 
HNE/1\tiMP-13 adduct 
~-actin.,.l~.... --------~ 
1 6.8-fold 
Figure 6.6 Evidence of HNE binding to MMP-13 by immunoprecipitation. 100 mg of 
total protein were immunoprecipitated using anti-MMP-13 antibody and then 
subjected to Western blotting using anti-HNE antibody. Total proteins from IL-1~­
treated chondrocytes showed a 6.8-fold increase in HNE/MMP-13 adduct levels as 
compared to untreated cells . ~-Actin was used as a loading control in Western blot 
analysis . 
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A targeted analysis was performed on the IP-enriched sample to screen 
peptides encompassing all possible HNE modification sites as previously detected 
during in vitro experiments. All the modification sites were detected in the IP sample 
and the corresponding peptides were confirmed using accurate mass MS and MS/MS 
spectra on the QqTOF system as well as LC-MRM. Each of the modified peptides 
found represent unique sequences from MMP-13 , except for LLAH 187AFPPGP, 
which could also originate from MMP-9, however the latter protein was not detected 
in the biological sample. Interestingly, the peaks related to the modified peptides 
containing His-340, His-343 and His-387 (IDAA YEH340PSH343DLIFIFR and 
ISAA VH387FEDTGK), all located on the hemopexin-like domains, were more 
prominent in the culture sample (relative to other modification sites) than in the HNE-
treated recombinant MMP-13 samples. This increased preference can be regarded as 
an indication that these sites may be more accessible than other identified 
modification sites in a cellular context. On the other band, cysteine modifications 
were much less evident in the cell culture sample. 
The modification at Cys-96 was confirrned by accurate mass and MRM 
analysis, however, was less prominent than in the in vitro sample. No peptide signal 
was found containing Cys-284, in its modified or unmodified forrns. Therefore, 
sufficient evidence was not found to support the "cysteine-switch" mechanism 
(Morquette et al., 2006) as the principal cause for the increased activity of MMP-13 
in OA patients. The presence of each of the modified peptides in the biological 
sample was confirrned using high-resolution TOF-MS (accurate mass of precursor 
ion and associated charge state confirmation), full scan HR-MS/MS, and MRM 
analysis. All modified peptides were confirmed by accurate precursor mass (and RT 
matching) as well as MRM signal, and many also had enough intensity to produce 
high quality HR-MS/MS spectra (Table 6.5). Figure 6.7 illustrates XICs from the 
HNE-modified peptides from the treated recombinant sample and from the 
immunoprecipitated cell culture sample. 
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6.5 Conclusions 
In conclusion, covalent modification of MMP-13 by HNE was investigated 
usmg a LC-HR-MS/MS metbod developed to pinpoint and characterize HNE 
modification sites combined with a MRM-based analysis for targeted monitoring of 
these modification sites. Incubation of MMP-13 with HNE in vitro demonstrated tbat 
seven histidine and two cysteine residues were covalently modified in the protein 
sequence. Time-course and concentration-dependent experiments revealed that 
histidine adduction was more dependent on HNE concentration and reaction time 
than cysteine modification. Since previous data bad suggested that certain covalent 
modifications may lead to activation or over-expression of the enzyme resulting in 
accelerated progress of joint degenerative diseases such as OA, the deve1oped method 
was employed to screen HNE modifications in human chondrocyte cultures extracted 
from OA patients. The results of this study e1ucidated that the HNE modifications 
previously identified in vitro were also present in cell culture samples. Three histidine 
modification sites (His-340, His-343 and His-387) seemed to be more extensively 
targeted by HNE in cells from OA patients compared to the relative contribution of 
each site obtained from in vitro incubations. 
The main goal of this study was to develop an analytical method to 
characterize covalent modification of MMP-13 by HNE. The results from the OA 
patients were regarded as a proof-of-concept to demonstrate the viability of the 
developed method, although further investigations could be perforrned on biological 
samples using the developed methodology, including comparing severity of disease 
with negative controls and to probe the importance of HNE modification under 
different cell treatment conditions. These follow-up studies have the potential to 
mcrease our understanding of the development of chronic diseases related to 
MMP-13 activity and may lead to novel treatrnent avenues. 
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CHAPTER SEVEN 
SUMMARY AND CONCLUSIONS 
Throughout the prevwus chapters, efforts were made to demonstrate the 
importance of each step of the analytical method development for effective detection 
of protein covalent modifications in complex biological samples using LC-MS/MS. 
Two well-studied reactive metabolites, NAPQI and HNE, were selected and used as 
models to establish a systematic approach for the identification of protein adduction 
sites in vitro . To achieve this, three following questions had to be answered: 
1. What are the optimal sample preparation conditions to minimize possible 
interferences and maximize the detection potential of low-abundant covalently 
modified peptides in complex mixtures? 
2. What is the most efficient combination of separation techniques to reduce 
sample complexity for the most efficient LC-MS/MS analysis? 
3. How to process large quantities of LC-MS/MS data to filter interferences, 
eliminate false positives, detect and verify covalently modified peptides m 
xenobiotic-treated samples. 
The present dissertation attempted, in a methodical way, to answer the above 
questions based on the results obtained through each part of the optimization. The 
following sections summarize these findings and present a global outlook of the steps 
to take in the future to further ameliorate the established methods, test their efficiency 
for other research designs, and clinically validate the current results. 
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7.1 Summary of Findings 
The focus of Phase I of this research was to answer the frrst question for 
fmding the efficient preparation of li ver microsomal samples, planned to be employed 
as a relevant model to study protein covalent modification by reactive metabolites. In 
order to answer this question, three experimental procedures needed to be established 
based on the existing knowledge on the analysis of liver microsomes (Qiu et al. , 
1998; Rombach and Hanzlik, 1999; Evans et al. , 2004; Plant, 2004; Shin et al. , 2007; 
Liebler, 2008; Tzouros and Pahler, 2009; Kalgutkar, 2011; Yang et al. , 2014): (1) 
protein solubilization, (2) digestion, and (3) the initial protein identification approach 
using LC-MS/MS. 
To maximize the solubility of microsomal proteins, reagents from different 
classes of solubilizing agents were tested: SDS, FC-14 and SDC (ionie detergents), 
DDM (non-ionie detergent), guanidinium hydrochloride ( chaotrope), methanol, 
formic acid and TFA (organic solvents and carboxylic acids). SDS demonstrated the 
best performance in terms of number of proteins and peptides, and average protein 
sequence coverage. To optimize digestion conditions, trypsin, pepsin, endoproteinase 
Glu-C, and cyanogen brornide were compared separately, and in combination. 
Trypsin produced better results particularly for hydrophilic proteins, whereas pepsin 
yielded higher sequence coverage for membrane proteins. Sequential trypsin-pepsin 
dual digestion did not work as efficiently as each enzyme separately, and combining 
the two digestion steps in parallel was better only if samples were digested and 
fractionated separately and LC-MS/MS data were then co-processed at the protein 
search level. To compare the different treatment strategies, a data analysis workflow 
was also developed using ProteinPilot protein search software and free access web-
based bioinformatics tools. Figure 7.1 depicts the steps involved in this workflow. 
Using these methods, a total of 1095 proteins were identified in rat liver microsomes 
at 1% FDR, out ofwhich 213 proteins (19.5%) were IMPs. 
~ 
P
ro
te
in
P
il
o
t 
Pr
ot
ei
n-
Pr
ot
ei
n 
In
te
ra
ct
io
ns
 
1 
c 
Cy
to
sc
ap
e 
In
te
ra
ct
io
n 
N
et
w
o
rk
 
~ 
..
 
' 
""
"'
 
/ 
FD
R
 A
na
ly
si
s 
# 
Pr
ot
ei
ns
 
PD
ST
 
Li
st
 o
rP
ep
tid
es
 
--
41
11
1~
 L
is
t o
fP
ro
te
in
s 
at
 1
%
 F
D
R
 
.
.
.
.
.
 
#
Pe
pt
id
es
 
Li
st
 o
fP
ro
te
in
s 
1 
~P
AN
TH
ER
 
l 
G
en
e 
O
nt
ol
og
y 
o
le
cu
la
r 
Fu
nc
tio
n
s 
B
io
lo
gi
ca
l P
ro
ce
ss
es
 
Ce
llu
la
r 
C
om
po
ne
nt
s 
%
 C
ov
er
ag
e 
A
cc
es
si
on
 
u
m
be
rs
 
1 
1 
8N
C
B
I 
B
a
tc
h 
E
nt
re
z 
~ 
B
at
ch
 F
A
ST
A
 F
ile
s 
1 
1 
P
ho
bi
us
 
G
R
A
V
Y
· 
CA
LC
UL
A 
TO
R èJ
; ~ 
Fi
gu
re
 7
.
1 
W
or
kf
lo
w
 fo
r 
th
e 
bi
oi
nf
or
m
at
ic
s 
an
al
ys
is 
o
fr
at
 li
ve
r m
ic
ro
so
m
al
 p
ro
te
in
s.
 
FD
R:
 f
al
se
 d
isc
ov
er
y 
ra
te
; 
G
RA
 V
Y
: 
gr
an
d 
av
er
ag
e 
o
fh
yd
ro
pa
th
y;
 IM
P:
 i
nt
eg
ra
l m
em
br
an
e 
pr
ot
ei
n;
 
M
W
: m
o
le
cu
la
r w
ei
gh
t; 
PD
ST
: P
ro
te
in
Pi
lo
t™
 d
es
cr
ip
tiv
e 
st
at
ist
ic
s 
te
m
pl
at
e.
 
-
.
.
) 
0
0
 
----------
179 
The methods developed in Phase I were used to treat samples and data in 
Phases II and III. The publication compiling the results of this work (Golizeh and 
Sleno, 2013) bas since been cited by other studies aiming at improving proteomics 
analysis performance using multi-enzyme digestion strategies (Lin et al. , 2013; Lin et 
al. , 2014; Zhang, 2015; Dunston et al. , 2015; Nardiello et al. , 2015). 
Four combinations of ion-exchange fractionation with RP-LC were examined 
in Phase II to optimize peptide separation prior to the MS/MS analysis. Different 
modes of ion exchange chromatography were compared, separately and in tandem, 
for protein fractionation and then tested against SCX peptide fractionation in 2D and 
3D configurations. The 2D approach combining SCX with RP-LC yielded the best 
results . The four multidimensional LC-MS/MS approaches compared in this study are 
demonstrated in Figure 7 .2. 
The core- shell RP column used in this study enabled higher resolving power 
and enhanced peak capacity. Core- sbell particles are composed of a solid silica core 
and a thin porous outer layer, and are used in LC columns employed in the analysis of 
complex mixtures . In theory, a core- shell particle ' s diffusion behaviour resembles a 
fully porous counterpart with a diameter equal to the thickness of the core- shell 
particle's outer layer. These packing materials therefore enable UHPLC separations 
with virtually smaller particles without a drastic increase in backpressure due to 
reduced particle size according to Darcy' s law (De Vos et al., 2012). Furthermore, 
since it is only the outer layer that acts as the stationary phase, columns filled with 
core-shell particles have less solvent capacity thus enabling a faster elution compared 
to the conventional co lumns. 
The RP-LC separation was optimized in Phases I and II. However, based on 
initial tests it was decided to use a longer gradient in Phase III to allow for a more 
efficient separation of APAP-modified peptides from the unmodified counterparts. 
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MS/MS data were acquired in this study using information-dependent (IDA) 
(or data-dependent, DDA) acquisition. In this approach, precursor ions are "selected" 
from a MS ("survey") scan based on a set of given selection criteria, activated, and 
subjected to the MS/MS ("dependent") scan (Figure 7.3). However, since a portion of 
precursor ions will not be selected for MS/MS, usually due to low signal intensity, 
sorne information, particularly related to less-abundant peptides, can get lost in this 
type of analysis. Nevertheless, DDA is an efficient way to increase data acquisition 
speed and can generate more MS data with higher quality from LC peaks, compared 
to the conventional LC-MS/MS methods. DDA parameters including the maximum 
number and threshold signal intensity of selected precursor ions, MS/MS acquisition 
time, and dynamic exclusion conditions were optimized in Phase II leading to a 46% 
increase in the number of proteins (1 % FDR), 20% more average protein sequence 
coverage, 48% more IMPs and 19% shorter cycle time compared to Phase I. DDA 
also allows for selective acquisition of MS/MS spectra for a given list of precursor 
ions ("inclusion list") enabling better characterization of complex mixtures. This 
strate gy was used to confirm the structure of modified peptides in Chapters 5 and 6. 
Dynamic Exclusion Dependent MS2 Scan Sur;ey MS Scan 
nexr cycle 
Figure 7.3 A typical data-dependent acquisition (DDA) cycle with dynamic exclusion 
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Once the different steps of the analytical method were optimized, li ver S9 and 
microsomal fractions from rat, mouse and human were analyzed for an inter-species 
comparison. GO analysis demonstrated that most identified proteins had catalytic, 
receptor or binding properties and were primarily involved in cellular and metabolic 
processes and response to the stimuli. This information provides insights into what 
types of biological processes can potentially be affected by covalent modification of 
these proteins, which can be useful in molecular toxicology and pharmacology 
studies (Golizeh et al. , 20 15c ). 
In Phase III, an approach was developed for the identification of covalently 
modified proteins in rat liver microsomes incubated with APAP. A large focus was 
put to devise a data processing workflow to effectively detect APAP-modified 
peptides with a high capacity for removing potential false positives. Peptide spectral 
matching, with an increased AP AP-modification probability, was combined with 
differentiai analysis of LC-MS signal intensities in treated and control samples, 
AP AP-Cys adduct-related CID-product ion screening, and searching for peak-pairs 
with an AP AP-adduction mass difference. Putative modified peptides found by more 
than one data analysis approach were subjected to multiple levels of data verification 
and five AP AP-modified peptides were finally confirmed by exact mass and MS/MS 
spectra highlighting covalent modification of four proteins: MGSTl , CP2C6, NU5M 
and MADD. These proteins are believed to be associated with oxidative stress and 
their covalent modification could potentially be linked to the cellular damage 
involved in APAP-induced toxicity (Golizeh et al., 2015a). 
Figure 7.4 illustra tes the overall scheme of the approach developed 
throughout Chapters 2 to 5 of this dissertation for identification of reactive metabolite 
protein targets using LC-MS/MS . 
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In Chapter 6, a more targeted method was developed to examine covalent 
modification of MMP-13 by HNE in vitro using LC-HR-MS/MS and LC-MRM. 
Analysis of HNE-incubated rhMMP-13 demonstrated that seven histidine and two 
cysteine residues were HNE-modified. Kinetic and concentration-dependent studies 
allowed for the comparison of the reactivity of these modification sites . The same 
HNE-modifications were detected on MMP-13 in chondrocyte culture extracts from 
osteoarthritis patients, providing insights to support the previously suggested 
(Morquette et al. , 2006) potential involvement of HNE and oxidative stress in the 
development of OA. The publication describing these results (Golizeh et al. , 2014) 
bas been cited by other studies on detection of protein lipoxidation products (Aldini 
et al., 2015), as well as qualitative (Milic et al., 2015) and quantitative (Yang et al., 
20 15) analysis of prote in alkylation by HNE. 
ln summary, methods were developed using LC-MS/MS for the identification 
of reactive metabolite protein targets in complex mixtures, detem1ination of their 
modification sites, and screening under different conditions. These methods can 
potentially be adapted for the analysis of similar sample types from animal models 
and human samples to provide useful information on protein adduction in both 
in vitro and in vivo studies. 
7.2 Limitations and Perspectives 
The study of reactive metabolites is a dynamic and progressive area of 
research with increased interest over the past few decades . Although initial studies 
were mainly focused on structural characterization of reactive metabolites (Kalgutkar, 
2011 ), suggested links between their reactions with macromolecules and the resulting 
toxicity has drawn more attention to covalent binding reactions and identification of 
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their potential targets, an area which gradually became more feasible by means of 
technological advancements in bioanalysis. 
In this work, four proteins were systematically identified to be modified by 
APAP in rat liver microsomes in vitro using a 2D-LC-MS/MS approach. The scope 
of this study is therefore limited to: (1) APAP protein targets, (2) rat liver 
microsomes, (3) covalent binding occurring in vitro. From a technical point of view, 
the method involved an unbiased separation of modified and unmodified peptides, 
and did not incorpora te targeted enrichment of AP AP-modified sequences prior to the 
MS/MS analysis. This work has paved the road for further improvements in scope, 
flexibility and efficiency of analysis for other types of molecules and samples. Sorne 
of these improvements and suggestions for future research will be discussed in the 
next few pages. 
The method optimized in the preliminary experiments was ultimately utilized 
to identify AP AP-modified proteins in a microsomal sample. However, with slight 
modifications, this method can be virtually used for any other reactive metabolite. For 
example, HNE is the most studied lipid-derived electrophile and one of the most 
abundant, reactive, and toxic endogenous metabolites (Yang et al. , 20 15). However, 
unlike AP AP or other drugs, HNE is already a reactive species and do es not require 
biotransformation prior to the 2D-LC-MS/MS analysis . Severa! studies have 
previously suggested methods for characterization of protein-HNE adducts (for a 
recent review see Aldi ni et al. , 20 15). 
A preliminary experiment was conducted to study HNE covalent binding to 
liver microsomal proteins in parallel to the APAP-protein adducts analysis described 
in Chapter 5. Initial data processing demonstrated that, compared to AP AP, a 
remarkably larger number of proteins were targeted by HNE. Future work would 
employ a comprehensive data analysis workflow, as developed for APAP, to 
determine rat li ver microsomal HNE targets in vitro . The overlap between AP AP and 
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HNE targets can a1so be interesting as it reveals what proteins are more susceptible to 
electrophilic attacks potentially opening doors to new therapeutic or protective 
approaches against reactive metabolite-mediated toxicity. 
Another perspective from the work detailed in this thesis is the application of 
the optimized method to in vivo samples. As discussed in Chapter 6, HNE-
modification sites found through in vitro incubations with MMP-13 were also 
detected from cell culture ex tracts, indicating that the reactivity of these sites towards 
HNE does not limit to simple protein incubations. Similar experiments can be 
designed using animal models to test if the identified AP AP target pro teins can also 
be found in li ver homogenates of animais receiving a toxic AP AP dose or patients 
diagnosed with APAP-induced toxicity. In this regard, severa! groups of rats and 
mice have been dosed with AP AP. Livers were removed after different time points, 
and homogenized with solubilization using SDS and urea/thiourea. The same 2D-LC-
MS/MS procedure bas been employed as for the RLM samples. These results , once 
compiled, will be able to reveal if any of the previously detected APAP-adducted 
proteins were also found to be modified in vivo. In addition, these results can help 
identify other potential AP AP targets not found through the RLM in vitro ex periment. 
Moreover, the study of AP AP-modifications at different ti me-points and dosing 
levels can provide insights into relative reactivity of the target proteins towards 
AP AP in rat and mou se. These findings and the eventual results obtained from human 
studies could shed light on the mechanisms proposed for AP AP-induced 
hepatotoxicity (Jaeschke et al., 2013; Jiang et al., 2015). 
The approach developed in this thesis was used to identify protein adduction 
without any bias in the purification of modified and unmodified peptides. Although 
multi-dimensional separation and data-dependent acquisition greatly reduce the 
spectral complexity allowing for efficient MS/MS detection, less-abundant modified 
peptides may still be masked by the large excess of unmodified counterparts present 
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in the sample (Tzouros and Pàbler, 2009). To address this challenge, more targeted 
methods have been developed using affinity tagging to selectively fish out the 
adducted peptides prior to the LC-MS/MS analysis. Affinity enrichment techniques 
have recently provided new opportunities to increase the specificity and selectivity of 
protein adduct detection methods. Biotin-tagging was first introduced by Adam et al. 
(2002) as an enrichment strate gy to improve ICA T quantitative proteomics. Shin et 
al. (2007) developed two biotin-coupled reagents incorporating iodoacetamide and 
maleimide moieties to selectively bind to the thiol groups of cysteine-containing 
peptides (Figure 7.5 a- b). 
Another approach, known as MeCAT, 13 was introduced by Ahrends et al. 
(2007) to enable selective separation and detection of cysteine-containing peptides 
tagged by a metal-chelating group (DOTA 14) with enhanced sensitivity using ICP-MS 
(Figure 7.5 c). A similar biotin-tagging approach bas been investigated in our group 
by LeBlanc et al. (20 15) for selective enrichment of AP AP-modified peptides using 
alkyne analogs of AP AP (APAPyne) with "click chemistry". Using this approach, 
adducted peptides can be conjugated with an azide-containing biotinylation reagent 
which allows for subsequent enrichment of peptides via streptavidin affinity 
separation (Figure 7.6). A caveat of this type of method of course is the specifie 
tagging of the compound to be studied, and therefore it is not applicable to all drugs 
or reactive species. 
13 Metai-Coded Affinity Tagging 
14 1 ,4, 7,1 0-Tetraazacyclododecane-1 ,4, 7, 1 0-tetraacetic ac id 
o:r~~~~~~ (b) 
0 
(c) 
H 
N~ N 
H 
0 
0 
188 
Figure 7.5 Biotin-coupled reagents for selective enrichrnent of peptides using affinity 
separation incorporating iodoacetamide (a) and maleirnide (b and c) rnoieties for 
specifie conjugation with the thiol functionality of cysteine-containing peptides 
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Another strategy to improve the separation capacity, detection sensitivity, and 
analysis throughput of the present method could be the application of micro- or nano-
HPLC. This can be achieved by using reduced-dimension or capillary LC columns 
packed with sub-micron-sized (< 2 Jlm) C 18-bonded porous particles. The major 
advantage of using such columns is their ability to work with small sample volumes 
at low flow rates decreasing band dilution on the column bence offering enhanced 
sensitivity compared to conventional LC. Other benefits of micro/nano-LC are 
reduced solvent consumption, easy temperature control due to the fast and effective 
beat transfer on small co lumns, and high separation efficiency and peak capacity due 
to decreased sorbent particle diameter. However, since the pressure generated across 
a LC column is proportional to the square of the sorbent particle diameter, 
micro/nano-LC columns require pumps tbat can ensure higb backpressure. 
Moreover, since peak volume decreases dramatically with column dimensions, 
elution band broadening can considerably deteriorate the separation if extra-column 
void volume (capillary connections, detector cell volume) is not minimized. This of 
course demands fast data acquisition using mass analyzers with high scanning rates 
(Sestâk et al., 2015). Microfluidic chip-based nano-LC bas effectively dealt with 
these tecbnical challenges and shown in practice to be more efficient than capillary 
LC columns (Liu et al. , 2013). In the HNE-MMP13 adduct detection experiment 
discussed in Chapter 6, a signal-to-noise ratio improvement of up to 40 times was 
obtained using a micro-LC (Eksigent Micro-LC 200) system on a Halo C, s 0.5 x 150 
mm column packed with 0.5 Jlm porous silica-layer particles at 20 llllmin for in vitro 
samples (unpublished results) . However, smaller columns have much less loading 
capacity and the system is considerably less robust. Therefore, we chose to run our 
analyses at more conventional flow rates, since sensitivity was sufficient to monitor 
ali characterized HNE modifications from cell culture samples in a targeted manner. 
Furthermore, the present study integrated a 2D-LC-MS/MS approach 
combining ion-exchange fractionation and RP chromatography. However, as 
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discussed in Section 1.2.3, HILIC is also commonly used for detection of modified 
peptides (Di Palma et al. , 2012). Due to the difference in mechanisms of separation, 
HILIC demonstrates remarkable orthogonality with RP chromatography and thus 
could be coupled with RP to enable MD separations. Previous works have 
demonstrated that HILIC-RP can increase the number of identified proteins compared 
to SCX-RP (Li et al. , 2013; Longworth et al. , 2012). However, despite its remarkable 
separation power and orthogonality of 2D HILIC combinations for shotgun 
proteomics analyses, HILIC-based platforms suffer from sorne technical challenges 
including solvent incompatibility between HILIC and other dimensions, and poor 
solubility of peptides in the highly organic solvents used in HILIC (Zhao et al. , 
2012). Nonetheless, a HILIC-based MD-LC approach could be tested in the future to 
improve the detection efficiency of AP AP-modified peptides from in vivo samples. 
As discussed earlier (Section 7.1), the use of data-dependent acquisition can 
be another limitation to the method developed in this thesis. As demonstrated in 
Figure 7.7, horizontal selection of the precursor ions (usually by signal intensity) used 
in DDA (Figure 7.7a) can exclude less sensitive ions from MS/MS analysis and thus 
sorne potentially interesting peptides would not be sequenced. On the contrary, data-
independent acquisition (DIA) operates via unbiased acquisition of consecutive 
survey scans and product ion spectra for ail the precursors contained in predetermined 
vertical selection frames known as "isolation" or "selection windows" (Figure 7.7b). 
DIA thus can potentially provide higher sensitivity and greater reproducibility than 
DDA (Bem et al. , 2010). A more recent variation of DIA, SWATH 15, combines a 
sequentia1 windowed acquisition with a post-acquisition targeted data analysis 
allowing for better quantitation of complex proteomics samples with higher accuracy 
and reproducibility (Gillet et al. , 2012). Therefore SWATH-MS analysis of the RLM 
samples can in theory lead to a more efficient detection of less-abundant and/or less-
15 Sequential Window-Acquisition of Ali Theoretical Mass Spectra 
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sensitive APAP-modified peptides. However, DIA considerably increases the MS 
cycle time, and thus often requires longer LC gradients reducing the analysis 
throughput. 
(a) 
* 
* 
Selection 
criteria 
(b) Selection 'Yindo\\'S 
11'1 11 '~ H'3 1\'J 
* 
ml: 
Figure 7.7 Graphical comparison between horizontal and vertical selection of 
precursor ions in DDA (a) and DIA (b). Selected ions for the dependent MS/MS are 
marked with an asterisk. 
Finally, as described in Chapter 1, covalent adduct formation is not limited to 
proteins, and other biomolecules can be targeted by reactive metabolites, depending 
on the chemical and structural nature of the species involved. For example, RNA 
covalent modifications, such as methylation, inosination and polyadenylation, have 
been widely studied in recent years as they severely impair systematic 
characterization of the "epitranscriptome": the entire set of coding and noncoding 
RNA chemical modifications. These modifications are believed to influence 
parameters such as RNA stability, translation, trafficking, localization, enzymatic or 
sensing activity, regulatory capabilities, or patterns of interaction with other 
molecules. Current methods for identification of RNA modifications are mostly based 
on immunoprecipitation followed by RNA-sequencing, which offer law limit of 
detection and limited accuracy. LC-MS/MS methods have been recently introduced to 
this area enabling more sensitive, accurate, and robust measurements (Satterlee et al. , 
2014). LC-MS/MS is also the method of choice for characterization and quantitation 
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of DNA covalent modifications in biological samples (Balbo et al. , 2014). DNA 
adduct detection strategies often include SPE or immunoaffinity enrichment, HILIC 
or CE separations, combined with MALDI or ESI-MS. Alkylation, oxidation, 
epoxidation, nitrosylation and cyclization are the most common DNA covalent 
modifications cause by reactive metabolites with potential mutagenic consequences 
(Tretyakova et al. , 20 13). With appropria te sample preparation, the present approach 
can be adapted to identify covalent adducts of other macromolecules including 
phospholipids, RNA and DNA. Table 7.1 summarizes improvements that can be 
made to increase the efficiency and/or flexibility of the analytical method developed 
in this study. 
Table 7.1 List of suggested modifications and extensions to this work for future 
studies 
Conceptual Modifications and lmprovements 
Identification of prote in adducts formed with other reactive metabolites ( e.g. HNE) 
Validation of the findings through in vivo studies 
Application of affinity separation techniques for sample enrichment prior to the 
LC-MS/MS analysis 
Method adaptation for the analysis of covalent modification of other macro-
molecules (e.g. RNA, DNA) 
Technical Enhancements 
Incorporation of other orthogonal LC combinations to increase separation 
efficiency (e.g. HILIC-SCX, HILIC-RP) 
Replacing DDA with DIA (or SWATH) to increase sensitivity for more targeted 
applications 
* * * 
APPENDIX A 
HIGH-RESOLUTION UHPLC-RP-MS/MS DATA FROM THE APAP-
MODIFIED PEPTIDES IDENTIFIED IN RAT LIVER MICROSOMAL 
INCUBATIONS 
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APPENDIX B 
MS AND MS/MS SPECTRA FROM APAP-MODIFIED PEPTIDES 
IDENTIFIED IN RAT LIVER MICROSOMAL SAMPLES AND AP AP-
MODIFIED SYNTHETIC STANDARDS (TRAPPING EXPERIMENTS) 
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APPENDIXC 
HIGH-RESOLUTION MS/MS SPECTRA OF THE UNMODIFIED AND HNE-
MODIFIED PEPTIDES ASSOCIATED WITH EACH MMP-13 
MODIFICATION SITE CHARACTERIZED IN IN VITRO SAMPLE 
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APPENDIXD 
MASSBOX PEAK PICKER SOURCE CODE 
"Peak-picking" is often employed in LC-MS-based "omics" for data reduction 
and filtering using LC-MS signal-related parameters. Severa! commercial and free 
software packages are available for this purpose based on different search, or picking, 
algorithms (Rafiei and Sleno, 2015). In Chapter 5, an in-bouse custom-built open-
source application (MassBox) was employed for peak-picking based on the exact 
mass difference and retention time shift between LC-MS peak pairs. MassBox was 
originally developed during this dissertation for routine MS-based omics applications 
using Java programming language (JDK version 1.7) and Eclipse Kepler (Eclipse 
Foundation, Ottawa, ON, Canada) integrated development environment (IDE). 
MassBox is a package of six operational modules including molecular weight (MW) 
calculator, neutral/ion converter, protein MW and GRA VY calculator, formula finder, 
LC-MS data redundancy remover, and peak-picker. The package is freely available 
for download via SourceForge public source code repository at 
http://massbox.sourceforge.net. 
MassBox Peak Picker employs a generic double comparison algorithm where 
mlz and retention time (RT) values are compared between two peak lists, nom1ally 
from a control and treated sample. Peak pairs with a given mass difference within a 
certain mass error threshold (in ppm) and RT window will be reported. To remove 
potential false positives within each data set, m/z and RT values are only compared 
between the two lists, and each list is not compared to itself. The source code for this 
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module is included below. By convention, Java code comments are placed after Il 
tags, or enclosed within 1** *1 delimiters . 
import java . awt . Cursor ; 
import java . awt . event . ActionEvent ; 
import java.awt . event . ActionListener ; 
import java.beans . PropertyChangeEvent ; 
import java . beans . PropertyChangeListener ; 
import java . text.DecimalFormat ; 
import javax . swing . JFrame ; 
import javax . swing . JPane l; 
import javax . swing . border . EmptyBorder ; 
import javax . swing . JLabel ; 
import javax . swing . JOptionPane ; 
import javax . swing . JScrol lPane ; 
import javax . swing . JTextArea ; 
import javax . swing . JTextField ; 
import javax . swing . JButton ; 
import javax . swing . JProgressBar ; 
import javax . swing . ScrollPaneConstants ; 
import javax . swing . SwingUtilities ; 
import javax . swing . SwingWorker ; 
import java . awt . Toolkit ; 
import javax . swing . border . Beve l Border ; 
public class frmPeakPicker extends JFrame implements ActionListener , 
PropertyChangeListener { 
/** PeakPicker c l ass defi n ition Tl 
private JPanel pnlMain ; 
private JTextField txtDeltamass , txtErrorThresho ld , tx RTWidth ; 
private JTextArea txtListl , txtList2 , txtRTl , txtRT 2 , 
txtResults ; 
private JButton btnSearch ; 
private JProgressBar progressBar ; 
private JLabel lblSearc hing ; 
pri vate Task task ; 
private int progre ss ; 
private long hits ; 
private long startTime , e lapsedTime ; 
/** Task to be done in background */ 
class Task extends SwingWorker<Void , Vo id> { 
@Override 
public Void doinBackground() 
Il To verify the input 
if (! isDouble (txtDeltamass . getText ()) 11 
! isDouble (txtErrorThreshold . getText () ) 1 1 
! isDouble (txtRTWidth . getText ())) { 
JOptio n Pane . showMessageDi alog (null , 
" Unexpected search parameters! " ) ; 
return null ; 
Il To initialize the search 
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double d e l ta 
Math . abs (Doub l e . valueOf (txtDeltamass . getText())) ; 
double e r t hr = 
Math. abs (Doub l e . valueOf (txtErrorThreshold . getText ())) ; 
double rt t h r = 
Math . abs(Double . valueOf (txtRTWidth . getText ())); 
double upperLimit = delta + er_th r 1 le6 ; 
double lowerLimit = de l ta - er_ thr 1 l e6 ; 
double mz_l, mz_2 , r t _ l , rt 2 , dmz , drt ; 
boolean match_mz , match_rt ; 
Dec i ma l Format mzFor ma t new DecimalFormat ( " O. OOOO " ); 
Dec i ma l Format rtFormat = new DecimalFormat ( " O. O" ) ; 
hits = 0 ; 
St r i ng mz l Li st 
St ring r t l Li s t 
Stri ng mz2L i st 
String rt2L i st 
txtListl . getText (); 
txtRTl . getText (); 
txtList2 . getText () ; 
txtRT2 .getText (); 
int mzlLines , mz2Lines , rtlLines , rt2Lines ; 
mzlLines = mz2Lines = rtlLines = rt2Lines = 0 ; 
for (String l i n e mz l List . sp l it ( " \ \n " )) mzlLines++ ; 
for (String li n e r tlList . sp l it ( " \ \n " )) rt l Li nes++ ; 
for (St ri ng li n e mz2List . split ( " \ \n " )) mz2Li nes++ ; 
for (St ri ng l i n e r t2List . spli t ( " \ \n " )) rt2Li nes++ ; 
if (mzlLines ! = rt l Lines Il mz2Lines ! = rt2Lines ) 
JOptionPane . showMessageDialog( null , 
"Number of peaks and retention times do not match! " ) ; 
return null ; 
if (mzlList . charAt(mz l List . length ()- 1) > 0 ) mz l List += 
"\n " ; 
if (rtlList . c harAt (rt l List . length ()- 1 ) > 0 ) rtlList += 
"\n " ; 
if (mz2L i st . c harAt( mz2List . length ()- l ) > 0 ) mz2List += 
" \n il ; 
if (rt2List.charAt(rt2List.length()-l) > 0) rt2List += 
"\n " ; 
String [] mzl new String [mzlLines] ; 
String [] rtl new String [rtlLines] ; 
String [] mz2 new String [mz2Lines] ; 
String [] rt2 new String [rt2Lines] ; 
String delim "\n " ; 
int i = 0 , j 0 , k 0 ; 
while (j >= 0) { 11 To initia e mzl list 
j = mzlList . indexOf(delim, i) ; 
if (j == i ) break ; 
if (j >= 0) { 
k++ ; 
mzl [k] = mzlList . substring(i , j) ; 
i = j + delim . length() ; 
i j = k = 0; 
while (j >= 0 ) { // To initiale rtl list 
j = rtlList.indexOf(delim , i ); 
if (j == i ) break ; 
if (j >= 0) { 
k++ ; 
rtl [k] = rtlList . substring(i , j) ; 
i = j + delim . length() ; 
i j = k = 0; 
while (j >= 0) T initiate mz- ~ist 
j = mz2List . index0f(delim , i) ; 
if ( j == i ) break ; 
if ( j >= 0 ) { 
k++ ; 
mz2 [k] = mz2List . substring(i , j) ; 
i = j + delim . length(); 
i j = k = 0 ; 
while (j >= 0) To ini ia e rt2 list 
j = rt2List . index0f(delim , i ); 
if ( j == i ) break ; 
if (j >= 0 ) { 
k++ ; 
rt2 [k] = rt2List.substring(i , j) ; 
i = j + delim . length() ; 
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Il To initialize task ' s progress propPrty 
long offset = l ; 
long maxHits = mz l Lines * mz2Lines ; 
progress = 0 ; 
setProgress (O); 
progressBar . setVa l ue (O) ; 
startTime = System . currentTimeMillis (); 
Il To do in background (the peak-picking operation) 
while (progress < 100) 
for (int m = 0 ; m < mz l Lines ; m++ ) 
for (int n = 0 ; n < mz2Lines; n++ ) 
if (isDouble (mzl [m)) && 
isDouble(mz2 [n)) && 
isDouble(rtl [m)) && 
isDoubl e (rt2 [n))) { 
mz l 
mz 2 
rt l 
rt 2 
dmz 
drt 
Doubl e . valueOf (mz l [m)) ; 
Double . value0f (mz2 [n)); 
Doub l e . valueOf (rt l [m)); 
Double . value0f (rt2 [n)); 
Math.abs(mz_l - mz 2 ) ; 
Math . abs (rt l - rt 2 ) ; 
match mz dmz < upperLimit && 
dmz > lowerLimit ; 
drt < rt thr ; match rt 
if (match_mz && match rt ) 
txtResults . append (mzFormat . format (mz l) + " ( " + 
rtFormat . format (rt l) + " min) & " + 
mzFormat . format (mz_2 ) + " ( " + 
rtFormat . format (rt 2 ) + " min) \ n " ) ; 
return null ; 
hits ++ ; 
offset++ ; 
setE l apsedTime (); 
progress = (int ) (offset * lOO 1 
maxHits ); 
setProgr ess (progress ) ; 
1** Calcu late elapsed time *1 
private void setElapsedTime( ) 
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elapsedTime = (System . currentTimeMillis () - startTime ) 1 
1000 ; 
if (elapsedTime < 60) 
progressBar . setString( "Elapsed time : " + 
Math . round (elapsedTime ) + " sec " ); 
return ; 
else if (elapsedTime < 3600 ) 
progressBar . setString( "Elapsed time : " + 
Math . round (elapsedTime /60 ) + " min " ); 
return ; 
else if (elapsedTime < 86 40 0 ) 
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progressBar . setString ("Elapsed time : " + 
Math.round( elapsedTime /3600 ) + " h " + 
Math . round(( elapsedTime /3600 -
Math . round (elapsedTime /3600 )) *60 ) + " min " ); 
el se 
return ; 
progressBar . setString( " Elapsed time : " + 
Math.round( elapsedTime /86400 ) + " d " + 
Math . round (( elapsedTime /86400 -
Math . round( elapsedTime /86400 ) )*24) + " h " + 
Math . round (( elapsedTime /3600 -
Math. round (elapsedTime /3600 )) *60 ) + " min " ); 
return ; 
/** While task is completed */ 
@Override 
public void done () 
Toolkit . getDefaultToolkit () . beep (); 
btnSearch . setEnabled( true ); 
setCursor (null ); 
lblSearching . se tText( hits + " peak pair(s) found ! " ); 
private boolean isDouble(String input) 
try { Double . parseDouble (input ); } 
catch (NumberFormatExceptio n e ) { return false ; } 
return true ; 
/** Launch the application */ 
public static void main(String[) args) 
SwingUt ilit ies .invokeLater (new Runnable() 
public void run() { 
try { 
frmPeakPicker frame = new frmPeakPicker (); 
frame . setVisibl e (true ); 
} ) ; 
catch (Exception e) 
e.printStackTrace () ; 
/** Create the frame */ 
public frmPeakPicker() 
setResizable( false ) ; 
setTitle( " Peak Picker " ) ; 
setDefaultCloseOperation(JFrame . DISPOSE_ON_CLOSE) ; 
setBounds (1 00 , 100 , 930 , 404) ; 
pnlMain = new JPanel( ); 
pnlMain . setBorder( new EmptyBorder(5 , 5 , 5 , 5) ) ; 
setContentPane( pnlMain ) ; 
pnlMain . setLayout(null ) ; 
JPanel pn1List1 = new JPanel () ; 
pnlList1 . setBorder (new BevelBorder(BevelBorder . LOWERED, 
null , null , null , null )); 
pnlList1 . setBounds (1 0 , 32 , 292 , 271 ); 
pnlMain . add (pnlList1) ; 
pnlList1 . setLayout( null ) ; 
txtList1 = new JTextArea() ; 
txtList1 . setBounds (1 0 , 32 , 130 , 226) ; 
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JScrollPane scrol1List1 = new JScrollPane (txtList1 ) ; 
scrollList1.setBounds (10 , 32 , 130 , 226) ; 
scrollList1 . setVerticalScrollBarPolicy(ScrollPaneConstants . 
VERTICAL_ SCROLLBAR_ALWAYS ) ; 
pnlList1 . add(scrollList1) ; 
txtRT1 = new JTextArea () ; 
tx RT1 . setBounds(150 , 32 , 130 , 226) ; 
JScro1 1Pane scrol l RT1 = new JScrollPane ( txtRT1 ) ; 
scrollRT1 . setBounds (150 , 32 , 130 , 226) ; 
scrol lRT 1 . setVerticalScrollBarPolicy(ScrollPaneConstants . 
VERTICAL_ SCROLLBAR_ALWAYS ) ; 
p nlList1 . add (scrollRT1); 
JLabe l l b1Lis1 = new JLabel( " Peak List 1 (control) :" ); 
lblLisl.setBounds(10 , 10 , 147 , 14) ; 
pnlMain . add(lblLis1 ) ; 
JLabel lblMZ1 = new JLabel( "m/z :" ); 
lblMZ1.setBounds(10 , 11 , 147 , 14) ; 
pnlList1 . add(lblMZ1 ); 
JLabe1 lblRT1 = new JLabel( "Retention time (min) :" ); 
lblRT1 . setBounds(150 , 11 , 147 , 14) ; 
--------
pnlList1 . add(lb lRT1); 
JPanel pn1List2 = new JPane l() ; 
pnlList2 . setLayout( null ) ; 
p nlList2 . setBorder (new BevelBorder (BevelBorder . LOWERED, 
null , null , null , null )) ; 
p n lList2 . setBounds (312 , 32 , 292 , 271 ); 
pnlMain . add (pn l Li st2 ) ; 
txtList2 = new J TextAr ea () ; 
txtList2 . setBounds (1 0 , 32 , 1 30 , 226 ) ; 
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JScrollPane scrol1List2 = new JScrollPane (txtList2 ) ; 
scrollList2 . setBounds (1 0 , 32 , 130 , 226 ) ; 
scrollList2 . setVerticalScrollBarPolicy (ScrollPa n eConstants . 
VERTICAL_SCROLLBAR_ALWAYS ) ; 
pnlList2 . add (scrollList2 ) ; 
txtRT2 = new JTextArea () ; 
txtRT2 . setBounds (1 50 , 32 , 130 , 226) ; 
JScrollPane scro llRT2 = new JScrollPane (txtRT2 ); 
scrol l RT2 . setBounds (1 50 , 32 , 130 , 226 ) ; 
scrol lRT2 . setVerticalScrol lBarPo l icy (Scrol lPaneConstants . 
VERTICAL_SCROLLBAR_ALWAYS ); 
pnlList2 . add (scrollRT2 ) ; 
JLabe l l b 1List2 = new JLabel (" Peak List 2 (sample) : " ) ; 
lblList2.setBounds(312 , 10 , 147 , 14) ; 
pnlMain . add (lb l List2) ; 
JLabe l l b lMZ2 = new JLabe l( "m/z :" ); 
lblMZ2 . setBounds (10, 11 , 147 , 14) ; 
pnlList2 . add (lblMZ2 ) ; 
JLabe l l b lRT2 = new JLabe l ( "Retention time (min) :" ); 
1blRT2 . setBounds (1 50 , 11 , 14 7 , 14) ; 
pnlList2 . add (lblRT2 ); 
JPanel pnlResults = new JPanel (); 
pnlResult s . setLayout(null ); 
pn lResult s . setBorder (new BevelBorder(BevelBorder. LOWERED, 
null , null , null , null )); 
p nlResult s . setBounds(612 , 32 , 302 , 27 1) ; 
pnlMain . a dd( pn lResults); 
txtResults = new JTextArea () ; 
txtResults . setEditable( false ); 
txtResults . setBounds(286 , 32 , 1 28 , 222) ; 
JScro1 1Pane scrollResults = new JScrol lPane (txtResults ) ; 
scro llResults . setBounds(10 , 32 , 282 , 226 ) ; 
scro llResults . setVertical ScrollBarPolicy( 
ScrollPaneConstants . VERTICAL SCROLLBAR ALWAYS ) ; 
pnlResu l ts . add(s cro llResults ) ; 
JLabel l blPeakPairs = new JLabel (" Peak pairs: " ) ; 
lblPeakPairs . setBou nds(1 0 , 11 , 147 , 14) ; 
pnlResu1ts . add (lblPeakPairs ); 
txtDeltamass = new JTextField () ; 
txtDeltamass . setColumns(10 ); 
txtDeltamass . setBounds(106 , 3 1 6 , 90 , 20 ) ; 
pnlMain . add (txtDeltamass ) ; 
txtErrorThreshold = new JTextField () ; 
txtErrorThreshold . setText( " lO " ) ; 
txtErrorThreshold . setColumns(10) ; 
txtErrorThreshold . setBounds(347 , 31 6 , 52 , 20 ) ; 
pnlMain . add (txtErrorThreshold ) ; 
btnSearch = new JButton( " Search " ) ; 
btnSearch . addActionListener( this ) ; 
txtRTWidth = new JTextField (); 
txtRTWidth . setTex t ( " 0 . 5 " ) ; 
txtRTWidth .setColumns(10) ; 
txtRTWidth . setBounds (55 2 , 31 6 , 52 , 20 ) ; 
pnlMain . add( txtRTWidth ) ; 
btnSearch . setBounds(809 , 315 , 10 5 , 23 ) ; 
pnlMain . add( btnSearch ) ; 
progressBar = new J ProgressBar( ) ; 
progressBar . setStri ngPainted (true ) ; 
progressBar . setSt ring( "" ) ; 
progressBar . setBounds (1 0 , 3 47 , 904 , 16) ; 
pnlMain . add (progressBar ) ; 
lblSearching = new JLabe l( "" ) ; 
lblSearching . setBounds( 622 , 319 , 248 , 14) ; 
pnlMain . add (lblSearching ) ; 
JLabel lblDeltamass = new JLabel( " Delta mass (Da): " ) ; 
lblDeltamass . setBounds( 10 , 31 9 , 128 , 14); 
pnlMain . add (lb l De ltamass ); 
JLabel lblErrorThreshold = new JLabel (" Error threshold 
(ppm) : " ) ; 
l blErrorThreshold . setBound s (220 , 319 , 128 , 14); 
pnlMain . add (lb lErrorThreshold) ; 
JLabel lblRTWidth = new JLabel ( " RT width (min) 
lblRTWidth.setBounds(444 , 31 9 , 128 , 14) ; 
pnlMain . add (lblRTWidth) ; 
JLabe l lblResu lt s = new JLabel ( "Results :" ); 
+/- " ); 
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lblResults . setBounds(612 , 10 , 147 , 14); 
pnlMain . add (lblResults) ; 
/** When an action is performed */ 
public void actionPerformed(ActionEvent evt ) 
reset() ; 
task = new Task () ; 
task . addPropertyCh a ngeListener (this ) ; 
task . execute( ); 
/** When task ' s progress property changes */ 
public void proper t yChange (PropertyChangeEvent evt ) 
if ( "progress " == evt . getPropertyName() ) { 
int progress = (Integer) evt . getNewValue(); 
progressBar . setVa l ue (progress) ; 
lblSearching . setText(String . format( 
" Searching ... %d %% \n " , task . getProgress ())); 
private void reset() 
txtResults . setText ( "" ); 
lblSearching . setText ("" ); 
progressBar . setString ( "" ); 
btnSearch . setEnabled( false ); 
se t Cursor(Cursor . getPredefinedCursor(Cursor . WAIT_ CURSOR )) ; 
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